<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-HEADER AEXT-CLASS="Y">
<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20210122">4.2</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="01136597">주식회사 마더스제약</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">164811-0060785</EXTRACTION>
</SUMMARY>
</DOCUMENT-HEADER>

<BODY>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 정정문서 작성시 『정오표』 삽입</COMMENT>
<LIBRARYLIST>정정신고(보고)-대표이사등의확인.LCommon</LIBRARYLIST>
</INSERTION>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P USERMARK="F-11">&cr;&cr;&cr;</P>
<P USERMARK="F-11">                                    (제 10기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20200101">2020년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-11"></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2021년   03   월  25  일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="3">증권 모집ㆍ매출법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">주식회사 마더스제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">김   좌    진</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="30">서울 동작구 보라매로5길 51  롯데타워501호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화)02-6958-8620</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>

<TD WIDTH="400" HEIGHT="30">
<SPAN>(홈페이지) </SPAN>
<SPAN>http://www.mtspharm.co.kr</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 이  사       (성  명) 전  환  숙</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 02-6958-8620</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TOC>
<TITLE ATOC="N">목     차</TITLE>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</TOC>

<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>
<P USERMARK="F-GL11">&cr;</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="588" ALIGN="CENTER" HSPACE="0">대표이사등의확인서명.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사등의확인서명</IMG-CAPTION>
</IMAGE>
<P USERMARK="F-GL11">&cr;&cr;&cr;</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『연결재무제표를작성하는주권상장법인』 삽입</COMMENT>
<LIBRARYLIST>11011#*연결재무제표를작성하는주권상장법인.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL11">가. 회사의 법적, 상업적 명칭&cr;   </SPAN>
<SPAN USERMARK="F-GL11">당사의 명칭은 "주식회사 마더스제약"라고 표기합니다. 또한 영문으로는 MOTHER'SPHA   RMACEUTICAL CO.,LTD"라고 표기합니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">나. 설립일자</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">   당사는 2011년 7월</SPAN>
<SPAN USERMARK="F-GL11"> 18일</SPAN>
<SPAN USERMARK="F-GL11">자</SPAN>
<SPAN USERMARK="F-GL11">로 설립되었습니다.&cr;&cr;다. 회사의 주소, 전화번호, 홈페이지 주소</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="468"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="477" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">본사주소</TD>
<TD WIDTH="477" VALIGN="MIDDLE" HEIGHT="30">서울특별시 동작구 보라매로5길 51 롯데타워 501호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전화번호</TD>
<TD WIDTH="477" VALIGN="MIDDLE" HEIGHT="30">02-6958-8620</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">홈페이지주소</TD>
<TD WIDTH="477" VALIGN="MIDDLE" HEIGHT="30">http://www.mtspharm.co.kr/</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;라. 중소기업 해당여부&cr;   당사는 사업보고서 제출일 현재 중소기업 및 벤처기업에 해당합니다.&cr;&cr;마. 향후 추진하려는 신규사업&cr;     당사는 사업보고서 제출일 현재 영위하고 있는 사업이외에 신규로 추진하고자&cr;     하는 사업은 없습니다.&cr;&cr;바. 신용평가에 관한 사항&cr;     당사는 사업보고서 제출일 현재 해당사항이 없어 기재를 생략합니다.&cr; &cr; 사.회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;여부</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHK">해당없음</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="SPC_DATE" AUNITVALUE="-">-</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHP">해당없음</TE>
<TE WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_LAW">해당업음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>
<P USERMARK="F-GL11">  당사의 설립이후 중요한 연혁은 다음과 같습니다&cr;&cr;가. 회사의 연혁</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="599">

<COLGROUP>
<COL WIDTH="93"></COL>
<COL WIDTH="488"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">일       자</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">     연                                 혁</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2011년 7월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">(주)마더스 설립</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="34" VALIGN="MIDDLE">2011년 11월</TD>
<TD WIDTH="497" HEIGHT="34" VALIGN="MIDDLE">업허가 변경(대표자변경-김좌진,사명변경-(주)아남제약),휴업재게 신고</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2011년 12월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">품목허가변경, 원자재준비, 시험가동 등 생산준비</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2012년 01월 </TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">의약품 정상 생산준비</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2012년 03월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">사명변경 (주)아남제약 --> (주)마더스제약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2012년 03월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">벤처기업확인 (기술보증기금)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2012년 09월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">발효홍삼 제조방법 특허출원 (10-2012-0030142)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2012년 12월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 8억 ( 3.5억원 --- 11.5억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2013년 06월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">연구전담개발부서 인증 ( 한국산업기술진흥협회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2014년 02월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">첨단의료복합단지 연구개발지원사업 ( 2013.09.23.-2016.09.22.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2014년 04월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">전문의약품 영업부 조직</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2014년 11월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">자본금 증자 8억5천 ( 11.5억원 --> 20억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2015년 02월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">벤처기업연장 (기술보증기금 15.11.11- 16.11.10)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2015년 05월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">마더스제약 기업부설연구소 설립 (한국산업기술진흥협회)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2015년 09월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">INNOBIZ(기술혁신형중소기업 인증) - 인증일 : 2015.05.21. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2015년 10월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">경산공장 여유부지를 이용한 증축완료 (3층) (756.02㎡)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2016년 01월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">병역특례지정업체 (산업기능요원지정업체 선정 인증일 15.11.23)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2016년 10월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">중소기업진흥공단 정책자금 (신성장기반 5억원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2016년 11월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">신약개발연구소 설립 (연구인원 8명)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2016년 12월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">관절용 지황파스 제조방법 특허등록 ( 제10-1690927호 )</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2017년06월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">중소기업청 연구마을 사업 (2017.6.1.-2019.5.31.)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2017년09월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">본사 구입 (서울 동작구 보라매로 5길 51번 롯데타워 5층,6층구입)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2018년01월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">경산공장 관리동 증축완료 (지하-4층) (1,335.75㎡)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2018년03월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">본사 이전 (동작구 롯데타워 501호 )</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2018년 10월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">익산시 삼기면 오룡리 1252번지 산업시설용지 38,361.1㎡ 구입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2020년 09월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">익산공장 착공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2020년 09월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">제3자배정 유상증자 (투자금 8,463백만원 )</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2020년11월 </TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">국가생산성대상 종합대상  대통령상 수상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="102" HEIGHT="30" VALIGN="MIDDLE">2020년10월</TD>
<TD WIDTH="497" HEIGHT="30" VALIGN="MIDDLE">무상증자 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;나. 회사의 본점소재지 및 그 변경&cr;  </SPAN>
<SPAN USERMARK="F-GL11">당사의 본점은 서울특별시 동작구 보라매로5길 51 롯데타워 501호에 위치하고 있으며, 2017년 중 서울 금천구 가산디지털2로 98 롯데it캐슬 1동 305호에서 서울특별시동작구 보라매로5길 51 롯데타워 501호로 이전하였습니다.  &cr;&cr;다. 경영진의 중요한 변동</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="300" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일자</TH>
<TH WIDTH="300" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.6.22</TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 기타비상무이사(송현순) 취임</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;라. 최대주주의 변동&cr;   당사는 사업보고서 제출일 현재까지 최대주주의 변경사항은 없습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">마. 상호의 변경&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 설립 후</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11"> 사</SPAN>
<SPAN USERMARK="F-GL11">업보고</SPAN>
<SPAN USERMARK="F-GL11">서  제출일 현재까지 상호의 변경사항은 다음과 같습니다</SPAN>
<SPAN USERMARK="F-GL11 0X0000FF">.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="622" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="167"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="176" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="105" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일자</TH>
<TH WIDTH="341" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30">주식회사 아남제약</TD>
<TD WIDTH="105" HEIGHT="30">2011.09.07</TD>
<TD WIDTH="341" HEIGHT="30">(주)마더스에서 (주)아남제약으로 상호 변경</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30">주식회사 마더스제약</TD>
<TD WIDTH="105" HEIGHT="30">2011.12.16</TD>
<TD WIDTH="341" HEIGHT="30">(주)아남제약에서 (주)마더스제약으로 상호 변경</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;바. 회사가 화의, 회사정리절차 그 밖에 이에 준하는 절차를 밟은 적이 있거나 현재&cr;진행중인 경우 그 내용과 결과&cr;   당사는 </SPAN>
<SPAN USERMARK="F-GL11 0X0000FF"> </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 제출일 현재 해당사항 없습니다&cr;.&cr;사. 회사가 합병 등을 한 경우 그 내용&cr;  당사는 </SPAN>
<SPAN USERMARK="F-GL11 0X0000FF"> </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 작성기준일 현재  해당사항 없습니다.&cr;&cr;아. 그 밖에 경영활동과 관련된 중요한 사항의 발생내용&cr;   당사는 사업보고서 제출일 현재 해당사항 없습니다&cr;    </SPAN>
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="598" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="767" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행&cr;(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)&cr;형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="472" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당&cr;액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행&cr;(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20110720">2011년 07월 20일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">10,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">설립자본</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20110829">2011년 08월 29일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">60,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>

<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">
<SPAN>주주배정</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20120921">2012년 09월 21일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">160,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>

<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">
<SPAN>주주배정</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20140407">2014년 04월 07일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">170,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">5,000</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">주주배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20171221">2017년 12월 21일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="02">유상증자(주주배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">2,625</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">6,500</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">주주배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180605">2018년 06월 05일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="1">유상감자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">301,965</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT"> -</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">(주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20180710">2018년 07월 10일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">250,000</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">(주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20191007">2019년 10월 07일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="13">상환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">5,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">(주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="INC_DT" AUNITVALUE="20200707">2020년 07월 07일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="53" AUNIT="INC_DR_KND" AUNITVALUE="12">주식분할</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACODE="INC_CNT">905,940</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACODE="INC_SL_AMT">500</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="53">(주3)&cr;액면분할</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="INC_DT" AUNITVALUE="20200925">2020년 09월 25일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="53" AUNIT="INC_DR_KND" AUNITVALUE="04">유상증자(제3자배정)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACODE="INC_CNT">112,842</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACODE="INC_SL_AMT">75,000</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="53">(주4)&cr;제3자배정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="INC_DT" AUNITVALUE="20201023">2020년 10월 23일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="53" AUNIT="INC_DR_KND" AUNITVALUE="10">무상증자</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACODE="INC_CNT">10,074,978</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="114" HEIGHT="53">(주5)&cr;1주당 9주배정</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">주1) 2018년 6월에 모든 주주의 보유주식 75</SPAN>
<SPAN USERMARK="F-GL11">%를 </SPAN>
<SPAN USERMARK="F-GL11">균등하게</SPAN>
<SPAN USERMARK="F-GL11"> 유상감자하였습니</SPAN>
<SPAN USERMARK="F-GL11">다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">주2) 당사는 2018년 7월에 상환우선주를 발행하였으며, 2019년 10월에 전액 상환완료하였습니다. 따라서, </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 제출일 현재 미상환 된 상환우선주는 없습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">주3) 당사는 </SPAN>
<SPAN USERMARK="F-GL11">2020년 5월 24일 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">이사회를 결의를 통해</SPAN>
<SPAN USERMARK="F-GL11"> 보</SPAN>
<SPAN USERMARK="F-GL11">통주 1주의 액면금액을 5,000원에서 500원으로 하는 주식의 액면분할을 결의하였으며, 2020년 5월 24일 임시주주총회에서 승인 가결되었습니다. 이에 따라 1주의 액면가액은 5,000원에서 500원으로, 발행주식총수는 100,660주에서 1,006,600주로 905,940주가 증가되었습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11"> 주</SPAN>
<SPAN USERMARK="F-GL11">4) 2020년</SPAN>
<SPAN USERMARK="F-GL11">9월</SPAN>
<SPAN USERMARK="F-GL11">에 제3자배정</SPAN>
<SPAN USERMARK="F-GL11">유상증자를 하였고 112,842주 배정 되었습니다&cr; &cr;</SPAN>
<SPAN USERMARK="F-GL11">주5) 2020년 10월05일에 이사회에서  1주당 신주 9주 배정으로 의결하여  무상증자  를 시행 하였습니다  &cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환사채 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환사채발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 신주인수권부사채 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환신주인수권부사채등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환형 조건부자본증권 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환형조건부자본증권등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">주식의 총수 현황</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">우선주</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">100,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">0</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK1">100,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">11,496,385</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK2">11,500,385</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">301,965</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RST">305,965</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">301,965</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RDC_CNT">301,965</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">유상감자</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">4,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RFD_CNT">4,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ETC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">11,194,420</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK3">11,194,420</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_TRS_STK">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">11,194,420</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_FLT_STK">11,194,420</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11"> 주)  1. 주식의 총수 현황은 주식분할로 인한 주식수의 변경을 반영한 수치입니다&cr;      당사는 2020년 7월4일을 효력발생으로 보통주(각1주당 액면가5,000원)를                      ( 1주당 액면가 500원)로 분할하였습니다&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『자기주식 취득 및 처분 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*자기주식취득및처분현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">5_자기주식취득및처분현황</FILENAME>
<P USERMARK="F-GL11">자기주식 취득 및 처분 현황</P>

<TABLE-GROUP ACLASS="OWN_SHR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="766" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="377"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="148" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="386" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="767" BORDER="1">

<COLGROUP>
<COL WIDTH="53"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="57"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2" COLSPAN="3">취득방법</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기초수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="219" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">변동 수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기말수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취득(+)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">처분(-)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소각(-)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="14" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="420" AUPDATECONT="N">배당&cr;가능&cr;이익&cr;범위&cr;이내&cr;취득</TD>
<TD ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="240" AUPDATECONT="N">직접&cr;취득</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">장내 &cr;직접 취득</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AJ_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AJ_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AJ_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AJ_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AJ_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AJ_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AJ_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AJ_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AJ_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AJ_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AJ_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AJ_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">장외&cr;직접 취득</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AO_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AO_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AO_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AO_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AO_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AO_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AO_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AO_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AO_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AO_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AO_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AO_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE9">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">공개매수</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AK_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AK_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AK_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AK_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AK_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AK_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="AK_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="AK_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="AK_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="AK_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="AK_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="AK_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">소계(a)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ASUM_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ASUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ASUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ASUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="ASUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="ASUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ASUM_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ASUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ASUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ASUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="ASUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="ASUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="58" HEIGHT="180" AUPDATECONT="N">신탁&cr;계약에 의한&cr;취득</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">수탁자 보유물량</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BS_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BS_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BS_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BS_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BS_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BS_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BS_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BS_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BS_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BS_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BS_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BS_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">현물보유물량</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BH_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BH_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BH_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BH_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BH_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BH_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BH_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BH_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BH_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BH_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BH_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BH_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">소계(b)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BSUM_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BSUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BSUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BSUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BSUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BSUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE6">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="BSUM_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="BSUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="BSUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="BSUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="BSUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="BSUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="60" AUPDATECONT="N" COLSPAN="3">기타 취득(c)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ETC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ETC_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="ETC_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="ETC_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE7">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ETC_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="ETC_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="ETC_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="ETC_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="ETC_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="ETC_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="60" AUPDATECONT="N" COLSPAN="3">총 계(a+b+c)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="TOT_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="TOT_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="TOT_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="TOT_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE8">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="TOT_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="TOT_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="73" HEIGHT="30" ACODE="TOT_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACODE="TOT_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="72" HEIGHT="30" ACODE="TOT_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACODE="TOT_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACODE="OWN_NOTE8">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11">  당사는 사업보고서 제출일 현재 해당사항 없습니다</P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"> </P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『종류주식(명칭) 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*종류주식발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 의결권 현황</TITLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="62" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="ISU_STK">11,194,420</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="32" ACODE="ISU_STK_KND">상환전환우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="32" ACODE="ISU_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="32" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK_KND">소계</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="ISN_STK">11,194,420</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="65" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISQ_STK_KND">상환전환우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="35" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="35" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="64" AUPDATECONT="N">기타 법률에 의하여&cr;의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="34" ACODE="ISJ_STK_KND">상환전환우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="34" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="34" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="66" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="36" ACODE="ISB_STK_KND">상환전환우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="36" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="36" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="108" AUPDATECONT="N">의결권을 행사할 수 있는 주식수&cr;(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="35" ACODE="ISH_STK_KND">상환전환우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="35" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="35" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="30" ACODE="ISH_STK">11,194,420</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="43" ACODE="ISH_STK_KND">상환전환우선주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="43" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="43" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-6-0">6. 배당에 관한 사항 등</TITLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">주요배당지표                                                                </P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="607" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제10기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제09기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제08기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">5,000</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">5,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">-898</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">2,793 </TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">1,467</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">505</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="274" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">95.5</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">4,775</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="161" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="111" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『과거배당이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*과거배당이력.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-7-0">7. 정관에 관한 사항</TITLE>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『정관변경이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*정관변경이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">49_정관변경이력</FILENAME>
<P USERMARK="F-GL11">정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="169" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="150" HEIGHT="30" AUNIT="ART_DATE" AUNITVALUE="20200318" VALIGN="MIDDLE">2020년 03월 18일</TU>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="ART_NAME" VALIGN="MIDDLE">정기주주총회</TE>
<TE ALIGN="CENTER" WIDTH="169" HEIGHT="30" ACODE="ART_CHN" VALIGN="MIDDLE">임원 복지 변경</TE>
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="30" ACODE="ART_RSN" VALIGN="MIDDLE">지급기준의 현실화</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="150" HEIGHT="59" AUNIT="ART_DATE" AUNITVALUE="20200524" VALIGN="MIDDLE">2020년 05월 24일</TU>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="59" ACODE="ART_NAME" VALIGN="MIDDLE">임시주주총회</TE>
<TE ALIGN="CENTER" WIDTH="169" HEIGHT="59" ACODE="ART_CHN" VALIGN="MIDDLE">주식양도제한규정및 제3자배정 유상증자 안</TE>
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="59" ACODE="ART_RSN" VALIGN="MIDDLE">규정삭제 및 유상증자 관련 사항</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="150" HEIGHT="35" AUNIT="ART_DATE" AUNITVALUE="20200812" VALIGN="MIDDLE">2020년 08월 12일</TU>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="35" ACODE="ART_NAME" VALIGN="MIDDLE">임시주주총회</TE>
<TE ALIGN="CENTER" WIDTH="169" HEIGHT="35" ACODE="ART_CHN" VALIGN="MIDDLE">전자증권 도입</TE>
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="35" ACODE="ART_RSN" VALIGN="MIDDLE">제도 도입 변경안</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P USERMARK="F-16 0XFF0000 B">1. 사업의 개요</P>

<P>&cr;가. 산업의 개요&cr;제약 산업은 기술집약적이며 고부가가치 산업이라는 특성과 건강 및 삶의 질 향상을 목적으로 하는 국민보건산업으로 21세기 고도 성장이 기대되는 산업이며 신약개발 연구에서부터 의약품의 생산과 판매 등 모든 과정을 포괄하고 있습니다. 의약품은 크게 원료의약품과 완제의약품 중 완제의약품으로 나눌 수 있으며, 완제의약품은 다시 전문의약품(Ethical drug: ETC)과 일반의약품(Over the counter drug: OTC)으로 나뉩니다. 전문의약품이란 제형, 약리 작용의 특성상 의사의 감독 하에 사용되어야 하는 의약품으로서 의사의 감독 하에 사용되지 않을 경우 의료상 장해를 일으킬 수 있는 적응증을 갖는 의약품을 말합니다. 마약, 향정신성 의약품, 독약, 극약 등도 전문의약품의 범주에 포함됩니다. 이러한 전문의약품 외의 의약품을 일반의약품이라고 합니다.&cr;&cr;나. 산업의 특성&cr;
<SPAN>(1) 국내제조 생산 기반을 둔 내수완제품 중심산업기존의 제약산업은 국내제조 생산 기반을 둔 내수완제품 중심이었습니다.</SPAN>
<SPAN> </SPAN>
<SPAN>한국제약바이오협회에 따르면 2019년 완제의약품 생산실적은 19.7조원, 원료의약품 생산실적은 2.3조원으로 완제의약품 비중이 83%에 달합니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>(2) 엄격한 국가 규제를 따르는 산업&cr;제약산업은 인간의 생명과 보건에 관련된 제품을 생산하는 국민의 건강과 직결된 산업으로서 제품의 개발에서 임상시험, 인·허가 및 제조, 유통, 판매 등 전 과정을 통제하며, 판매 이후의 제품의 안정성까지 세심한 품질관리를 하고 있어 시행규칙과 관계법령들이 엄격합니다. 글로벌 경쟁력을 갖추기 위해 의약품 생산, 품질, 시설 강화를 위한 PIC/s(의약품상호실사 협력기구)와 제네릭 생물학적동등성시험 결과 보고서(CTD: 국제공통기술문서)를 작성해야만 하는 ICH (국제의약품규제조화위원회) 가입으로 제조품질관리에 대한 인적·물적 자원의지속적 투자를 진행해야만 합니다.&cr;&cr;
<SPAN>(3) 기술집약도가 높은 산업&cr;</SPAN>
<SPAN></SPAN>
<SPAN>제약산업은 신약개발을 위한 연구에서부터 원료 및 완제의약품의 생산과 판매 등 모든 과정을 포괄하는 첨단 부가가치산업으로 기술집약도가 높으</SPAN>
<SPAN>며</SPAN>
<SPAN></SPAN>
<SPAN>, 특허기술을 통한 독</SPAN>
<SPAN>점적 지위를 누릴 수 있는 산업입니다. </SPAN>
<SPAN>2019년 기준 산업별 부가가치 창출지표에 따르면 전 산업 평균 부가가치율은 21.05%인데 반해, 제약산업은 30.13%를 기록한 고부가가치산업입니다. &cr;</SPAN>
<SPAN USERMARK=" 0X59BB9B"></SPAN>&cr;
</P>

<P>(4) 안정적인 성장을 하고 있는 산업&cr;의약품가격은 비탄력적인 특성을 갖습니다. 의약품의 경우 생명 및 건강과 직접적인 관련이 있어 가격이 높아지더라도 비용을 지불하고 구매하려는 속성을 가지고 있습니다. 일반의약품의 경우 경기변동이나 계절적인 요인의 영향을 다소 받기는 하나, 전문의약품의 경우 의약품 특성상 안정적인 성장을 하고 있습니다. 따라서 타 산업에비해 경기변동에 큰 영향을 받지 않는다고 할 수 있습니다.&cr;&cr;                         
<SPAN USERMARK=" 0XBD814F">  </SPAN>
<SPAN USERMARK=" 0XFF1200">    </SPAN>
<SPAN> </SPAN>
<SPAN>  </SPAN>
<SPAN>  [국내 의약품 생산금액 및 증감률]</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="628" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="5" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="628" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위 : 십억원, %)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="252" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일반의약품</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="250" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전문의약품</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">생산금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감률</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">생산금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감률</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="30">2015</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">2,480</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">0.80</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">12,142</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">4.10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="30">2016</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">2,719</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">9.60</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">13,294</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">9.50</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="30">2017</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">2,936</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">7.98</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">14,274</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">7.37</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="30">2018</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">2,976</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">1.36</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">15,190</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">6.42</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="30">2019</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">3,216</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">8.06</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">16,232</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">6.86</TD>
</TR>
</TBODY>
</TABLE>
<P>(출처 : 한국제약바이오협회)</P>

<P>
<SPAN>&cr;</SPAN>다. 산업의 성장성&cr;(1) 글로벌 제약시장&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>인구 고령화와 건강에 대한 관심 증가로 전세계 제약시장은 2017년 약 1.2조 달러 규모에서 2022년 약 1.5조 달러 규모로 매년 3~6% 성장할 것으로 예상됩니다. </SPAN>
<SPAN>특히, 전통적 제약강국인 유럽 및 일본 의약품시장의 성장은 정체되는 반면 중국, 브라질, 러시아, 인도 등 신흥시장은 경제성장, 의료접근성 개선, 의약품 수요증가 등의 요인으로 향후 높은 성장을 지속하며 세계 의약품시장 성장을 견인할 것으로 예상되고 있습니다. </SPAN>
<SPAN></SPAN>
<SPAN>우리나라의 제약시장 역시 연구개발 성과와 정부의 제2차 제약산업 육성계획을 바탕으로 2017년 13.7억 달러에서 2022년 15~19억 달러로 3~6%의 성장세를 이어갈 것으로 예상됩니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<P>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(2) 국내 제약시장&cr;</SPAN>
<SPAN></SPAN>
<SPAN>국내 의약품시장은 인구 고령화와 만성질환의 증가가 진행되면서 양적, 질적으로 빠르게 성장하였습니다.</SPAN>
<SPAN> </SPAN>
<SPAN>국내 의약품 생산액은 2019년 기준 약 22조원으로 전년대비 5.7% 증가하였고, 수출액은 6조원으로 전년대비 17.8%, 수입액은 8조원으로 전년대비 12.6% 증가하였습니다. 전체 시장규모는 24.3조원으로 최근 5년 연평균 성장률은 4.8%입니다.&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN USERMARK=" 0X59BB9B">                        </SPAN>
<SPAN USERMARK=" 0X1814FF">          </SPAN>
<SPAN USERMARK=" 0XFF1200"> </SPAN>
<SPAN>   </SPAN>
<SPAN>  [국내 의약품 시장규모 현황]</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="505" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="505" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 억원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2017</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2018</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">생산</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">203,580</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">211,054</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">223,132</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">수출</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">46,025</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">51,431</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">60,581</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">수입</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">63,077</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">71,552</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">80,549</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">무역수지</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">-17,052</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">-20,121</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">-19,968</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">시장규모</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">220,633</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30">231,175</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">243,100</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>(출처 : 식품의약품안전처, 의약품 생산실적 및 수입실적 통계자료, 2019)&cr;</SPAN>
<SPAN></SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>2019년 건강보험통계연보에 따르면 2014년 이후 65세 이상 진료비 증가율은 10%를넘어섰고, 지속적인 노령인구의 증가로 노인진료에 대한 시장규모도 매해 커지고 있습니다.</SPAN>
<SPAN> </SPAN>
<SPAN>현 대한민국은 다른 연령에 비해 60세부터 요양급여 비용의 증감률이 매우 높아지고 있습니다. 연령과 의료비의 밀접한 상관성 및 개인 생애의료비 지출의 절반이상이 65세 이후 지출되는 양상을 볼 때, 기대수명의 신장 및 고령층의 증가에 따라 의료비는 급증할 것으로 전망됩니다.&cr;&cr;이에 따라 향후 국내 의약품시장은 경제수준 향상에 따른 의료 서비스의 기대치 상승과 급속한 인구 고령화에 따라 점진적으로 성장 추세가 이어질 것으로 보여집니다. </SPAN>
<SPAN>지금까지 다양한 마케팅에 의해 제약사들의 성장이 지속되어 왔으나, 약가인하와 리베이트 규제 정책, </SPAN>
<SPAN>특허 만료 제품에 대한 치열한 제네릭의약품 개발 경쟁</SPAN>
<SPAN> 등으로 인하여 장기적인 관점으로 보면 차별적인 임상데이터나 효능을 마케팅할 수 있는 업체, 신약 R&D </SPAN>
<SPAN>및 GMP 생산시설에 대한 지속적인 투자</SPAN>
<SPAN>, 우수 의약품의 품목 경쟁력, 글로벌 시장경쟁력, 정확한 수요예측에 따른 제네릭 의약품의 개발 등이 시장을 확대할 수 있는 핵심역량이자 핵심경쟁요소로 예측됩니다.&cr;</SPAN>
<SPAN USERMARK=" 0X59BB9B"></SPAN>&cr;                                            [연령별 요양급여비용]
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 원, %)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">요양급여비용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비율</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">0~9세</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">3,911,343,797</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">6.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">10~19</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">1,915,707,155</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">2.95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">20~29</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">2,947,191,707</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">4.54</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">30~39</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">4,743,619,421</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">7.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">40~49</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">6,506,812,357</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">10.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">50~59</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">10,637,429,626</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">16.39</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">60~69</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">13,299,814,637</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">20.50</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">70~79</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">12,392,784,756</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">19.10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">80세 이상</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">8,533,425,301</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">13.15</TD>
</TR>
</TBODY>
</TABLE>

<P>(출처 : 건강보험심사평가원 진료비 심사실적표)&cr;&cr;&cr;라. 국내외 시장여건&cr;[제네릭 시장]&cr;
<SPAN>각국의 약제비 억제정책에 따른 제네릭 의약품 사용권장과 글로벌 신약의 잇따른 만료 등으로 제네릭 의약품의 매출 비중이 증가하는 추세이며, 오리지널과 비교시 효능과 안전성 등은 동일하고 상대적으로 가격이 저렴하기 때문에 보험정책상 선호되고 있습니다. 2016년 IMS Health의 각 국가별 제네릭 의약품 처방비중 조사에 따르면 최대 제약시장인 미국의 경우 제네릭 의약품의 처방 비중이 89%에 달하는 것으로 나타났으나, 그러나 한국은 제네릭의약품의 사용 비중이 54%로 선진국 대비 낮아 추가적인 성장의 여력이 있을 것으로 판단됩니다.&cr;</SPAN>
<SPAN>&cr;</SPAN>
<SPAN></SPAN>
<SPAN>국내 제약시장의 주목할 만한 점은 중소제약사의 성장세입니다. </SPAN>
<SPAN>한국은행 기업경영분석에 따르면, 의료용 물질 및 의약품 제조 대기업의 2019년 평균 매출액은 전년대비 7.08% 성장한 반면 중소기업은 평균 9.82% 성장했습니다. 특히, 영업손익은 대기업이 전년대비 5.05% 하락한 반면 중소기업은 26.80%의 높은 성장율을 기록했습니다.&cr;</SPAN>
<SPAN USERMARK=" 0X59BB9B"></SPAN>&cr;마. 회사의 경쟁력
</P>
<P>당사는 완제의약품을 생산하는 제약회사로서 내용고형제에 대한 자체 생산 설비를 완비하고 있습니다. 특히, 고령화 및 만성질환을 대비하여 순환기계, 근골격계, 소화기계, 중추신경계 의약품을 중심으로 생산하고 있으며, 전국적인 영업망을 구축하고 있으며, 시장점유율도 높여가고 있습니다. 또한 주요 품목에 대하여 CMO사업을 병행하고 있으며, 매출액은 지속적으로 상승하고 있습니다. 특히, 생약 성분을 기반으로 한 제품의 소화기, 근골격 의약품 라인을 강화하고 있으며, 지속적으로 신제품을 출시하여 해당 분야의 핵심 제약사로 발돋움하고 있습니다.</P>
<P></P>
<P USERMARK="F-16 0XFF0000 B">2. 주요제품, 서비스 등</P>

<P>&cr;
<SPAN></SPAN>
<SPAN>가. 주요제품 등의 생산 실적 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="713">

<COLGROUP>
<COL WIDTH="87"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="68"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="713" VALIGN="MIDDLE" COLSPAN="9" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천T, 백만원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH COLSPAN="2" WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년</P>
</TH>

<TH COLSPAN="2" WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년</P>
</TH>

<TH COLSPAN="2" WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년</P>
</TH>

<TH COLSPAN="2" WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2017년</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="96" VALIGN="MIDDLE" HEIGHT="30">
<P>근골격계</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   44,839 </TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  6,812 </TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>33,569</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>5,302</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>28,134</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,384</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>18,648</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,485</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="96" VALIGN="MIDDLE" HEIGHT="30">
<P>기타용제</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 17,376 </TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  5,039 </TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>18,769</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,697</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,848</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,209</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>8,272</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,517</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="96" VALIGN="MIDDLE" HEIGHT="30">
<P>비만용제</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,844 </TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   6,312 </TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>27,269</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7,728</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>29,345</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,389</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>31,998</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,901</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="96" VALIGN="MIDDLE" HEIGHT="30">
<P>소화기용제</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 43,774 </TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  6,172 </TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>43,734</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,567</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>38,034</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,313</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>57,987</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7,780</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="96" VALIGN="MIDDLE" HEIGHT="30">
<P>순환기용제 </P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,608 </TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    6,401 </TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>14,807</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,948</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>10,741</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,578</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7,642</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,588</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="96" VALIGN="MIDDLE" HEIGHT="30">
<P>항생제</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 7,662 </TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  5,450 </TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,324</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,402</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>5,290</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,555</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,024</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,333</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 주요제품등의 가격 변동 추이</P>
<P>(1) 가격 변동 추이</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="718">

<COLGROUP>
<COL WIDTH="94"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="718" VALIGN="MIDDLE" COLSPAN="6" ALIGN="RIGHT" HEIGHT="30" USERMARK=" BC0XD7D7D7"> 단위: 원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="103" HEIGHT="30" USERMARK=" BC0XD7D7D7">구분</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30" USERMARK=" BC0XD7D7D7">제품명</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">2020년</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">2019년</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">2018년</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">2017년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="103" HEIGHT="150" USERMARK=" BC0XD7D7D7">근골격계</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">레이본정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           220 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           220 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           220 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           244 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">아페락정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           180 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           180 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           180 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           180 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">락소펜엠정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           125 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           125 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           125 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           125 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">알티스정480mg </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           832 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           832</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">　-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">-　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">에페릴엠정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           113 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           113 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           113 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           113 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="103" HEIGHT="150" USERMARK=" BC0XD7D7D7">기타용제</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">도네펜정5mg </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         2,060 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         2,060 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         2,060 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         2,060 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">메모릴엠정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           523 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           523 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           523 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">              - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">에나틴정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           457 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           457 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           457 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           457 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">모베타스프레이</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">        10,692 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">        10,692 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">        10,692 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">              - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">렘피드캡슐</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           196 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           196 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           196 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           196 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="103" HEIGHT="150" USERMARK=" BC0XD7D7D7">비만용제</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">아트민정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           770 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           770 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           770 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           770 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">토파원정25mg</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           396 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           396 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           396 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           396 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">제로팻캡슐120mg </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           950 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           950 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           950 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           950 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">엠피온정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           300 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           300 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           300 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           300 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">유메이드정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           220 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           220 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           220 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           220 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="103" HEIGHT="150" USERMARK=" BC0XD7D7D7">소화기용제</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">니자딘엠캡슐</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           356 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           356 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           356 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           356 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">스토엠정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           124 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           124 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           124 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           124 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">에스오피엠정20mg</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           764 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           764 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           764 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           764 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">마더스염산이토프리드정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           108 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           108 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           108 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           108 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">디펜티딘정10mg</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           155 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           155 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">              - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">              - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="103" HEIGHT="150" USERMARK=" BC0XD7D7D7"> 순환기용제 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">아토틴엠정10mg</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           647 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           647 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           647 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           647 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">클피도엠정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,164 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,164 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,164 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,164 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">비니스틴캡슐</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           276 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           276 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           276 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           276 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">사포그릴엠SR정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,050 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,050 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">              - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">              - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">칼디나제정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           209 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           209 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           209 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           209 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="103" HEIGHT="150" USERMARK=" BC0XD7D7D7">항생제</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">세클엠캡슐</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           438 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           438 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           438 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">           438 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">디트라정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,268 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,268 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,268 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,268 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">넬케어네일라카</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">        23,190 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">        23,190 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">        23,190 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">        23,190 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">더이트라정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,268 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,268 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,268 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,268 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="183" HEIGHT="30">푸나졸엠캡슐</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,784 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,784 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,784 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="108" HEIGHT="30">         1,784 </TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 가격 변동 원인</P>
<P>의약품은 요양급여의 기준에 관한 규칙에 의거하여 약가가 결정됩니다 . 이외에 약제의 결정 및조정기준에 조정은 다음과 같습니다</P>
<P>1) 사용량 - 연동 협상에 따른 약제 상한금액 조정</P>
<P>2) 사용범위 확대에 따른 약제 상한 금액 조정</P>
<P>3) 실거래가 조사에 따른 약제 상한 금액 조정</P>
<P>4) 제네릭 출시로 약가 가산 종료등</P>
<P> </P>
<P>정부의 약가 정책에 따라 연동하여 변동될 수 있습니다. </P>
<P></P>
<P USERMARK="F-16 0XFF0000 B">3. 주요 원재료에 관한 사항&cr;</P>
<P>가. 주요 매입현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="716">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="716" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="34" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매입유형</P>
</TH>

<TH WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2020년</P>
</TH>

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년</P>
</TH>

<TH WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2017년</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="16" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="534">
<P>원재료</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당귀</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   3,699,579 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,374,803</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,609,925</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,593,600</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>애엽</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,592,925 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,341,250</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>710,283</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>814,900</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>콘드로이친&cr;(Sinchuan)</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">    503,500 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>614,675</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>905,200</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>700,050</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>철단백추출물</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33"> 902,030 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>835,650</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>719,900</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>694,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>약용효모</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    393,360 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>447,000</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>401,000</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>264,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">약용효모</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 181,421 </TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>케라틴</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     423,450 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>339,625</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>280,885</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>223,905</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>티아민질산염</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   232,100 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>77,200</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>117,000</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>33,080</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>에르도스테인</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">  275,500 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>301,600</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>399,475</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>264,625</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>알티옥트산트로메타민염</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  572,780 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,018,700</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>874,000</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>86,500</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>트리메부틴&cr;말레산염</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">   194,500 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>266,200</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>128,008</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>115,403</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>판크레아틴</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 47,650 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>50,250</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>117,250</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>61,450</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="61">
<P>기타</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">   7,652,469 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>4,615,027</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>6,991,425</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>5,795,933</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수입</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    258,737 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>666,746</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>457,180</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,003,923</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="63">
<P>원재료합계</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33"> 16,489,843 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>14,281,980</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>14,254,350</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>10,647,445</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수입</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    440,157 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>666,746</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>457,180</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,003,923</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="151">
<P>포장재료</P>
</TD>

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>PE용기</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    384,887 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>321,413</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>285,929</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>215,790</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>포장호일</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  373,700 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>365,481</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>311,555</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>283,700</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>라벨 및 설명서</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 312,413 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>847,848</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>796,770</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>652,844</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,461,311 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>863,403</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>729,096</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>657,885</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>부자재합계</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31"> 2,532,311 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>2,398,145</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>2,123,350</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="31">
<P>1,810,219</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="261" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>외주가공비</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,781,882 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>11,325,933</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>10,045,581</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,587,956</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="3" WIDTH="261" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="93">
<P>합계</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  30,804,036 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>28,006,058</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>26,423,281</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>22,045,620</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수입</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 440,157 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>666,746</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>457,180</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,003,923</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="33">
<P>합계</P>
</TD>
<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33"> 31,244,193 </TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>28,672,805</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>26,880,461</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="33">
<P>23,049,543</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN>주) 외화로 적시된 금액의 환율은 물품(원료) 통관일의 관세청 고시율을 기준으로 함. (원달러 환율)&cr;</SPAN>&cr;나. 주요 원재료 등의 가격변동 추이
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="849">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="849" VALIGN="MIDDLE" COLSPAN="7" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>
<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년</P>
</TH>

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년</P>
</TH>

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2017년</P>
</TH>

<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당귀</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">105,928 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>110,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>133,548</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>140,000</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>제조원 추가 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>애엽</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  149,122 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>145,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>145,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>160,000</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>시장가격에 따른 단가변동 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>콘드로이친&cr;(Sinchuan)</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">   111,888 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>112,500</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>113,750</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>115,000</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="53">
<P>제조원 추가 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>철단백추출물</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  930,000 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>930,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>926,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>930,000</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>　</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>약용효모</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    135,561 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>149,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>150,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>150,000</P>
</TD>
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>케라틴</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      497,708 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>550,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>550,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>550,000</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>　</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>티아민질산염</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   84,708 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>74,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>90,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>61,000</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>시장가격에 따른 단가변동 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>에르도스테인</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    145,000 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>145,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>145,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>145,000</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>　</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>알티옥트산트로&cr;메타민염</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53"> 515,553 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>411,428</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>380,000</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>415,000</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="53">
<P>시장가격에 따른 단가변동 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>트리메부틴&cr;말레산염</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">    136,490 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>125,388</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>119,118</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>115,766</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="53">
<P>제조원 추가 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>판크레아틴</P>
</TD>

<TD WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    56,058 </TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>33,500</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>33,500</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>34,125</P>
</TD>

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>시장가격에 따른 단가변동 </P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-16 0XFF0000 B">4. 생산 및 생산설비에 관한 사항</P>
<P>&cr;가. 생산능력 및 생산실적</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="868">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="64"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="868" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="RIGHT" HEIGHT="30" COLSPAN="11">(단위 : 천개, 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">
<P>제형</P>
</TH>

<TH ROWSPAN="2" WIDTH="77" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">
<P>구분</P>
</TH>

<TH ROWSPAN="2" WIDTH="131" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">
<P>제품명</P>
</TH>
<TH COLSPAN="2" WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2020년</TH>

<TH COLSPAN="2" WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>2019년</P>
</TH>

<TH COLSPAN="2" WIDTH="148" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>2018년</P>
</TH>

<TH COLSPAN="2" WIDTH="147" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>2017년</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>수량</P>
</TH>

<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>금액</P>
</TH>

<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>수량</P>
</TH>

<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>금액</P>
</TH>

<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>수량</P>
</TH>

<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>금액</P>
</TH>

<TH WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>수량</P>
</TH>

<TH WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>정제</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산능력</P>
</TD>

<TD ROWSPAN="4" WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>레이본정 외</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 503,193 </TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>503,193</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>503,193</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>377,395</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산실적</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 538,570 </TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,979 </TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>443,300</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>26,242</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>356,920</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>21,537</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>297,980</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,710</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가동율</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">107%</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>88%</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0%</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>71%</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0%</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>79%</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기말재고</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  35,070 </TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     743 </TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,230</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>337</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>10,616</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>516</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7,149</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>319</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="143">
<P>캡슐제</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산능력</P>
</TD>

<TD ROWSPAN="4" WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="143">
<P>캐라시딜캡슐 외</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 172,523 </TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>172,523</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>172,523</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>172,523</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>생산실적</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53"> 122,700 </TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">  6,722 </TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>107,700</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>7,034</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>71,000</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>5,179</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>44,850</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>3,375</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가동율</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71%</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>62%</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0%</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>41%</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0%</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>26%</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기말재고</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  10,740 </TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        43 </TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,397</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>61</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,159</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>174</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>366,996</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>32</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>외주가공품목</P>
</TD>

<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기말재고</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>비니스틴캡슐 외</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">   53,613 </TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53"> 5,483 </TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>31,367</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>2,430</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>28,312</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>2,170</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>31,234</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>2,317</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(1) 생산능력의 산출근거</P>
<P>각 제형별로 생산설비 1대당 하루 생산 가능수량에 년가 평균 근무일수(24)일)와 하루 중 평균 가동시간(준비, 조립, 세척시간 감안) 비중(80%) 곱하여 산출하였습니다.</P>
<P>&cr;(2) 연간 생산능력 산출방법</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="594">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="183"></COL>
<COL WIDTH="183"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="105" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>품목</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>사업소</P>
</TH>

<TH WIDTH="192" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>가동기기</P>
</TH>

<TH WIDTH="192" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>생산능력</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>정제</P>
</TD>

<TD ROWSPAN="5" WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">
<P>경산공장</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정1호기</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>125,798,400T/년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정2호기</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>125,798,400T/년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정3호기</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>125,798,400T/년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정5호기</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>125,798,400T/년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>캡슐제</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>캡슐충전기</P>
</TD>

<TD WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>172,523,520C/년</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;나. 생산설비에 관한 사항&cr;&cr;(1) 생산설비 현황(생산동 기준)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="793">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="793" VALIGN="MIDDLE" COLSPAN="8" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>자산별</P>
</TH>

<TH ROWSPAN="2" WIDTH="225" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>소재지</P>
</TH>

<TH ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기초&cr;(2020.1월)</P>
</TH>

<TH COLSPAN="2" WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기증감</P>
</TH>

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>당기상각</P>
</TH>

<TH ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기말잔액&cr;(2020.12월)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>증감</P>
</TH>

<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>감소</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="78" VALIGN="MIDDLE" HEIGHT="180">
<P>유형자산</P>
</TD>

<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" HEIGHT="60">
<P>토지</P>
</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>경산시 생산동</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　1,691,942</P>
</TD>

<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　213,800 </P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> 1,905,742</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>익산시 삼기면오룡리 1252번지</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　-</P>
</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,842,997</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,842,997</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>건물 </P>
</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>경산시 공장동</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　4,510,479</P>
</TD>

<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　 -</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">124,156</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,386,323</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>기계장치</P>
</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>경산시 기계　</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　1,729,616</P>
</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">516,303</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">657,059</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,588,860</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>시설장치</P>
</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>경산시 설비　</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　152,193</P>
</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">399,300</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,674</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">481,819</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30">
<P>비품</P>
</TD>

<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">
<P>경산시　비품</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　223,057</P>
</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63,483</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,856</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">216,684</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="381" VALIGN="MIDDLE" HEIGHT="30">
<P>합계</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>8,307,287</P>
</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,035,883</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　-</P>
</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">920,745</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,422,425</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(2) 최근 3년간 변동 사항</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1031">

<COLGROUP>
<COL WIDTH="316"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="216"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="1031" VALIGN="MIDDLE" COLSPAN="6" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="325" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>설비자산명</P>
</TH>

<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득(처분)가액</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득(처분)일</P>
</TH>

<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득사유</P>
</TH>

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>용도</P>
</TH>

<TH WIDTH="225" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득(제조)처</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1031" VALIGN="MIDDLE" COLSPAN="6" HEIGHT="30">
<SPAN>                                                                            </SPAN>
<SPAN USERMARK=" B">   [2020년]</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">전기스팀보일러(120kw)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,900,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/01/16</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">신화이엔지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">세포실험실 실험기기</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,024,750</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/02/04</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">신약연구소  </TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">라온바이오(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">세포배양 현미경(Ts2)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/02/19</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">신약연구소 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)엔아이텍</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">Automatic Mercury Analyzer</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/04/08</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료 및 제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">시험검사기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)한국아이티에스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">T5 Excellence Titrator</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/04/22</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료 및 제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">시험검사기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">주식회사 올발란스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">시약냉장고  LCV-203GR</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,040,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/04/23</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료 및 제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">시험검사기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">뉴진테크</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">자동포장기(250kg)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">210,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/06/02</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)파마텍코리아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">ICP OES (PQ 9000) & Microwave (TOPwave)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">122,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/06/16</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료 및 제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">시험검사기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">어날리틱예나코리아 유한회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">자동계수기&실리카겔투입기</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">105,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/06/24</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)카운텍</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">수동캡슐충진기</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/10/06</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">신약연구소</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)굿윌스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">병포장라인 및 일련번호 시스템 </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">96,702,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/10/19</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">기계장치</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">주식회사 타스코 (TASCO)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">Liner for pressure vessel CX 100 made of</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,270,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/10/19</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">신약연구소</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">시험검사기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">어날리틱예나코리아 유한회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">실험대</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,700,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/11/10</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">신약연구소</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">주식회사 아이티랩산업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">CheBI, Chemi-Luminescence Imaging System</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-12-11</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">신약연구소</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">라온바이오(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">HPLC3대</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">150,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/12/15</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">신약연구소</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(유)워터스코리아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">연구소실험실셋팅기기</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,680,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020/12/16</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">신약연구소</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">주식회사 아이티랩산업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1031" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="6" ALIGN="CENTER" USERMARK=" B">[2019년]</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="53">TOOL SET FOR BLISTER&cr;(멜라엘 서방정)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">11,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019/12/30</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">주식회사 제이비엠</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">자동카톤포장기 PTP 자동공급장치</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/12/17</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">서울포장기계</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="53">건식과립기</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">62,000,907</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019/11/26</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">신약연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">수입(건식과립기_롤러콤팩터)&cr;_YENCHEN</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="53">건식과립기</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">269,612,522</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019/11/26</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">수입(건식과립기_롤러콤팩터)&cr;_YENCHEN</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">HPLC</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/11/07</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">신약연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">한국애질런트테크놀로지스(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="53">TOOL SET FOR BLISTER&cr;(캡슐1호)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">10,800,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019/10/24</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">주식회사 제이비엠</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="53">TOOL SET FOR BLISTER&cr;(아토젯 정)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">16,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019/10/24</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">주식회사 제이비엠</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">실험대 외</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,668,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/09/20</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">신약연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">주식회사 아이티랩산업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">품질관리부 HPLC </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,772,594</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/09/09</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">WATERS (HPLC 수입)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">LABDB_E,LCSOLUP,E 외 4건</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/08/29</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)시마즈사이언티픽코리아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">Microscope</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,150,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/07/08</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">신우텍</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">용출기  </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,449,667</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/06/25</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER"> 연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">제제연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">인천세관</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">HS-20(220-240V)EN  </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">61,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/06/24</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)시마즈사이언티픽코리아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">hplc 2대</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/06/24</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)시마즈사이언티픽코리아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">novAA800F</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/06/10</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">신약연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">디와이하이테크</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">용출기  </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,367,472</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/04/02</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">신약연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30"> 수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">용출기  </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">54,367,472</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/04/02</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30"> 수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">Alliance HPLC systems</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/03/26</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(유)워터스코리아</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">에스오피엠 정40mg TOOLSET,20mg 충전장치</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/02/20</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">주식회사 제이비엠</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">SPECORD 210 PLUS BU</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/02/15</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">디와이하이테크</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">uplc </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">65,836,312</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/01/30</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">WATERS (HPLC 수입)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">SCD G60, Cleaner 외 1건</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">53,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019/01/24</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">신약연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">주식회사 올발란스</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="53">TOOL SET FOR BLISTER&cr;(에스오피엠 정 20mg)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">16,300,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2019/01/15</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="53">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">주식회사 제이비엠</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1031" VALIGN="MIDDLE" COLSPAN="6" HEIGHT="30">

<P>                                                                   
<SPAN>    </SPAN>
<SPAN USERMARK=" B">   [2018년]</SPAN>
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="53">TOOL SET FOR BLISTER&cr;(에스오피엠 정)</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">34,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2018/11/12</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="53">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">주식회사 제이비엠</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="53">블리스터 포장기&cr;(PTP,모델JB150VAL)  </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">420,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2018/11/12</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="53">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="53">주식회사 제이비엠</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">자동정제&캡슐외관선별기</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">310,000,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018/09/17</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">제품생산용</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">생산부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">주식회사 엔에프에이</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">HPLC</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,214,826</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018/09/05</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">WATERS (HPLC 수입)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">UPLC</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">97,627,915</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018/07/04</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">신약연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">WATERS (HPLC 수입)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">HPLC</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">101,630,064</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018/07/04</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">제제연구소</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">제제연구자재</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">WATERS (HPLC 수입)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">Microplate Reader </TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,300,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018/06/27</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">연구소시험기기</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">신약연구소</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)영화과학</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="325" VALIGN="MIDDLE" HEIGHT="30">자동경도계등 2종</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">48,300,000</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018/06/22</TD>
<TD WIDTH="133" VALIGN="MIDDLE" HEIGHT="30">원료및제품분석</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">품질관리부</TD>
<TD WIDTH="225" VALIGN="MIDDLE" HEIGHT="30">(주)미래에스티</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN></SPAN>
<SPAN>(3) 설비의 신설 , 매입계획</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="854">

<COLGROUP>
<COL WIDTH="139"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="74"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="854" VALIGN="MIDDLE" COLSPAN="9" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="148" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>설비능력</P>
</TH>

<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>총소요자금</P>
</TH>

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기지출액</P>
</TH>

<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>지 출</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>착공예정일</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>준공년월일</P>
</TH>

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>진척율</P>
</TH>

<TH WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" VALIGN="MIDDLE" HEIGHT="30">
<P>토 지 </P>
</TD>

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>38,361.1㎡</P>
</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,842,997</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,842,997 </TD>

<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>- </P>
</TD>

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>2020.8.24</P>
</TD>

<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>2021.08</P>
</TD>

<TD ROWSPAN="3" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>11.3%</P>
</TD>

<TD ROWSPAN="3" WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>공장 신축</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" VALIGN="MIDDLE" HEIGHT="30">
<P>건 물</P>
</TD>

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,442.37㎡</P>
</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,450,000</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,866,600</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,583,400 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" VALIGN="MIDDLE" HEIGHT="30">
<P>기계장치.제조시설</P>
</TD>

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　</P>
</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,605,534</TD>

<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　287,176</P>
</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,318,358 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="148" VALIGN="MIDDLE" HEIGHT="30">
<P>합 계</P>
</TD>

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　</P>
</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,898,531 </TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,996,773 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,901,758 </TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">
<P>　</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30">
<P>　</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30">
<P>　</P>
</TD>

<TD WIDTH="83" VALIGN="MIDDLE" HEIGHT="30">
<P>　</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-16 0XFF0000 B">5. 매출에 관한 사항</P>

<P>&cr;
<SPAN></SPAN>
<SPAN>가. 매출실적</SPAN>
</P>
<P>  (1) 주요제품의  판매 실적                                                                   단위: 원</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">분류</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 제품명</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 제10기 (2020년)</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 제09기  (2019년)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">근골격계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">레이본정</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="201" HEIGHT="30">               10,267,880,688 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="198" HEIGHT="30">                8,606,194,490 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">소화기용제</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">스토엠</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                6,375,934,155 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                4,066,633,588 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">니자딘엠캡슐</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                1,165,509,454 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                  990,447,534 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">기타용제</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">케라시딜</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                3,048,774,870 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                2,243,407,520 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">도네펜정5mg</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                  543,973,631 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                  507,552,155 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">순환기용제 </TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">아토틴엠정10mg</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                1,404,149,096 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                1,240,221,696 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">센시락</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                  762,240,960 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                  134,226,600 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">비만용제</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">아트민정</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                1,560,565,300 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                  518,266,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">체비거</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                  209,714,400 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                  125,848,800 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">항생제</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">세클엠캡슐</TD>
<TD WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                1,267,379,765 </TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">                1,031,821,232 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="98" HEIGHT="60">기타</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타제품</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="201" HEIGHT="30">             40,903,522,705 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="198" HEIGHT="30">            40,903,522,705 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수수료.용역</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="201" HEIGHT="30">              3,257,447,781 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="198" HEIGHT="30">              5,469,375,878 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="226" HEIGHT="30">합     계</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="201" HEIGHT="30">             70,767,092,805 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="198" HEIGHT="30">            65,837,518,198 </TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 판매경로</P>
<P> </P>
<P>(1) 판매조직&cr;전문의약품은 병원, 의원, 약국, 도매업체를 통해서 유통 및 판매되고 있으며, 일반적인 유통망을 통해서는 판매될 수 없습니다. 이러한 이유로 판매조직 또한 판매처에 맞춰 구성하는 것이 일반적입니다.</P>
<P> </P>
<P>(2) 판매조직도</P>

<TABLE WIDTH="715" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="211"></COL>
<COL WIDTH="486"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>판매조직</P>
</TH>

<TH WIDTH="495" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>판매방식</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>한국MAG(자회사)</P>
</TD>

<TD WIDTH="495" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>CSO 업체와의 계약, 관리를 통해 병의원 영업</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>마더스바이오메드(자회사)</P>
</TD>

<TD WIDTH="495" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>병의원 영업</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>마케팅1팀</P>
</TD>

<TD WIDTH="495" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타제약사에 상품 공급 영업</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="220" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>CMO 사업부</P>
</TD>

<TD WIDTH="495" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타제약사의 제품을 생산하는 의약품 위. 수탁생산</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;(3) 판매경로</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="590">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="280"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH COLSPAN="2" WIDTH="438" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>판매 경로</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">
<P>자사의약품</P>
</TD>

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>도매 유통</P>
</TD>

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="53">
<P>회사→도매업체→약국→소비자→ 병의원 &cr;→ 소비자(원내처방)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>상품 공급</P>
</TD>

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>회사 → 제약사</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="301" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>CMO</P>
</TD>

<TD WIDTH="289" VALIGN="MIDDLE" HEIGHT="30">
<P>회사 → 제약사</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;① 전문의약품은 도매업체를 통해 공급하여 약국 및 병의원을 거처 소비자에게 전달됩니다. 이로 인해 도매 유통 비중이 높아 보일 수는 있으나, 이러한 특수성과 유통비등 소모비용을 고려할 때 도매상을 이용한 거래가 비용 절감 효과 측면과 안정적인 매출 구조 유지 차원에서 장점이 있습니다.&cr;&cr;② 일부의 전문의약품은 제약사와의 공동판매 계약을 통해 제약사로 공급합니다.&cr;&cr;③ CMO 영업은 거래 제약사의 주문에 따라 적시 생산, 수탁납기 준수, 원가절감, 생약성분의 의약품, 전문의약품을 수행하고 임상과 공동생동을 통해 제품을 추가함으로써 해당 부문 역량을 강화하고 있습니다.&cr;&cr;(4) 판매전략&cr;당사는 임·직원들에게 고도화된 약품과 의료서비스에 대한 지식을 부여하기 위하여지속적으로 교육을 하고 있으며, 외부 전문가의 강의를 실시 하여 마케팅 기법, 외부커뮤니케이션 능력 등을 향상 시키고 있습니다. 당사가 취급하는 주된 의약품은 전문의약품으로 공익사업 후원 등을 통해 당사의 기업 인지도를 높이고 있습니다. 또한 우수거래처 확보 및 유지를 통해 영업 효율을 높이고자 브로슈어 및 판촉물 제작하여홍보활동을 실시하고 있습니다. 무엇보다 기본적으로 제품력이 뛰어난 우수 의약품 개발 및 생산에 전력을 다하고 있습니다.</P>
<P></P>
<P USERMARK="F-16 0XFF0000 B">6. 수주상황</P>
<P>&cr;당사는 국내매출의 경우 도매상 매출 및 병의원, 약국의 직접매출을 진행하고 있기 때문에 장기계약에 의한 판매가 일어나지 않고, CMO매출의 경우에도 국내제약사의Order를 받아 통상 1~3개월내에 출고를 진행하고 있어 제출일 현재 품목별 수주금액 및 수주잔고는 의미 가 없습니다</P>
<P></P>
<P USERMARK="F-16 0XFF0000 B">7. 시장위험과 위험관리</P>
<P>&cr;당사는 여러 활동으로 인하여 시장위험, 신용위험 및 유동성위험과 같은 다양한 재무위험에 노출되어 있습니다. 회사의 전반적인 위험관리정책은 금융시장의 변동성에 초점을 맞추고있으며 재무성과에 미치는 부정적 영향을 최소화하는데 중점을 두고 있습니다. 위험관리는 이사회에서 승인한 정책에 따라 이루어지고 있습니다. 이사회는 전반적인 위험관리에 대한 문서화된 정책, 외환위험, 이자율 위험, 신용 위험, 파생금융상품과 비파생금융상품의 이용 및 유동성을 초과하는 투자와 같은 특정 분야에 관한 문서화된 정책을 검토하고 승인합니다.&cr;&cr;가. 주요 시장위험 내용&cr;당사는 해외 영업활동 등으로 인하여 외환에 대한 환위험에 노출되어 있으며, 외환위험은 미래 예상거래, 인식된 자산과 부채와 관련하여 발생하고 있습니다. 그리고 당사의 이자율위험은 주로 미래 시장이자율 변동에 따라 변동금리부 차입금에서 발생하는 이자비용이 변동될 위험과 관련되어 있습니다. 회사의 이자율위험관리의 목표는 이자율변동으로 인한 불확실성과 순이자비용의 최소화를 추구함으로써 기업의 가치를 극대화하는데 있습니다.</P>
<P>&cr;나. 신용위험&cr;신용위험은 금융상품의 계약자 중 일방이 의무를 이행하지 않아 상대방에게 재무손실을 입힐 위험을 의미하며, 주로 거래처에 대한 매출채권 및 기타수취채권 등에서 발생합니다. 이러한 신용위험을 관리하기 위하여 회사는 주기적으로 고객과 거래상대방의 재무상태와 과거 경험 및 기타 요소들을 고려하여 재무신용도를 평가하고 있습니다. 회사는 매출채권 및 기타수취채권 등에서 발생할 것으로 예상되는 손실에 대해 충당금을 설정하고 있습니다. 회사는 고객의 재무 상태, 과거 경험 등 기타 요소들을 고려한 개별분석 및 과거의 대손경험률에 의한 추산액에 근거하여 충당금을 설정하고 있습니다.&cr;&cr;다. 유동성 위험&cr;유동성위험은 만기도래 시에 금융부채에 관련된 의무를 충족하는 데 어려움을 겪게 될 위험입니다. 그 결과는 부채를 상환하거나 금융보증 및 미사용 대출약정을 이행할의무를 충족하지 못하는 것입니다. 회사의 유동성위험관리에 대한 궁극적인 책임은 단기 및 중장기 자금조달과 유동성관리규정을 적절하게 관리하기 위한 기본정책을 수립하는 이사회에 있습니다.&cr;&cr;회사는 충분한 적립금과 차입한도를 유지하고 예측현금흐름과 실제현금흐름을 계속하여 관찰하고 금융자산과 금융부채의 만기구조를 대응시키면서 유동성위험을 관리하고 있습니다.&cr;</P>
<P>라. 자본위험관리&cr;당사의 자본관리 목적은 계속기업으로서 주주 및 이해당사자들에게 이익을 지속적으로 제공할 수 있는 능력을 유지하고 자본비용을 절감하기 위해 최적의 자본구조를 유지하는 것입니다. 자본구조의 유지 또는 조정을 위하여 필요한 경우 회사는 배당을 조정하거나, 주주에 자본금을 반환하며, 부채감소를 위한 신주발행 및 자산매각 등을실시하는 정책을 수립하고 있습니다.</P>
<P></P>
<P USERMARK="F-16 0XFF0000 B">8. 파생상품 및 풋백옵션 등 거래현황</P>
<P>&cr;당사는 사업보고서 작성기준일 현재 해당사항이 없습니다.&cr;</P>
<P USERMARK="F-16 0XFF0000 B">9. 경영상의 주요계약 등</P>
<P></P>
<P>가. 라이센스아웃(License-out) 계약&cr;당사는 사업보고서 제출일 현재 해당사항 없습니다.&cr;&cr;나. 라이센스인(License-in) 계약&cr;당사는 사업보고서 제출일 현재 해당사항 없습니다.&cr;&cr;다. 기술제휴 계약&cr;당사는 사업보고서 제출일 현재 해당사항 없습니다.&cr;&cr;라. 기타계약&cr;당사는 사업보고서 제출일 현재 원자재, 통화, 증권, 이자율 등에 기초하여 성립된 선물, 스왑, 선도, 옵션 기타 이와 유사한 계약을 체결하거나 매매한 사실이 없습니다.&cr;</P>
<P USERMARK="F-16 0XFF0000 B">10. 연구활동</P>
<P>&cr;가. 연구개발활동의 개요</P>
<P>당사는 2016년 신약연구소를 설립하여 제네릭의약품 및 퍼스트제네릭의 연구개발을담당해 왔으며, 제네릭의약품의 안전성 검사 및 파이프라인 강화를 위해 노력하고 있습니다. 당사는 다수의 천연물의약품과 일반의약품의 개발로 활발한 수탁사업을 벌여왔으며, 이를 바탕으로 개량신약 및 신약 연구개발에 아낌없는 투자를 이어오고 있습니다.</P>
<P></P>
<P>나. 연구개발 조직도 및 업무</P>

<P>
<SPAN USERMARK="F-13 B"></SPAN>
<SPAN USERMARK="F-13 B">(1) 연구개발 담당 조직 개요</SPAN>
</P>
<P USERMARK="F-13">당사의 연구개발조직은 개발부(서울시 동작구 소재) 산하 5개 담당 9개팀(신약개발연구소 서울시금천구 소재, 제제연구소 경북 경산시 진량읍 소재, 그 외 서울시 동작구 소재)으로 구성되어 있으며 그 현황은 다음과 같습니다.</P>
<P></P>
<P>(연구소 조직별 업무)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>조직구분</P>
</TH>

<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>부서</P>
</TH>

<TH WIDTH="371" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요업무</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>개발</P>
</TD>

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>BD팀</P>
</TD>

<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">
<P>자사 제품 Pipline 관리, 신제품 개발 기획, 특허 검토</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>RA팀</P>
</TD>

<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">
<P>의약품 인허가, 약가 신청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상팀</P>
</TD>

<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">
<P>임상시험 진행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위수탁 사업팀</P>
</TD>

<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">
<P>위수탁 사업 관리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="219">
<P>R&D센터</P>
</TD>

<TD WIDTH="129" ALIGN="CENTER" HEIGHT="30">
<P>비임상팀</P>
</TD>

<TD WIDTH="371" HEIGHT="30">
<P>천연물 및 합성신약 개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" ALIGN="CENTER" HEIGHT="53">
<P>제제연구팀</P>
</TD>

<TD WIDTH="371" HEIGHT="53">
<P>의약품(제네릭, 천연물, 개량신약, 신약)의 제제 연구, &cr;DDS설계 및 평가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" ALIGN="CENTER" HEIGHT="53">
<P>분석연구팀</P>
</TD>

<TD WIDTH="371" HEIGHT="53">
<P>의약품(제네릭, 천연물, 개량신약, 신약)의 분석 연구, 분석법 개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" ALIGN="CENTER" HEIGHT="53">
<P>CMC팀</P>
</TD>

<TD WIDTH="371" HEIGHT="53">
<P>의약품(제네릭, 개량신약) 개발 인허가 및 프로젝트 &cr;일정 관리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제제연구소(경산)</P>
</TD>

<TD WIDTH="371" VALIGN="MIDDLE" HEIGHT="30">
<P>의약품(제네릭, 천연물)의 제제 연구 및 공정 개선</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;    
<SPAN USERMARK=" 0XFF1200">(조직도)</SPAN>
</P>
<P>      </P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="226" ALIGN="CENTER" HSPACE="0">조직도1.jpg</IMG>
<IMG-CAPTION ATOC="N">조직도1</IMG-CAPTION>
</IMAGE>

<P>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>2</SPAN>
<SPAN>) 연구개발인력 구성&cr;</SPAN>
<SPAN>증권신고서 작성기준일 </SPAN>
<SPAN>현재 당사는 총 29명의 연구인력</SPAN>
<SPAN>을 보유하고 있으며, 그 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" ROWSPAN="2" WIDTH="235" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="152">
<P>구 분</P>
</TH>

<TH COLSPAN="4" WIDTH="369" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">
<P>인원(단위 : 29명)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="88" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="122">
<P>박사</P>
</TH>

<TH WIDTH="82" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="122">
<P>석사</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="122">
<P>학사</P>
</TH>

<TH WIDTH="121" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="122">
<P>합계&cr;&cr;&cr;&cr;</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">
<P>개발</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">
<P>부서장</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">
<P>BD팀</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P> -</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">
<P>RA팀</P>
</TD>
<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">-</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>4</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">
<P>임상</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">
<P>위수탁팀</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="212">
<P>R&D센터</P>
</TD>

<TD WIDTH="118" HEIGHT="30">
<P>센터장</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" HEIGHT="30">
<P>소장</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" HEIGHT="30">
<P>바이오약리팀</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P> -</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>3</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>3</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" HEIGHT="30">
<P>제제연구팀</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P> -</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>5</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>5</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" HEIGHT="30">
<P>분석연구팀</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P> -</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>3</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>4</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" HEIGHT="30">
<P>CMC팀</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P> -</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="118" HEIGHT="32">

<P>
<SPAN>제제연구소</SPAN>
<SPAN USERMARK="F-8">(경산)</SPAN>
</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="32">
<P> -</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="32">
<P>3</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="32">
<P>1</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="32">
<P>4</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="235" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>

<TD WIDTH="88" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="82" ALIGN="CENTER" HEIGHT="30">
<P>18</P>
</TD>

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>9</P>
</TD>

<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">
<P>29</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0XFF1200"></P>

<P>
<SPAN USERMARK="F-13 B"></SPAN>
<SPAN USERMARK="F-13 B">(3) 핵심 연구인력</SPAN>
</P>

<P USERMARK="F-13 0X1814FF B">
<SPAN USERMARK=" 0X000000 !B">당사의 핵심 연구 인력은 신약개발연구소장 송릿다 상무이사, 제품개발연구소장 배현주 이사 등 입니다.</SPAN>
<SPAN USERMARK=" 0X000000 !B"></SPAN>
</P>

<P USERMARK="F-13 B">
<SPAN>&cr;</SPAN>
<SPAN>[핵심 연구인력 현황]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="999">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="261"></COL>
<COL WIDTH="424"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">
<P>직위</P>
</TH>

<TH WIDTH="82" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">
<P>성명</P>
</TH>

<TH WIDTH="97" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">
<P>담당업무</P>
</TH>

<TH WIDTH="270" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">
<P>주요경력</P>
</TH>

<TH WIDTH="433" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="31">
<P>주요연구실적</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="582">
<P>R&D센터장 및 </P>
<P>신약개발연구소장(상무이사)</P>
</TD>

<TD WIDTH="82" HEIGHT="582">
<P>송릿다</P>
</TD>

<TD WIDTH="97" HEIGHT="582">
<P>R&D센터 및 </P>
<P>신약개발 </P>
<P>업무총괄</P>
</TD>

<TD WIDTH="270" HEIGHT="582">
<P>하임바이오 부사장, R&D 총괄본부장 (20‘)</P>
<P>하나제약 판교 R&D 센터 상무, 연구기획실장, 신약연구실장 (17‘)</P>
<P>한국파스퇴르연구소 의약화학&화학생물학 Group leader, 연구기획협력실장 (04‘)</P>
<P>이화여자대학교 화학과 연구교수 (03‘)한국과학기술연구원 생체과학부 박사 후 연구원 (97‘)</P>
<P>서울대학병원 약제부 (88‘)</P>
<P>바이엘 코리아 품질관리?생산관리부 (87‘)</P>
<P>Universite de Toulouse III , Biomolecular chemistry, 박사 (96‘)</P>
<P>Institut National Polytechnique, Natural product chemistry, 석사 (93‘)</P>
<P>이화여자대학교 약학과, 학사 (87‘)</P>
</TD>

<TD WIDTH="433" HEIGHT="582">
<P>[SCI 논문]</P>
<P>1. Identification of piperidine-3-carboxamide derivatives inducing senescence-like phenotype with anti-melanoma activities, ACS MedChem. Lett. (in press)</P>
<P>2. Discovery of 4H-Chromeno[2,3-d]pyrimidin-4-one Derivatives as Senescence Inducers and Their Senescence-Associated Antiproliferative Activities on Cancer Cells using Advanced Phenotypic Assay, European Journal of Medicinal Chemistry 2021, 209, 112250</P>
<P>3. Benzothiazepine Carboxamides: Novel hepatitis C virus inhibitors interfering with viral entry and release, Antiviral Research 2016, 129, 39-46</P>
<P>4. Synthesis and Evaluation of Quantum Dot-based Fluorescence in Situ Hybridization (FISH) Probe for Telomere Detection, J. Nanosci. Nanotech. 2015, 15/2, 1708-1713. </P>
<P>  </P>
<P>외 SCI 게재 논문 60편</P>
<P>  </P>
<P>[특허] </P>
<P>1. Compounds and a pharmaceutical compound for treatment of inflammatory disease Korean patent application no. 10-1496095</P>
<P>2. Compound for treatment of inflammatory disease Korean patent application no. 10-1715448</P>
<P>3. Compound for treatment of inflammatory disease Korean patent application no. 10-1715449</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="605">
<P>제품개발연구소장(이사)</P>
</TD>

<TD WIDTH="82" HEIGHT="605">
<P>배현주</P>
</TD>

<TD WIDTH="97" HEIGHT="605">
<P>제품개발 </P>
<P>연구총괄</P>
</TD>

<TD WIDTH="270" HEIGHT="605">
<P>국제약품 중앙연구소 실장(18‘)</P>
<P>대원제약 중앙연구소 DDS실장</P>
<P>광동제약 R&D I 부서장(09‘)</P>
<P>건일제약 중앙연구소 제제실장(06‘)</P>
<P>성균관대학교 약제학 박사(14‘)</P>
<P>한남대학교 고분자과 석사(94‘)</P>
<P>조선대학교 고분자학과 학사(94‘)</P>
</TD>

<TD WIDTH="433" HEIGHT="605">
<P>[SCI 논문]</P>
<P>1. Effect of gastro-retentive forms of ecabet sodium in the treatment of gastric ulcer in rats. The Pharmaceutical Society of Korea 20132. A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits. Molecules 2020 Feb; 25(3): 663.</P>
<P>  </P>
<P>[특허]</P>
<P>1. 안정성이 우수한 ACE 저해제를 포함하는 약제학적 조성물</P>
<P>2. 시부트라민유리염기를 함유한 습식과립물</P>
<P>3. 입자크기가 조절된 술포데히드로 아비에트산을 함유한 쓴맛이 저감된 경구용 액상 조성</P>
<P>4. 신규한 벤조[b]싸이오펜 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물</P>
<P>5. 신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물</P>
<P>6. 신규한 메타논 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물</P>
<P>7. 사이클로스포린 함유 무자극성의 안약조성물 및 편리한 제조방법</P>
<P>8. 아다만틸기를 갖는 헤테로고리 카복스아미드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물</P>
<P>9. 설파살라진 및 히알루온산을 함유하는 안약 조성물</P>
<P>10. 레바미피드의 가용화 방법 및 이에 의해 제조된 안구건조증 치료용 액제</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN></SPAN>
<SPAN>다. 연구개발비용</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="720">

<COLGROUP>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="6" WIDTH="720" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(단위: 천원)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>
<TH WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>

<TH WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2019년</P>
</TH>

<TH WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2018년</P>
</TH>

<TH WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2017년</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">
<P>비용의 성격별 분류</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>재료비</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">395,137</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>359,703</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>249,819</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>56,888</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>인건비</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">844,387</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>802,917</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>675,886</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>589,153</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>위탁용역비</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,614,265</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,155,735</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>362,063</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>512,560</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>기타</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">284,049</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>204,711</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>90,464</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>102,768</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,137,838</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,523,066</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,378,232</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,261,369</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>회계처리내역</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>판매관리비</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,817,184</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,115,477</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>963,418</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>935,948</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>제조경비</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">320,654</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>407,590</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>414,814</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>325,421</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>개발비</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>　-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,137,838</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,523,067</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,378,232</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,261,369</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품매출액</P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67,509,645</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>59,164,158</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>40,961,664</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>32,341,126</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>매출액대비비율 </P>
</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.64%</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4.26%</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3.36%</P>
</TD>

<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3.90%</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;라. 연구개발 완료 실적</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="891">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="188"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>제품명</P>
</TH>

<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>분류</P>
</TH>

<TH WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>개발완료시기</P>
</TH>

<TH WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>현재현황</P>
</TH>

<TH WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>천연물</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>레이본정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해열ㆍ진통ㆍ소염제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>헤모나민정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>무기질제제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>천연물</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>센시락정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타의 조직세포의 기관용 의약품</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>디멘리스캡슐3mg </P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타의&cr;중추신경용약</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>디멘리스캡슐1.5mg </P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>　기타의&cr;중추신경용약</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이부쎈에프정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해열ㆍ진통ㆍ소염제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>포리겔정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제산제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기시설정 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>알티스정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>따로 분류되지 않는 대사성 의약품</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2018년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사생동 입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>에제베러정</P>
<P>(에제티미브)</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>동맥경화용제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2018년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사생동 입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>천연물</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아이눈정 </P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>안과용제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>디멘리스캡슐 4.5mg</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타의&cr;중추신경용약</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 수탁 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>디멘리스캡슐 6mg</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타의&cr;중추신경용약</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 수탁 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>에스오피엠정 40mg (자사)</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소화성궤양용제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사생동 입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>에스오피엠정 20mg (자사)</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소화성궤양용제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사생동 입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>브로나제장용정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>효소제제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">화학합성</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제네릭</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">멜라엠서방정</TD>
<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최면 진정제</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019년</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내 판매중</TD>
<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자사생동 입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이지렉트정0.5mg</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타의 중추신경용약</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사생동 입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이지렉트정1mg</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타의 중추신경용약</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사생동 입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>천연물</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이탄돌플러스정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>치과구강용약</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>천연물</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제네릭</P>
</TD>

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>스토엠투엑스정</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소화성궤양용제</P>
</TD>

<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020년</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내 판매중</P>
</TD>

<TD WIDTH="197" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>마. 연구개발 계획</P>
<P>당사는 노인성 약물에 대한 제품 라인업 강화를 주 연구개발계획으로 수립하였습니다. 65세 이상의 고령 환자들은 복합적인 질병으로 많은 의약품을 복용하고 있고, 이것은 복용의 불편함과 사회적 비용의 증가를 야기시키고 있습니다. 이에 당사는 노인성 질환과 관련한 의약품 라인업 확대를 위해 신약에 대한 연구개발계획을 수립하여 개발을 준비하고 있습니다. 준비 중인 신약에 대하여 당사 보유 특허를 연계 예정이며, 이를 통해 개발될 신약에 대한 권리보호 준비에 힘쓰고 있습니다.&cr;</P>
<P>또한 현재 다수의 임상시험을 진행하여 당뇨, 고혈압, 비만제품군의 확장을 준비하고있고, 이를 위하여 다수의 제제연구장비 및 인력을 확보하여 개발계획을 차질 없이 수행하기위해 노력하고 있습니다.</P>
<P></P>
<P>(1) 신약 연구 계획</P>
<P><개발 진행 현황표></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="615">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD ROWSPAN="2" WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>품목</P>
</TD>

<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>적응증</P>
</TD>

<TD ROWSPAN="2" WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>연구개시 시기</P>
</TD>

<TD COLSPAN="2" WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>단계</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>승인 및 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="65" USERMARK=" BC0XD7D7D7">
<P>합성신약</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>MTS-DM</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2형 당뇨</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.06</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>미정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35">
<P>MTS-NP</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35">
<P>신경병증성 통증</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35">
<P>2018.10</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35">
<P>연구단계</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="35">
<P>미정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>천연물의약품</P>
<P>및</P>
<P>기능성화장품</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>MTS-AL</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>탈모</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2018.06</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>연구단계</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>미정</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;1) 품목(과제명): MTS-DM</P>

<TABLE WIDTH="612" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="486"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="495" HEIGHT="30">
<P>합성신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="495" HEIGHT="30">
<P>2형 당뇨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="495" HEIGHT="145">
<P>MG53 단백질은 골격근 및 심근에서만 발현하는 특이적인 단백질이며&cr; MG53 단백질의 음성적 제어는 IRS-1의 유비퀴티네이션(분해)을 억제해 포도당흡수를 증가시키고 인슐린저항성을 감소(인슐린 감수성 증가)시키며 골격근의 분화를 촉진시키고 췌장에서의 peroxisome proliferator-activated receptor-gamma(PPAR-γ)를 활성화하여 인슐린의 분비를 활성화하기 때문에 직접적인 2형 당뇨치료효과를 기대할 수 있음.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="495" HEIGHT="53">
<P>질환의 특성상 장기 복용이 필요하나 저 용량, 경구투여로 복용편의성을 높이고 독성이 낮아 향후 복합제의 개발전략도 가능 할 것으로 사료됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="495" HEIGHT="30">
<P>동물 약리효능/독성시험 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후 계획</P>
</TD>

<TD WIDTH="495" HEIGHT="30">
<P>GLP 독성시험 및 IND신청 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="495" HEIGHT="30">
<P>없음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 시장규모</P>
</TD>

<TD WIDTH="495" HEIGHT="30">
<P>글로벌 366달러(51조원), 국내 3,176억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P>⑨ 기타사항</P>
</TD>

<TD WIDTH="495" HEIGHT="122">
<P>MG53 단백질의 주요기능인 손상된 세포막을 복구하는 기능을 제어함과 동시에 골격근과 심근의 조절, 근육질환의 치료와 예방, 당뇨병성 심근증, 심근경색 그리고 뇌졸중과 같은 작용기전에도 관여하여 2형 당뇨 뿐만 아니라 여러 가지 합병증 및 타 적응증의 치료제 소재로 개발 가능성이 매우 높은 타겟으로 보고됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 연구 개시일</P>
</TD>

<TD WIDTH="495" HEIGHT="30">
<P>2018.06</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>2) 품목(과제명): MTS-NP</P>

<TABLE WIDTH="613" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="490"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="499" HEIGHT="30">
<P>합성신약 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="499" HEIGHT="30">
<P>신경병증성 통증 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="499" HEIGHT="145">
<P>Trk A는 신경성장인자(NGF)와 가장 높은 결합 친화력이 가지고 침해수용성 뉴런의 발현에 관여하는 인자이며 펩타이드성 통각 수용체 뉴런은 주로 trk A를 발현하고 trk B 또는 trk C는 발현하지 않음. </P>
<P>Trk A 저해제는 세포내에서 효소 활성 반응을 조절/저해 (suppression) 하여 침해 수용성 감각뉴런의 발현을 억제하고 통증감각의 억제를 유발하여 진통제의 중요한 타깃이 됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="168" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="499" HEIGHT="168">
<P>Trk A(Tropomyosin receptor kinase A) 저해제는 기존의 비스테이로드 소염제나 타이레놀 계열보다 약효가 뛰어나고 마약성 진통제의 부작용이 없으며 효능은 마약성 진통제와 대등한 비마약성 진통제로 개발 가능성이 높은 타깃임.</P>
<P>또한 장기 복용 시에도 부작용이 나타나지 않고 효과가 빠르고 확실하며환자의 복약순응도를 높일 뿐만 아니라 다양한 적응 증을 포함하는 신규한 기전을 가짐</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="499" HEIGHT="30">
<P>신규화합물 유도체 합성 및 동물효능시험 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후 계획</P>
</TD>

<TD WIDTH="499" HEIGHT="30">
<P>GLP 독성시험 및 IND신청 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="499" HEIGHT="30">
<P>공개불가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 시장규모</P>
</TD>

<TD WIDTH="499" HEIGHT="30">
<P>글로벌 407억 달러 (57조원)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>⑨ 기타사항</P>
</TD>

<TD WIDTH="499" HEIGHT="145">
<P>Trk A저해제는 궁극적으로 광범위한 통증질환에 대해 신규한 타깃으로 기존의 통증치료제에 대해 확실한 차별성을 가지며 선택적인 Trk A의 억제로 통증질환 뿐만 아니라 암, 피부질환, 염증성질환 등 추가적인 적응 증을 확대해 나갈 수 있기 때문에 기존에 통증 및 항염증 효능을 갖는 복합제 제형의 부작용을 감소시키고 동일하거나 높은 효능을 보일 것으로 예상함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 연구 개시일</P>
</TD>

<TD WIDTH="499" HEIGHT="30">
<P>2018.10</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>3) 품목(과제명): MTS-AL</P>

<TABLE WIDTH="613" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="489"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="498" HEIGHT="30">
<P>천연물의약품 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="498" HEIGHT="30">
<P>탈모 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="498" HEIGHT="122">
<P>JAK-STAT 신호전달 과정에서 JAK1과 JAK3는 인산화 효소에 의하여 STAT이 활성화되어 핵으로 이동하며 각기 다른 DNA 전사조절부위에 결합하여 유전자 발현을 조절하고 결국 탈모에 직접적으로 관여하는 신호전달경로임을 확인하였으며, JAK-STAT 신호전달을 제어함에 따라 탈모치료가 가능함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="498" HEIGHT="76">
<P>천연물 유래 추출물질로 공급원가가 저렴하고, 취급공정이 쉬우며, 다양한 투여경로로 장기간 투여에도 불구하고 기존 치료제보다 부작용이 적을 뿐만 아니라 더 안전하고 광범위한 효능을 가짐.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="498" HEIGHT="30">
<P>동물 약리효능/독성시험 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후 계획</P>
</TD>

<TD WIDTH="498" HEIGHT="30">
<P>GLP 독성시험 및 IND신청 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="498" HEIGHT="30">
<P>공개불가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 시장규모</P>
</TD>

<TD WIDTH="498" HEIGHT="30">
<P>세계탈모인구 약 1천만 명, 탈모관련제품 4조원, 매년 20%이상 성장 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P>⑨ 기타사항</P>
</TD>

<TD WIDTH="498" HEIGHT="122">
<P>JAK-STAT의 신호전달과정의 억제는 류마티스 관절염 등 염증성 질환과 암 등의 자가면역질환의 치료제로서 응용할 수 있는 분야가 광범위하다고 알려짐. 따라서 주요 약리작용인 JAK-STAT 신호전달과정의 억제가 다양한 염증성 질환 및 자가면역질환의 치료방법 개발에 매우 중요하며 새로운 치료제 개발소재로 신약 재창출의 기회를 제공할 것임.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="115" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 연구 개시일</P>
</TD>

<TD WIDTH="498" HEIGHT="30">
<P>2018.06</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>(2) 개량신약 및 제네릭 연구 계획</P>
<P><개발 진행 현황표></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="781">

<COLGROUP>
<COL WIDTH="76"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD ROWSPAN="2" WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>제품명</P>
</TD>

<TD ROWSPAN="2" WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>분류</P>
</TD>

<TD ROWSPAN="2" WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>연구개시시기</P>
</TD>

<TD COLSPAN="2" WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>진행단계</P>
</TD>

<TD ROWSPAN="2" WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>승인 및 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제로팻정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>따로 분류되지 않는 대사성 의약품</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2018.08月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상 진행중</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.10月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>테네글립엠정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.10月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상 완료</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.10月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>테네글립엠</P>
<P>서방정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2018.10月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상 완료</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2022.10月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>포시가+자누비아 복합제</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.05月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2023.09月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>노르믹스정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>그럼양성, 음성균에 작용</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.07月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상완료시</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>엠파글리엠정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.10月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생동 완료</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2025.10月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>엠파글리엠듀오정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2023.06月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2025.10月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>펠루엠서방정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해열ㆍ진통ㆍ소염제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.08月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.05月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>뉴로가발린CR</P>
<P>서방정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타의 중추신경용약</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.05月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>생동 진행중</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2022.11月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>천연물</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>고덱스정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>간장질환용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017.05月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상완료시</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>천연물</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>이모튼캡슐</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>따로 분류되지 않는 대사성 의약품</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017.05月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상완료시</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>천연물</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>시네츄라시럽</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>진해거담제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017.07月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상완료시</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아토틴엠정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>동맥경화용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생동 진행중</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.06月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>도네펜정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타의 중추신경용약</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생동 진행중</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.06月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>클피도엠정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>동맥경화용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.06月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>니자딘엠캡슐</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소화성궤양용제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.06月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>베포엠정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>항히스타민제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.06月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>사포그릴엠SR정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>항응고제, 항혈소판제, 섬유소용해제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2022.06月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>모사프리엠정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위장관 운동조절제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.06月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>락소펜엠정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해열·진통·소염제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.12月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>트라플엠정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해열·진통·소염제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.01月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.12月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세렉캡슐</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해열·진통·소염제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.06月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.12月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>로수엠젯정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>고지혈증 치료제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.06月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.12月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아페락정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>해열·진통·소염제</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.06月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.12月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>엠록신정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>그람양성균, 리케치아, 비루스에 작용</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.06月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2022.12月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환 생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>화학합성</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>에나틴정</P>
</TD>

<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타의 알레르기용약</P>
</TD>

<TD WIDTH="102" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.06月</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구단계</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2022.12月</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사전환 생동</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>1) 품목(과제명): 제로팻정</P>

<TABLE WIDTH="605" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="479"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="30">
<P>따로 분류되지 않는 대사성 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="53">
<P>위와 췌장에서 장의 리파제의 가역적 억제제로, 음식물 중에 포함된 지방의 흡수를 억제함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="488" VALIGN="MIDDLE" HEIGHT="30">
<P>2019.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;2) 품목(과제명): 테네글립엠정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>①구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>②적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="168" USERMARK=" BC0XF2F2F2">
<P>③작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="168">
<P>teneligliptin은 dipeptidyl peptidase 4 (DPP-4) 효소를 억제하여 활성 incretin 작용을 연장시킴.</P>
<P>Incretin호르몬 (예: glucagon-like peptide-1[GLP-1], glucose-dependent &cr;insulinotropic polypeptide [GIP])은 iusuline을 분비시킴.</P>
<P>혈중 insuline 증가, glucagon 감소를 통해 고혈당이 조절됨.</P>
<P>Teneligliptin은 stagliptin에 비해 5배 더 높은 활성을 나타내며, S2에 더 광범위하게 결합함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>허가 완료 후 발매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2018.10月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>3) 품목(과제명): 테네글립엠 서방정</P>

<TABLE WIDTH="629" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="503"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="168" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="168">
<P>teneligliptin은 dipeptidyl peptidase 4 (DPP-4) 효소를 억제하여 활성 incretin 작용을 연장시킴.</P>
<P>Incretin호르몬 (예: glucagon-like peptide-1[GLP-1], glucose-dependent &cr;insulinotropic polypeptide [GIP])은 iusuline을 분비시킴.</P>
<P>혈중 insuline 증가, glucagon 감소를 통해 고혈당이 조절됨.</P>
<P>Teneligliptin은 stagliptin에 비해 5배 더 높은 활성을 나타내며, S2에 더 광범위하게 결합함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>임상 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>허가 완료 후 발매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="512" VALIGN="MIDDLE" HEIGHT="30">
<P>2018.10月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>4) 품목(과제명): 포시가+자누비아 복합제</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="329" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="329">
<P>선택적, 가역적인 나트륨-글루코스 공동수송체2 저해제</P>
<P>여과된 포도당의 재흡수 감소</P>
<P>포도당에 대한 신장의 역치 감소</P>
<P>포도당의 신장 배설 증가</P>
<P>Sitagliptin은 dipetidyl peptidase 4 (DPP-4) 효소를 어거제하여 활성 incretin 농도를 지연시킴.</P>
<P>Incretin호르몬(glucagon-like peptide-1(GLP-1), glucose-dependent insulinotropic polypeptide(GIP)은 췌장 베타세포로부터 인슐린합성과 방출을 증가시키고 췌장 알파세포로부터 glucagon 분비를 감소시켜 혈당의 항상성을 조절함.</P>
<P>Glucagon분비가 감소되면 간에서의 혈당생산이 감소</P>
<P>정상적인 경우 incretin 호르몬은 낮동안 장에서 분비되어 식사시 혈중농도가 증가됨</P>
<P>Incretin호르몬은 DPP-4 효소에 의해 신속히 불활성화 됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2020.05月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>5) 품목(과제명): 노르믹스정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>그럼양성, 음성균에 작용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="76">
<P>1. 리팍시민은 리팜피신의 구조적 유사체로 반합성 비전신적 항생제임</P>
<P>2.박테리아의 DNA-dependent RNA polymerase의 베타 subunit에 결합함으로 박테리아의 RNA 합성을 억제함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2020.07月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>6) 품목(과제명): 엠파글리엠정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="99">
<P>empagliflozin 은 신정 근위세뇨관에서 당 재흡수에 관여하는 SGLT2를 억제 → 소변 중 당 배설이 증가하여 혈당 수치 감소</P>
<P>empagliflozin은 공복혈당과 식후혈당을 감소시키며, b세포 기능 및 인슐린 경로와 독립적으로 작용하므로 저혈당 위험이 낮음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>생동 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>허가 완료 후 발매</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2019.10月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;7) 품목(과제명): 엠파글리엠듀오정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="99">
<P>empagliflozin 은 신정 근위세뇨관에서 당 재흡수에 관여하는 SGLT2를 억제 → 소변 중 당 배설이 증가하여 혈당 수치 감소</P>
<P>empagliflozin은 공복혈당과 식후혈당을 감소시키며, b세포 기능 및 인슐린 경로와 독립적으로 작용하므로 저혈당 위험이 낮음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2023.06月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>8) 품목(과제명): 펠루엠서방정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>해열진통소염제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>비스테로이드성 소염진통제(NSAIDs)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2019.08月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;9) 품목(과제명): 뉴로가발린CR 서방정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>기타의 중추신경용약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="145">
<P>1. 프레가발린은 GABA 유사체로 중추신경계의 알파(2)-델타 부위(전위차 의존적 칼슘 채널의 아단위)에 강하게 결합함</P>
<P>2.알파(2)-델타 아단위에 결합하여 신경학적 통증과 발작 제어에 프레가발린의 효과를 발할 수 있음</P>
<P>3.프레가발린은 정확한 기전은 알려져 있지 않으나 칼슘 채널의 기능을 조절하여 여러 신경전달물질의 칼슘 의존적 방출 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>생동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2020.05月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  &cr;10) 품목(과제명): 고덱스정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>천연물</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>간장질환용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>지방산 대사에 필수적인 작용을 하는 조효소로 아미노산 유도체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2017.05月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>11) 품목(과제명): 이모튼캡슐</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>천연물</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>따로 분류되지 않는 대사성 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="835" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="835">
<P>1. 단백질 분해 억제</P>
<P>HLE:단백질을 분해하고 치은 매트릭스를 변화시켜 염증 반응을 초래</P>
<P>HLE에 의한 치은 탄력섬유 분해 억제</P>
<P>2.자유라디칼 제거</P>
<P>자유라티칼: 연골파괴에 관여하는 것으로 알려져 있음</P>
<P>Tocopherol,b-Sitosterol함유: 자유라디칼 제거 작용</P>
<P>3.IL-1억제</P>
<P>IL-1:연골을 분해한다고 알려져 있음</P>
<P>IL-1,TNF-a가 연골세포를 자극하여 MMP 생성을 증가시키는 데 MMP는 골관절염에서 연골을 침식시킨다고 알려져있음</P>
<P>단핵구에서 분비된 IL-1가 연골주위 육아종성 조직으로 유입되는 것을 억제함</P>
<P>IL-1의 효과를 활막세포에서 부분적으로 역전시킴 및 연골세포에서 전체적으로 억제시킴</P>
<P>4.Collagenase생성 억제</P>
<P>IL-1:활막세포 및 연골세포를 자극하여 Collagenase를 생성</P>
<P>Collagenase과잉생산: 골관절염 진행의 원인 요소일 수 있음</P>
<P>5.콜라겐과 Proteoglycan의 합성 증가</P>
<P>6.TGFbeta-1,TGFbeta-2,PAI-1의 생성을 자극</P>
<P>위 인자들은 연골 분해 방지 및 관절 연골의 회복에 필요한 매트릭스 합성에 관여할 가능성이 있음</P>
<P>TGF:초기 관절염에서 매트릭스 유전자 발현과 IL-1 길항 효과를 통해 연골 회복을 자극할 수 있음. 피부 섬유아세포, 활막세포, 관절 연골세포 등 매트릭스 요소의 합성을 증가시킴</P>
<P>PAI-1:연골에서 Proteoglycans의 분해 억제, Stromelysin의 활성화 억제</P>
<P>7.Collatenase등의 분지 억제 또는 생성 감소</P>
<P>IL-1beta의 자극으로 Collagenase, stromelysin, IL-6, IL-8, PGE2가 분비되는 것을 부분적으로 억제할 수 있음</P>
<P>또한 Stromelysin, IL-6, IL-8, PGE2의 생성을 감소시킬 수 있음</P>
<P>8.Lysyloxidase억제</P>
<P>Lysyloxidase:화상, 상처치유, 간섬유화, granuloma, 폐섬유화 등 조직 리모델링이 있을 때 증가하는 효소, 결합조직 질환에서 콜라겐 축적 조절에 관여</P>
<P>콜라겐 교차결합을 감소시켜, 콜라겐 분해를 증가시키는 것으로 보임</P>
<P>CompoundC:Lysyloxidase억제 활성성분으로 종자유의 지질 분획 및 Avocado oil의 불검화물 분획에서 발견됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2017.05月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>12) 품목(과제명): 시네츄라시럽</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>천연물</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>진해거담제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="99">
<P>기도 평활근 수축을 유발하는 Tachykinin NK1, Tachykinin NK2, PDE4, Adenosin A3를 억제</P>
<P>주요 염증매개물질 중의 하나인 LTB4의 생성을 유발하는 효소인 lipoxygenase의 활성을 효과적으로 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>임상</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2017.07月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>13) 품목(과제명): 아토틴엠정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="497"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="506" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="506" VALIGN="MIDDLE" HEIGHT="30">
<P>동맥경화용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="506" VALIGN="MIDDLE" HEIGHT="122">
<P>1. 콜레스테롤 생합성의 율속 단계에 관여하는 효소인 3--hydroxyl-3-metylglutaryl-coenzyme A(HMG-CoA) reductase를 경쟁적으로 저해함(HMG-CoA로부터 mevalonic acid의 합성을 억제)</P>
<P>2.간에서 콜레스테롤 합성을 억제하고 흡수를 증가 및 LDL의 이화를 위해 세포 표면의 간 LDL 수용체의 수를 증가함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="506" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="506" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="506" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="506" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>14) 품목(과제명): 도네펜정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>기타의 중추신경용약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="53">
<P>1. 중추에서 선택적으로 acetylcholinesterase를 가역적, 비경쟁적으로 저해하여 시냅스에서 아세틸콜린의 농도를 증가시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>15) 품목(과제명): 클피도엠정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>동맥경화용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="76">
<P>혈소판 응집 억제제 - ADP-유도성 응집 억제제</P>
<P>혈소판의 ADP 수용체와 glycoprotein GP 2b/3a의 활성을 저해</P>
<P>→ Fibrinogen의 결합을 차단함 → 혈소판의 점착과 응집을 감소시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>16) 품목(과제명): 니자딘엠캡슐</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>소화성궤양용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="53">
<P>위산분비세포의 H2-수용 체에 대한 히스타민의 결합을 경쟁적, 가역적으로 저해함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>17) 품목(과제명): 베포엠정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>항히스타민제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="76">
<P>선택적 항히스타민 H1 수용체 길항제.</P>
<P>강력한 H1 수용체 길항작용, 호산구 침윤억제작용, IL-5 생성 억제작용을 가짐.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>18) 품목(과제명): 사포그릴SR정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>항응고제, 항혈소판제, 섬유소용해제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="53">
<P>혈소판 및 혈관평활근의 5-HT2 수용체에 특이적 길항작용을 나타내, 항혈소판 작용 및 혈관 수축 억제 작용을 나타냄.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>19) 품목(과제명): 모사프리엠정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>위장관 운동조절제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="53">
<P>아세틸콜린 유리를 증가시키는 5-HT4 수용체 효능제로 위장관 운동을 자극하고 5-HT3 길항 효과도 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;20) 품목(과제명): 락소펜엠정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>해열진통소염제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="145">
<P>비스테로이드성 소염진통제(NSAID) - propionin acid계</P>
<P>1.비스테로이드성 소염진통제(phenylpropionic acid의 전구체)로서 진통작용과 해열작용이 있음</P>
<P>2.Loxoprofen자체로서 약한 prostaglandin 합성 저해작용이 있음</P>
<P>3.invitro에서 중등도의 cyclooxygenase-2(COX-2) 선택성을 가짐(COX-2 선택성이 높으면 위장장애와 신독성이 작다)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>21) 품목(과제명): 트라플엠정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>해열진통소염제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="76">
<P>말초에서 통각 충동의 생성을 봉쇄하여 진통작용을 나타냄</P>
<P>시상하부의 열 조절 중추를 어거제하여 해열작용을 나타냄</P>
<P>약한 항염 작용: CNS에서 prostaglandin 합성 억제와 관련됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.01月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>22) 품목(과제명): 세렉캡슐</P>

<TABLE WIDTH="626" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="500"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>해열진통소염제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="99">
<P>선택적으로 cyclooxygenase 2 (COX-2)를 억제하여 arachidonic acid로&cr; 부터 prostaglandins 생합성을 감소시키며 위장관, 신장, 혈소판에서 &cr; 일어나는 cyclooxygenease 1 (COX-1)에 의한 정상적인 대사에는 영향을 주지 않음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.06月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>23) 품목(과제명): 로수엠젯정</P>

<TABLE WIDTH="626" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="500"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>동맥경화용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="145">
<P>HMG-CoA 환원효소를 경쟁적 억제하여 콜레스테롤 전구물질 mevalonic acid 합성을 저해하여 콜레스테롤 합성을 억제함.</P>
<P>소장의 NPC1L1 단백에 작용하여 내인성 콜레스테롤이 소장 세포로 재흡수를 억제함.</P>
<P>스타틴계열은 효과는 우수하나 고함량에 따른 부작용 발생 위험이 있을 수 있으므로, 에제티미브와 병용하여 이상지질혈증을 치료하고자 함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="509" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.06月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>24) 품목(과제명): 아페락정</P>

<TABLE WIDTH="628" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>해열진통소염제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="99">
<P>많은 염증 반응 매개에 영향을 미침</P>
<P>1.염증성 cytokines interleukin-1b와 tumor necrosis factor의 합성 저해</P>
<P>2.ProsraglandinE2의 생성 저해</P>
<P>3.관절 손상의 재생과 회복을 돕는 glycosaminoglycans(gag) 합성을 자극</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="511" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.06月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>25) 품목(과제명): 엠록신정</P>

<TABLE WIDTH="630" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="504"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">
<P>그람양성균, 리케치아, 비루스에 작용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="53">
<P>세균 리보솜의 50s 소단위에 비가역적으로 결합하여 사슬 연장 단계에서 RNA 의존성 단백질 합성을 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="513" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.06月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>26) 품목(과제명): 에나틴정</P>

<TABLE WIDTH="631" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="505"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구분</P>
</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">
<P>화학합성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">
<P>기타의 알레르기용약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>③ 작용기전</P>
</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="145">
<P>항히스타민제</P>
<P>1.직접적인 H1 수용체 길항제이면서 비만세포로부터 히스타민의 유리를 억제</P>
<P>2.H1수용체에 선택적으로 작용하며 H2-, gamma1-, gamma2-, 5-HT2 &cr; 수용체에 친화력이 있음</P>
<P>3.진정작용이 작은 항히스타민제 - 혈액뇌관문을 통과하지 않음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 진행경과</P>
</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">
<P>연구단계</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 향후 계획</P>
</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 기타사항</P>
</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 연구 개시일</P>
</TD>

<TD WIDTH="514" VALIGN="MIDDLE" HEIGHT="30">
<P>2021.06月</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P>  </P>
<P>바. 보유기술의 경쟁력</P>
<P>&cr;(1) 신약부분</P>
<P>당사는 4차 신약개발 혁명시대에 맞춰 BT와 IT 기술을 융합하여 인공지능 빅데이터 플랫폼 시스템을 구축하고 분석과 반복학습을 통해 화합물 구조의 물리, 화학적 특징, 임상시험 결과예측, 유전독성예측, 대사안정성, 타겟 단백질의 결합 친화력 그리고 on/off target 프로파일링을 통한 독성예측을 시행하여 개발 초기단계에서부터 명확한 신약후보물질 발굴과 독성예측을 통해 후보물질 발굴을 가속화하고 있습니다.&cr;</P>
<P>당사는 환자 임상데이타에서 특이적으로 과발현 또는 억제되는 단백질 프로파일을 분석하고 질환과 직접적으로 관련 있는 신규한 단백질을 탐색 및 도출하고 해당유전자조합을 모델링하여 질환 단백질의 구조를 분석하고 단백질 정보를 내부 플랫폼 시스템에 적용하여 질환 단백질의 3차 구조를 디자인하였고 NGS(next generation sequencing)를 이용하여 특이적인 조직에서 과 발현 또는 과억제 되는 mRNA 발현레벨을 확인하였습니다. 질환 단백질의 활성부분의 구조를 기반으로 각 해당 프로젝트의 선택적인 화합물의 예상 결합부위를 예측하고 약물을 디자인(CADD) 하였고 리간드 부분과 질환 단백질의 활성부위에 결합이 가능하도록 화합물 구조식(core)부분을 확인하여 약 1200개의 화합물을 도출하였고 잔기부분(residue site)을 자동합성 프로그램을 이용하여 다양한 화합물 구조를 합성하였으며 drug-likeness의 표준이 되는 Lipinski's rule 5를 적용하여 약 100개의 화합물을 도출하였습니다.&cr;</P>
<P>또한, CYP450 대사작용을 예측하고 약동학 예측, 약물의 물리화학적 특징 그리고 유전독성 (복귀돌연변이시험, AMES test) 예측을 시행하여 최적의 신약 후보물질을 단시간에 도출하였습니다.</P>
<P></P>
<P>(2) 제네릭의약품 부분</P>
<P>당사는 천연물의약품 개발 및 제조에 특화된 기술력과 제조 생산 기반을 보유하고 있으며 국내 7번째 천연물 신약 레일라정에 퍼스트제네릭 제품 발매를 통해 자사 연구 개발의 기술력을 인정받았고, 그 외 스토엠정, 스토엠투엑스정, 깅코라민정, 이탄탄플러스 등의 다양한 천연물 의약품을 연구 개발하여 식약처 허가를 받아, 현재는 제조 및 판매를 진행하고 있습니다. 또한 이모튼캡슐, 엔테론의 개량신약 개발을 통해 품질 기준 설정, 이화학적 동등성을 확보하고 원개발사의 특허 도전에 따른 고부가가치를 가지는 차세대 천연물 의약품 개발을 진행하고 있습니다.&cr;</P>
<P>환자들의 복용 편의성 향상을 위한 정제 사이즈 줄이는 축소기술과 복합제 제형설계로, 고혈압치료제 연구를 진행하고 있으며, 원개발사의 서방형 특허 도전을 통한 기술 플랫폼 기술 확보하기 위한 기술 개발을 진행하고 있습니다. 그리고 여러 국가 연구기관 및 대학교 연구기관과 연구 협업을 통해 신기술 개발 및 확보를 통해 ㈜마더스제약 연구 개발능력을 높이기 위한 오픈이노베이션 및 네트워크 형성에 노력을 하고 있으며 충북대 및 청주대와 협업하여 진행했던 중소기업진흥청 국가과제 '보센탄을 포함하는 고효율 건조분말흡입제 개발'는 성공적으로 마무리가 되었고, 추가적인 연구를 수행하여 당사의 차세대 사업개발 아이템으로 성장시키기 위해 노력하고 있습니다.&cr;</P>
<P>앞으로 국내 제약산업에서 약가 기준 변화, DMF 제도 개선, 의약품의 품질고도화 등의 변화 속에 당사는 대응하기 위한 준비를 빠르게 진행하고 있음. 약가 기준 변화가 시행되기 전에 시장성 및 경쟁력을 확보하기 위한 위탁제품을 자사 생산으로 변경하여 회사 내 매출 안정 및 품목을 확대하려고 노력 중에 있으며 DMF 제도 개선에 따라 원료사와 협업을 통해 연구 진행 전부터 원료 단계에서 품질에 영향을 줄 수 있는 유전독성 물질 및 발암성 물질 등에 대해 선재적으로 대응하여 우수 의약품 제조를 위한 연구 시스템을 확보하고자 노력하고 있으며 아울러 의약품 개발의 품질고도화를 위해서 생산 장비의 최신화, 생산 인력의 전문화, 연구 프로세스의 시스템 운용 및품질기반 연구를 진행하고 있습니다.&cr;</P>
<P>이와 더불어 ㈜마더스제약 신약개발연구소에서는 주로 신약 및 개량연구를 통해 원천기술, 특허확보를 위한 다양한 연구 개발증 진행하여 ㈜마더스제약만의 연구 플랫폼 기술을 확보하기 위해 노력하고 있으며 ㈜마더스제약 경산공장에 있는 제제연구소는 생산 공정 개선 및 천연물 의약품, 신소재 개발을 진행하고 있습니다. 그리고 전북 익산에 준공 예정인 ㈜마더스제약 제2 공장 연구소에서는 다양한 복합제, 서방형,개량신약 등을 연구 개발하고, 생산 공정의 품질 고도화를 위한 주요 공정 연구를 진행 예정이며 다양한 연구 기술 및 개발을 위한 연구 분업화를 통해 연구 효율성을 높이고 사이트 특성에 맞는 연구 전문성을 확보하기 위한 노력 중에 있습니다.</P>
<P></P>
<P USERMARK="F-16 0XFF0000 B">11. 그 밖에 투자의사결정에 필요한 사항</P>
<P>&cr;가. 특허, 실용신안 및 상표 등 지적재산권 현황&cr;[특허권]</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="791">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="244"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>명칭</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>출원/등록번호</P>
<P>(일자)</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>특허만료일</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>비고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>특허권(한국)</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>피라졸 아미드 유도체 화합물 및 &cr; 이를 포함하는 약제 조성물</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>출원: 2019-02-28</P>
<P>출원번호: 10-2019-0023970</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2039-02-28</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>PCT출원 준비중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>특허권(한국)</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>탈모치료 및 발모촉진용 조성물</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>출원: 2019-02-27&cr; 출원번호: 10-2019-0023403</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2039-02-27</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>PCT출원</P>
<P>KR2019/002378</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>특허권(한국)</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>피라졸 유도체 화합물 및 이의 용도</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>출원: 2020-04-03</P>
<P>출원번호: 10-2020-0041015</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2040-04-03</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>국내출원 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>특허권(한국)</P>
</TD>

<TD WIDTH="253" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>보센탄을 함유한 약학 제제</P>
</TD>

<TD WIDTH="203" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>출원: 2018-07-24</P>
<P>출원번호: 10-2018-0085856</P>
</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2038-07-24</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>국내출원 완료</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>나. 규제사항</P>
<P>                                          [제약업계 주요 정부 규제]</P>

<TABLE ACLASS="NORMAL" WIDTH="1024" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="713"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">시기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">규제</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="722" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요 내용</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">2002</TD>
<TD WIDTH="208" HEIGHT="30">약가 재평가</TD>
<TD WIDTH="722" HEIGHT="30">- 선진 7개국 약가와 비교하여 약가 재평가(2011년 폐지 결정)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="145">2006</TD>
<TD WIDTH="208" HEIGHT="145">약제비 적정화 방안</TD>
<TD WIDTH="722" HEIGHT="145">- 기등재 의약품 목록정비(약제비 적정화방안 후속조치): 건강보험 적용 의약품의 경제성 평가 후 가격 &cr;재조정&cr;- 선별등재시스템(Positive list system): 비용 대비 효과가 우수한 의약품만 선별적으로 건강보험 적용&cr;- 제네릭 약가 인하 폭 확대: 퍼스트 제네릭의 경우 오리지널의 68% 약가 인정&cr;- 사용량 약가 연동제: 보험 적용 1년 이후 예상사용량보다 30% 이상 실판매가 증가한 경우 최초 협상가격조정(최대 10% 인하)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">2008</TD>
<TD WIDTH="208" HEIGHT="53">새 GMP 제도 도입&cr;(선진국 수준으로 개선)</TD>
<TD WIDTH="722" HEIGHT="53">- 허가 전 품목별 평가 및 밸리데이션 도입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">2009</TD>
<TD WIDTH="208" HEIGHT="53">리베이트/약가 연동제</TD>
<TD WIDTH="722" HEIGHT="53">- 리베이트 적발 시 보험약가 최대 40% 인하 및 급여 정지 처분&cr;- 3~4차 위반 시, 급여정지 또는 매출액 최대 60~100% 과징금 (2014년 폐지 / 2018년 재도입)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">2010</TD>
<TD WIDTH="208" HEIGHT="30">리베이트 쌍벌제 </TD>
<TD WIDTH="722" HEIGHT="30">- 리베이트 받은 자에 대해서도 형사처벌 규정 신설</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="99">2012</TD>
<TD WIDTH="208" HEIGHT="99">건강보험 등재약&cr;일괄 약가인하</TD>
<TD WIDTH="722" HEIGHT="99">- 최초 제네릭 등재 시 오리지널 및 제네릭 가격을 특허만료 전 오리지널 가격의 53.55%로 일괄인하&cr;(계단식 약가구조 폐지)&cr;- 단독등재, 퇴장방지의약품 등 인하대상 제외&cr;- 3개사 이하 생산 의약품, 개량신약 등 약가 우대</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">2014</TD>
<TD WIDTH="208" HEIGHT="30">사용량-약가연동제 강화</TD>
<TD WIDTH="722" HEIGHT="30">- 청구금액이 전년대비 10%, 절대금액 50억원 이상 증가한 제품에 대한 청구액 상한기준 적용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">2014</TD>
<TD WIDTH="208" HEIGHT="53">리베이트 투아웃제</TD>
<TD WIDTH="722" HEIGHT="53">- 리베이트 금액, 지급횟수에 따라 최대 1년 요양급여 정지&cr;- 리베이트 2회 적발 시 해당 품목의 보험목록 삭제 (2018년 9월 28일 폐지)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="122">2014</TD>
<TD WIDTH="208" HEIGHT="122">저가 구매 인센티브제를&cr;포함하는 시장형 실거래가제</TD>
<TD WIDTH="722" HEIGHT="122">- 요양기관이 의약품을 저렴하게 구매하면 그 혜택을 요양기관과 환자가 공유하는 제도&cr;- 시장형 실거래가제: 정부가 지정한 상한금액보다 요양기관이 의약품을 저렴하게 구입 시, 실거래가 &cr;조사를 통해 상한가 대비 차액분만큼 인하&cr;- 저가 구매 인센티브제: 정부가지정한 상한금액보다 요양기관이 의약품을 저렴하게 구입 시, 저가 구매를통한 기관 절감액을 산정하여 기관별 지급율(10~30%)에 따라 인센티브를 차등하여 지급</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30">2016</TD>
<TD WIDTH="208" HEIGHT="30">약가 재평가(매년) </TD>
<TD WIDTH="722" HEIGHT="30">- 국내 약가를 선진 A7국가 조정평균가 이하로 인하</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">2016</TD>
<TD WIDTH="208" HEIGHT="53">실거래가제도</TD>
<TD WIDTH="722" HEIGHT="53">- 유통 실거래가를 가중평균으로 조사하여 보험약가 인하&cr;- 2년 단위 실시 → 약가조사 2년 단위로 기간 확대</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">2016</TD>
<TD WIDTH="208" HEIGHT="53">부정청탁금지법&cr;(김영란법)</TD>
<TD WIDTH="722" HEIGHT="53">- 공직자 등(국·공립 병원 의사 및 대학병원 교수 포함)이 직무 관련성과 상관없이 1회 100만원(연 300만원)이상 금품 수수 시 형사처벌</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">2018</TD>
<TD WIDTH="208" HEIGHT="53">경제적 이익지출보고서&cr; 작성 의무화</TD>
<TD WIDTH="722" HEIGHT="53">- 제약사 및 의료기기 업체에서 의료인에게 경제적 이익 제공 시 해당 내역을 보고서로 작성 및 5년간 &cr;보관 의무화</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="53">2019</TD>
<TD WIDTH="208" HEIGHT="53">제네릭 약가제도&cr;개편방안(시행예정)</TD>
<TD WIDTH="722" HEIGHT="53">- 자체 생물학적 동등성 시험 실시와 등록된 원료의약품 사용시에만 제네릭 약가 보장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="36">
<P>2020</P>
</TD>

<TD WIDTH="208" HEIGHT="36">
<P>제네릭 약가제도 개편</P>
</TD>

<TD WIDTH="722" HEIGHT="36">
<P>- 복제(제네릭) 의약품 약가 산정 기준 및 가산제도 개편</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="35">
<P>2020</P>
</TD>

<TD WIDTH="208" HEIGHT="35">
<P>불순물 자료제출 의무화</P>
</TD>

<TD WIDTH="722" HEIGHT="35">
<P>- 유전독성·발암물질(ICH M7) & 금속불순물(Q3D) 자료 제출 시행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="32">
<P>2020</P>
</TD>

<TD WIDTH="208" HEIGHT="32">
<P>제네릭 약가 협상 시행</P>
</TD>

<TD WIDTH="722" HEIGHT="32">
<P>- 「약가협상지침」개정에 따른 제네릭의약품 등 산정대상 약제도 협상을 실시</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『수주상황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_수주상황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>
<P USERMARK="F-GL11">                                                                                               ( 단위: 원)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="577">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">과           목</TD>
<TD WIDTH="135" VALIGN="MIDDLE" HEIGHT="30">제10기 (당기)</TD>
<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30">제 9 (전)기</TD>
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30">제 8 (전전)기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> 자                       산 </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅰ. 유  동    자  산  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　41,692,801,876</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">37,564,876,599</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">29,532,439,817</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> (1) 당  좌    자  산 </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　28,806,550,047</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">27,198,076,477</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">21,959,209,042</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> (2) 재  고    자  산 </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　12,886,251,829</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">10,366,800,122</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">  7,573,230,775</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅱ. 비  유  동  자  산  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　22,794,296,915</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">14,309,417,872</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30"> 14,356,798,427</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> (1) 투  자    자  산  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">  　1,114,346,906</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">    197,872,462</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">        4,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> (2) 유  형    자  산  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　20,408,228,572</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">12,534,362,120</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30"> 12,614,134,558</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> (3) 무  형    자  산 </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">    　460,213,677</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">    733,675,530</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">  1,030,731,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> (4) 기타  비유동자산  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">    　811,507,760</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">    843,507,760</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">     707,932,560</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30">자      산      총      계</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　64,487,098,791</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">51,874,294,471</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">  43,889,238,244</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> 부                       채 </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅰ. 유  동    부  채  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　35,762,862,741</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">32,963,902,204</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">27,427,785,230</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅱ. 비  유  동  부  채  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　  8,395,082,917</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">  6,063,861,942</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">  4,900,634,981</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30">부     채     총      계</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　44,157,945,658</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">39,027,764,146</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30"> 32,328,420,211</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> 자                       본 </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅰ. 자      본      금  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　  5,617,210,000</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">     523,300,000</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">     523,300,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅱ. 자  본  잉  여  금  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　  4,464,311,470</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">  1,174,512,500</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">   1,174,512,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅲ. 자   본    조   정  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅳ. 기타포괄손익누계액  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">       △5,227,659</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">    △2,205,970</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> Ⅴ. 이  익  잉  여  금  </TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">　10,252,859,322</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ALIGN="CENTER">11,150,923,795</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ALIGN="CENTER">9,863,005,533</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30">자     본     총     계</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">　20,329,153,133</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ALIGN="CENTER">12,846,530,325</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ALIGN="CENTER">11,560,818,033</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30">부  채  및  자   본  총  계</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">　 64,487,098,791</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ALIGN="CENTER">51,874,294,471</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ALIGN="CENTER">43,889,238,244</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30">(손익계산정보)</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">   2020년1-12월</TD>
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ALIGN="CENTER">2019년1-12월</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ALIGN="CENTER">2018년1-12월</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> 매      출      액</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">　 70,767,092,805</TD>
<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">64,633,534,009</TD>
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">43,133,025,244</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> 영    업   이   익</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">       798,255,072</TD>
<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3,088,190,882</TD>
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3,379,017,551</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> 법인세비용차감전순이익</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">　    294,830,900</TD>
<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2,834,139,117</TD>
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3,231,637,160</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30"> 당  기  순  이  익</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">  　(898,064,473)</TD>
<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2,793,685,477</TD>
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1,467,466,399</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="193" HEIGHT="30">주당순이익</TD>
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ALIGN="CENTER">(80.2)　</TD>
<TD WIDTH="121" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">    27,753</TD>
<TD VALIGN="MIDDLE" WIDTH="128" HEIGHT="30" ALIGN="CENTER">            14,578 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<WARNING>※ 아래 『재무제표』단위서식을 클릭하여 해당사항을 선택하면,&cr;    2.연결재무제표 ~ 5.재무제표주석 항목을 삽입할 수 있습니다.</WARNING>
</SECTION-2>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『재무제표』 삽입</COMMENT>
<LIBRARYLIST>11011#*재무제표_*.*</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">재무제표_직접작성</FILENAME>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>

<P>
<SPAN USERMARK="F-GL">  당사는 </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">사</SPAN>
<SPAN USERMARK="F-GL">업보</SPAN>
<SPAN USERMARK="F-GL">고서 제출일 현재 대상 연결회사가 없으므로 요약 연결재무현황은 작성하지 않습니다</SPAN>
</P>
<P USERMARK="F-GL"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P USERMARK="F-GL">  </P>

<P>
<SPAN USERMARK="F-GL">당사는</SPAN>
<SPAN USERMARK="F-GL 0X0000FF"> </SPAN>
<SPAN USERMARK="F-GL">사업보고서 제출일 현재 대상 연결회사가 없으므로 요약 연결재무현황은 작성하지 않습니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>
<P USERMARK="F-GL11">재 무 상 태 표</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="732" BORDER="0">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="415"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="732" HEIGHT="30">
<SPAN>제 10 기 </SPAN>
<SPAN>2020년</SPAN>
<SPAN> 12월 31일 현재</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="732" HEIGHT="30">
<SPAN>제 9 기 </SPAN>
<SPAN>2019년</SPAN>
<SPAN> 12월 31일 현재</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="732" HEIGHT="30">제 8 기 2018년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="308" HEIGHT="30">주식회사 마더스제약</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="424" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="989">

<COLGROUP>
<COL WIDTH="231"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="240" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과                        목</TH>
<TH WIDTH="257" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10 기</TH>
<TH WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 9기</TH>
<TH WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 8기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">자                        산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">I. 유동자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">41,692,801,876</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">37,564,589,479</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">29,532,439,817</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="240" HEIGHT="30">(1) 당좌자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">28,806,550,047</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">27,197,789,357</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">21,959,209,042</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">현금및현금성자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">8,490,558,181</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">902,672,039</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,668,850,545</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">정부보조금<주석8,9></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(3,506,823,336)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">단기금융상품</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,150,423,570</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">742,090,660</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">매출채권<주석14></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">21,980,070,531</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">23,192,940,789</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">18,281,785,004</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">대손충당금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(23,784,934)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(49,367,471)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(75,157,029)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">단기대여금<주석14></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">471,228,750</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">591,971,616</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">334,703,150</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">미수수익</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">24,747,065</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">17,397,134</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">26,291,707</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">미수금<주석14></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">704,911,174</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">784,465,908</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">399,347,170</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">선급금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">113,069,824</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">577,171,934</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">517,049,444</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">선급비용</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">551,559,662</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">30,113,838</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">64,248,391</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">당기법인세자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">1,013,130</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="240" HEIGHT="30">(2) 재고자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">12,886,251,829</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">10,366,800,122</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">7,573,230,775</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">제품</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">7,298,741,932</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,036,738,842</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,860,567,489</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">원재료</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">3,644,528,954</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,649,017,004</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,367,545,754</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">부재료</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">291,418,240</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">244,032,240</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">277,579,980</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">재공품</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">1,651,532,703</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,437,012,036</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,067,537,552</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">미착품</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">30,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">II. 비유동자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">22,794,296,915</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">14,309,417,872</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">14,356,798,427</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="240" HEIGHT="30">(1) 투자자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,114,346,906</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">197,872,462</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">4,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">장기금융상품<주석8></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">773,468,861</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">매도가능증권<주석3></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">340,878,045</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">193,872,462</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="240" HEIGHT="30">(2) 유형자산<주석4,8,14></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">20,408,228,572</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">12,534,362,120</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">12,614,134,558</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">토지</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">6,748,740,287</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,691,942,704</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,691,942,704</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">건물</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">7,197,405,383</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,096,499,026</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,015,518,176</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">감가상각누계액</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(751,758,919)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(572,244,232)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(395,675,311)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">기계장치</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">5,211,029,216</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,694,726,216</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,308,413,694</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">감가상각누계액</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(3,622,160,260)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(2,964,818,602)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(2,177,601,825)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">정부보조금<주석9></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(91,865,950)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">차량운반구</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">534,743,742</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">504,743,742</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"> 504,743,742</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">감가상각누계액</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(424,583,446)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(326,853,467)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(231,662,295)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">비품</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">1,476,763,393</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,380,979,860</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,213,091,468</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">감가상각누계액</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(811,475,669)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(565,848,386)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(338,599,772)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">시험검사기기</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">3,154,832,581</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,642,811,012</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,771,588,588</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">감가상각누계액</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(1,706,500,122)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,199,769,087)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(782,827,945)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">시설장치</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">578,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">178,700,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">35,800,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">감가상각누계액</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(96,181,664)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(26,506,666)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(596,666)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">4,744,416,664</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">정부보조금<주석9></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(1,733,176,664)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="240" HEIGHT="30">(3) 무형자산<주석5></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">460,213,677</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">733,675,530</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,030,731,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">특허권</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">315,443,706</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">412,825,886</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">510,208,066</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">상표권</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">761,136</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,775,984</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,790,832</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">면허권</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">45,006,990</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">105,975,682</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">167,551,441</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">개발비</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">56,081,011</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">149,575,144</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">266,056,136</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">42,920,834</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">63,522,834</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">84,124,834</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="240" HEIGHT="30">(4) 기타비유동자산</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">811,507,760</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">843,507,760</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">707,932,560</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">임차보증금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">247,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">209,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">145,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">기타보증금<주석14></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">62,659,370</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">62,659,370</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">62,659,370</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">회원권</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">501,848,390</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">571,848,390</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">500,273,190</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">자      산      총      계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">64,487,098,791</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">51,874,007,351</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">43,889,238,244</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">부                        채</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">I. 유동부채</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">35,762,862,741</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">32,963,615,084</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">27,427,785,230</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">매입채무<주석14,19></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">18,350,819,858</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">20,703,139,904</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">14,491,162,069</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">미지급금<주석14,19></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">3,585,760,794</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,118,773,697</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">945,624,014</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">미지급비용<주석19></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">1,165,965,614</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">712,805,634</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">627,569,558</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">단기차입금<주석6,8,19></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">9,803,408,033</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">8,043,236,912</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,169,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="53">유동성장기차입금<주석6,8,14,19></TD>
<TD WIDTH="136" HEIGHT="53" ALIGN="RIGHT">2,694,779,025</TD>
<TD WIDTH="121" HEIGHT="53" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="53" ALIGN="RIGHT">1,106,773,039</TD>
<TD WIDTH="121" HEIGHT="53" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="53" ALIGN="RIGHT">1,718,997,608</TD>
<TD WIDTH="121" HEIGHT="53" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">부가세예수금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">98,696,669</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">339,069,720</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">예수금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">87,953,762</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">64,930,017</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">55,695,650</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">선수금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">57,099,902</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">76,144,032</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">86,632,521</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">당기법인세부채</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">17,075,753</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">39,115,180</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,994,034,090</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">II. 비유동부채</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">8,395,082,917</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">6,063,861,942</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">4,900,634,981</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">장기차입금<주석6,8,19></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">8,205,082,917</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">5,888,861,942</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,755,634,981</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">임대보증금<주석14,19></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">190,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">175,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">145,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">부      채      총      계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">44,157,945,658</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">39,027,477,026</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">32,328,420,211</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">자                        본</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">I. 자본금<주석10></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">5,617,210,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">523,300,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">523,300,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">보통주자본금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">5,597,210,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">503,300,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">503,300,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">우선주자본금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">20,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">20,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">20,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">II. 자본잉여금<주석10></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">4,464,311,470</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,174,512,500</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,174,512,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">주식발행초과금(보통주)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">3,293,736,470</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,937,500</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,937,500</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">주식발행초과금(우선주)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">980,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">980,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">980,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">자기주식처분이익</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">190,575,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">190,575,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">190,575,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">III. 기타포괄손익누계액</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(5,227,659)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(2,205,970)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">매도가능증권평가손</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(5,227,659)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(2,205,970)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">Ⅳ. 이익잉여금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">10,252,859,322</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">11,150,923,795</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">9,863,005,533</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">이익준비금<주석13></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">79,980,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">79,980,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">29,980,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="240" HEIGHT="30">미처분이익잉여금<주석11></TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">10,172,879,322</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">11,070,943,795</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">9,833,025,533</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">자      본      총      계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">20,329,153,133</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">12,846,530,325</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">11,560,818,033</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">부  채  및  자  본  총  계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">64,487,098,791</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">51,874,007,351</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">43,889,238,244</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;&cr;</P>
<P USERMARK="F-GL11">손 익 계 산 서</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="714" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="405"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="714" HEIGHT="30">제 10 기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="714" HEIGHT="30">제 9 기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="714" HEIGHT="30">제 8기 2018년 01월 01일부터 2018년 12월31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">주식회사 마더스제약</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="414" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="948">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과                        목</TH>
<TH WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10기</TH>
<TH WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 9기</TH>
<TH WIDTH="246" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 8기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">I. 매출액<주석14></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">70,767,092,805</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">64,633,534,009</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">43,133,025,244</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">제품매출</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">67,509,645,024</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">59,164,158,131</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">40,961,664,931</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">수수료매출</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,669,571,262</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,528,021,065</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">798,311,563</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">용역매출</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">587,876,519</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,941,354,813</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,373,048,750</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">II. 매출원가<주석14></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">34,865,856,762</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">34,644,785,632</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">28,793,882,163</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">제품매출원가</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">34,865,856,762</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">34,644,785,632</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">28,793,882,163</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="210" HEIGHT="30">기초제품재고액</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,036,738,842</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,860,567,489</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,734,026,023</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="210" HEIGHT="30">당기제품제조원가</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">38,127,859,852</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">34,820,956,985</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">29,920,423,629</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="210" HEIGHT="30">기말제품재고액</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(7,298,741,932)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(4,036,738,842)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(3,860,567,489)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">III. 매출총이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">35,901,236,043</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">29,988,748,377</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">14,339,143,081</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">IV. 판매비와관리비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">35,102,980,971</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">26,900,557,495</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">10,960,125,530</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">급여<주석16></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,845,456,824</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,044,633,771</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,888,760,099</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">퇴직급여<주석7,16></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">212,959,045</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">269,498,928</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">147,016,599</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">복리후생비<주석16></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">238,150,230</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">305,367,475</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">243,358,509</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">여비교통비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">60,609,124</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">144,868,916</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">209,015,983</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">접대비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">158,262,482</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">140,384,541</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">120,927,557</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">통신비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">24,067,437</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">18,853,100</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">17,894,945</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">세금과공과<주석16></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">138,211,517</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">42,158,960</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">57,548,470</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">감가상각비<주석16></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">521,466,905</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">485,646,437</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">373,491,406</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">지급임차료<주석16></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">17,445,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">18,390,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">67,896,666</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">보험료</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">89,099,865</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">318,778,378</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">256,288,159</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">차량유지비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">28,534,518</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">30,320,592</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">27,657,448</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">경상연구개발비<주석15></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,817,184,187</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,115,477,856</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">963,417,511</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">운반비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">191,165,520</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">123,231,999</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">103,610,211</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">교육훈련비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">24,348,020</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">25,788,374</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">16,578,793</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">도서인쇄비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">85,019,264</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">74,352,488</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">44,593,967</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">회의비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,240,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">36,519,630</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">12,025,817</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">사무용품비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,714,721</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,854,605</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">5,568,402</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">소모품비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">17,524,561</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">24,672,172</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">37,511,724</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">지급수수료<주석14></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,329,563,104</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">900,858,438</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">680,202,821</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">광고선전비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">180,127,267</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">493,171,834</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">181,886,884</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">대손상각비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">195,529,392</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(25,789,558)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,034,306</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">건물관리비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">147,537,711</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">153,189,603</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">112,932,827</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">판매수수료</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">26,463,002,424</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">18,822,227,991</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,766,786,779</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">무형자산상각비<주석5></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">273,461,853</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">297,055,779</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">367,822,690</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">판매장려금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,705,186</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">235,896,957</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">협회비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">40,300,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">31,340,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">17,400,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">V. 영업이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">798,255,072</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">3,088,190,882</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">3,379,017,551</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">VI. 영업외수익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">302,552,063</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">351,767,369</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">333,404,356</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">이자수익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">32,037,917</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">19,535,439</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">28,251,991</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">외환차익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">694,341</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,039,406</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,091,274</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">   외화환산이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,586,999</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">단기매매증권처분이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,886,510</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">5,078,620</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">수입임대료<주석14></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">190,909,104</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">190,909,104</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">164,509,097</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">보험차익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">38,510,477</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">잡이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">32,513,714</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">138,283,420</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">131,886,375</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">VII. 영업외비용</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">805,976,235</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">605,819,134</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">480,784,747</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">이자비용</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">521,070,387</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">533,584,313</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">443,278,783</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">외환차손</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,787,917</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,951,166</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,392,934</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">기타의대손상각비</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">30,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">매출채권처분손실</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">18,617,788</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">20,923,806</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,751,534</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">회원권처분손실</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">6,363,636</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">   단기매매증권처분손실</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">682,082</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">투자자산평가손실</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">163,441,258</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">기부금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">58,100,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">17,500,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">17,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="210" HEIGHT="30">잡손실</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">5,595,249</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">31,859,849</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">12,679,414</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">VIII. 법인세비용차감전순이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">294,830,900</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,834,139,117</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">3,231,637,160</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">IX. 법인세등</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,192,895,373</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">40,453,640</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,764,170,761</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30">X. 당기순이익<주석17></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">(898,064,473)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,793,685,477</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,467,466,399</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;&cr;</P>
<P USERMARK="F-GL11">자 본 변 동 표</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">제 10 기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">제 9 기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">제 8기 2018년 01월01일부터 2018년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">주식회사 마더스제약</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="764">

<COLGROUP>
<COL WIDTH="168"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="177" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과     목</TH>
<TH WIDTH="116" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자 본 금</TH>
<TH WIDTH="125" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자  본&cr;잉여금</TH>
<TH WIDTH="96" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄&cr;손익누계액</TH>
<TH WIDTH="125" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이  익&cr;잉여금</TH>
<TH WIDTH="125" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">2018.01.01(전기초)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,013,125,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">194,512,500</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,596,851,634</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,804,489,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">당기순이익</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,467,466,399</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,467,466,399</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">연차배당</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(201,312,500)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(201,312,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">유상감자</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,509,825,000)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,509,825,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">유상증자</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">980,000,000</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">2018.12.31(전기말)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">523,300,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,174,512,500</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,863,005,533</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,560,818,033</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">2019.01.01 (전기초)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">523,300,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,174,512,500</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,863,005,533</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,560,818,033</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE" USERMARK=" P16">연차배당</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(500,000,000)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(500,000,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE" USERMARK=" P16">상환우선주의 상환</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,005,767,215)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,005,767,215)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="39" VALIGN="MIDDLE" USERMARK=" P16">매도가능증권평가손실</TD>
<TD WIDTH="116" HEIGHT="39" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="39" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="39" ALIGN="RIGHT" VALIGN="MIDDLE">(2,205,970)</TD>
<TD WIDTH="125" HEIGHT="39" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="39" ALIGN="RIGHT" VALIGN="MIDDLE">(2,205,970)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE" USERMARK=" P16">당기순이익</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,793,685,477</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,793,685,477</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">2019.12.31 (전기말)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">523,300,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,174,512,500</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,205,970)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,150,923,795</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,846,530,325</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">2020.01.01 (당기초)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">523,300,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,174,512,500</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,205,970)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,150,923,795</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,846,530,325</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">유상증자</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">56,421,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,402,608,800</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,459,029,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">무상증자</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,037,489,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(5,112,809,830)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(75,320,830)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">매도가능증권평가손실</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,021,689)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,021,689)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">당기순손실</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(898,064,473)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(898,064,473)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">2020.12.31 (당기말)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,617,210,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,464,311,470</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(5,227,659)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,252,859,322</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,329,153,133</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;&cr;</P>
<P USERMARK="F-GL11">현 금 흐 름 표</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="616" BORDER="0">

<COLGROUP>
<COL WIDTH="299"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="616" HEIGHT="33">제 10 기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="616" HEIGHT="33">제 9 기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="616" HEIGHT="33">제 8기 2018년 01월 01일부터 2018년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="308" HEIGHT="33">주식회사 마더스제약</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="308" HEIGHT="33">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1029">

<COLGROUP>
<COL WIDTH="262"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="271" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과                        목</TH>
<TH WIDTH="258" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10(당) 기</TH>
<TH WIDTH="250" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 9(전) 기</TH>
<TH WIDTH="250" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"></TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">Ⅰ. 영업활동으로인한현금흐름</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,836,727,143)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,960,908,601</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">474,833,977</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="271" HEIGHT="30">1.당기순이익</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(898,064,473)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,793,685,477</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,467,466,399</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="271" HEIGHT="30">2.현금의유출이없는비용등의가산</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">2,275,757,259</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,000,342,847</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,815,798,708</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">대손상각비</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">195,529,392</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(25,789,558)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,034,306</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">매출채권처분손실</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">18,617,788</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,751,534</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">감가상각비</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">1,751,784,590</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,729,076,626</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,439,190,178</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">273,461,853</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">297,055,779</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">367,822,690</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">회원권처분손실</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">6,363,636</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">기타의대손상각비</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">30,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="271" HEIGHT="30">3.현금의유입이없는수익등의차감</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(7,913,782)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(5,078,620)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">잡이익</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">27,272</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">단기매매증권처분이익</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">7,886,510</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">5,078,620</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="271" HEIGHT="30">4.영업활동으로인한자산부채의변동</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(3,206,506,147)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(2,833,119,723)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(2,803,352,510)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">단기매매증권의 감소(증가)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">7,886,510</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">10,486,307</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">매출채권의 감소(증가)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">973,140,541</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(4,911,155,785)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(11,637,702,074)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">미수수익의 감소(증가)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(7,349,931)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">8,894,573</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(26,291,707)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">미수금의 감소(증가)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">79,554,734</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(385,118,738)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(100,885,387)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">선급금의 감소(증가)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">464,102,110</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(60,122,490)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(356,598,589)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">선급비용의 감소(증가)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(521,445,824)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">34,134,553</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(40,096,429)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">당기법인세자산의감소(증가)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(726,010)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">재고자산의 감소(증가)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(2,519,451,707)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(2,793,569,347)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,361,821,137)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">매입채무의 증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(2,352,320,046)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">6,211,977,835</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,874,262,939</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">미지급금의 증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">333,987,097</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,186,235,783</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">698,226,170</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">미지급비용의 증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">453,159,980</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">85,236,076</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">312,512,088</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">부가세예수금의 증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(98,696,669)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(240,373,051)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">339,069,720</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">예수금의 증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">23,023,745</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">9,234,367</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">23,506,007</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">예수보증금의 증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(13,086,100)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(18,890,100)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">선수금의 증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(19,044,130)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(10,488,489)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(134,108,609)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">당기법인세부채의 증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(22,326,547)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,954,918,910)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,614,978,291</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">Ⅱ. 투자활동으로인한현금흐름</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(8,145,317,103)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(2,646,559,196)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(3,089,257,459)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="271" HEIGHT="30">1.투자활동으로인한현금유입액</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">3,267,077,598</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">433,875,040</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">377,428,105</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">단기금융상품의 감소</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">1,150,423,570</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">단기대여금의 감소</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">223,140,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">397,875,040</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">377,428,105</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">정부보조금의 수령</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">1,829,877,664</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">임차보증금의 감소</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">36,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">회원권의 처분</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">63,636,364</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="271" HEIGHT="30">2.투자활동으로인한현금유출액</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(11,412,394,701)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(3,080,434,236)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(3,466,685,564)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">단기금융상품의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">408,332,910</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">398,050,380</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">장기금융상품의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">769,468,861</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">매도가능증권의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">150,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">196,078,432</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">단기대여금의 증가</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">102,397,134</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">655,143,506</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">토지의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">5,056,797,583</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">건물의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">100,906,357</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">80,980,850</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">170,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">기계장치의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">7,900,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">386,312,522</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">771,800,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">차량운반구의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">30,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">25,115,070</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">비품의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">95,783,533</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">167,888,392</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">369,427,909</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">시험검사기기의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">453,021,569</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">871,222,424</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">293,072,805</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">시설장치의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">399,300,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">142,900,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">35,800,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">건설중인자산의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">4,178,819,664</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,079,576,510</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">임차보증금의 증가</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">68,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">100,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">72,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">       소프트웨어의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">103,010,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">       기타보증금의 증가</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">6,259,700</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">회원권의 취득</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">71,575,200</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">142,573,190</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">Ⅲ.재무활동으로인한현금흐름</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">14,063,107,052</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(80,527,911)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,848,051,431</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="271" HEIGHT="30">1.재무활동으로인한현금유입액</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">18,278,558,033</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">5,154,236,912</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,834,489,318</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">단기차입금의 증가</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">4,789,408,033</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,124,236,912</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">900,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">장기차입금의 증가</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">5,011,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,000,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,839,489,318</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">임대보증금의 증가</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">15,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">30,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">95,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">유상증자</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">8,463,150,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,000,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P16" WIDTH="271" HEIGHT="30">2.재무활동으로인한현금유출액</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">(4,215,450,981)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(5,234,764,823)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(986,437,887)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">단기차입금의 상환</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">3,029,236,912</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,250,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">유동성장기차입금의 상환</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">1,106,773,039</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,478,997,608</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">58,665,387</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">주식발행비용</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">79,441,030</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">상환우선주의 상환</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,005,767,215</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">       유상감자</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">726,460,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" P32" WIDTH="271" HEIGHT="30">현금배당</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">500,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">201,312,500</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">Ⅳ. 현금의증가(감소)(Ⅰ+Ⅱ+Ⅲ)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,081,062,806</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(766,178,506)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">233,627,949</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">Ⅴ. 기초의현금</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">902,672,039</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,668,850,545</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,435,222,596</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="271" HEIGHT="30">Ⅵ. 기말의현금</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,983,734,845</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">902,672,039</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">1,668,850,545</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" HEIGHT="33" ALIGN="CENTER">
<SPAN>제 10 기 </SPAN>
<SPAN>2020년</SPAN>
<SPAN> 12월 31일 현재</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" HEIGHT="33" ALIGN="CENTER">
<SPAN>제 9 기 </SPAN>
<SPAN>2019년</SPAN>
<SPAN> 12월 31일 현재</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="33">주식회사 마더스제약</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">1. 회사의 개요</P>
<P USERMARK="F-GL11">&cr;주식회사 마더스제약(이하 "회사"라 함)은 2011년 7월 18일자로 설립되었으며,  회사의 본사 및 공장소재지와 주요사업 내용 등은 다음과 같습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(1) 본사 및 공장 소재지</P>
<P USERMARK="F-GL11">   1) 본사 소재지 : 서울특별시 동작구 보라매로5길 51, 501호(신대방동, 롯데타워)&cr;   2) 공장 소재지 : 경북 경산시 진량읍 공단 6로 24길 18&cr;   3) 공장 건설 현장 : 전북 익산시 삼기면 오룡리 1252번지</P>
<P USERMARK="F-GL11">(2) 주요사업 내용 : 의약품 제조업</P>
<P USERMARK="F-GL11">(3) 대표이사 : 김좌진</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 주요 주주 및 지분율</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="614" BORDER="1">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주  주  명</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수(주)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수(주)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30">대표이사(최대주주)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">     4,430,100 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">39.57%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">44,301 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">44.01%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30">최대주주 특수관계인</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">     1,630,210 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">14.56%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">15,702 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">15.60%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30">기타</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">     5,134,110 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">45.87%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">40,657 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">40.39%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="158" HEIGHT="30">합    계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">    11,194,420 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">100.00%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">100,660 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(*1) 회사는 2020년 7월 7일자로 자본금에 대하여 1:10으로 액면분할을 실시하였으며, 이로 인하여 회사의 1주당 액면금액은 500원으로 변경되었고 발행주식총수는 1,006,600주가 되었습니다.&cr;(*2) 회사는 2020년 9월 25일자로 제3자배정 유상증자를 통해 112,842주를 신주발행하였고, 발행주식총수는 1,119,442주가 되었습니다.&cr;(*3) 회사는 2020년 10월 23일자로 무상증자를 실시하였으며, 구주 1주당 9주의 신주를 배정하여 발행주식총수는 11,194,420주가 되었습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>
<P USERMARK="F-GL11">2. 중요한 회계처리방침</P>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">회사의 재무제표는 일반기업회계기준에 따라 작성되었으며, 2020년 1월 1일 이후 최초로 시작하는 회계연도부터 적용되는 다음의 개정 기준서를 신규로 적용한 것을 제외하고는 전기재무제표 작성시 채택한 회계정책과 동일하게 적용되었습니다. &cr;&cr;- 일반기업회계기준 제8장 '지분법' (개정)&cr;&cr;개정된 기준은 실질적으로 기업의 관계기업에 대한 순투자액의 일부를 구성하는 우선주, 장기대여금, 장기수취채권 등과 같은 장기투자항목이 제6장 '금융자산ㆍ금융부채'의 적용 대상임을 명확히 하였으며, 관계기업에 대한 순투자의 일부를 구성하는 장기투자지분의 손상 회계처리에 대해서는 제6장 '금융자산ㆍ금융부채'를 우선하여 적용하고 제8장 '지분법'에 따른 관계기업의 손실을 추가로 반영하는 것으로 개정하였습니다. 동 개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr; &cr; - 일반기업회계기준 제16장 '수익' (개정)&cr;&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">개정된 기준은 기업이 구매자에게 지급할 대가가 구매자에게서 받은 구별되는 재화나 용역에 대한 지급이라면 수익에서 차감하지 않는다는 점을 명확히 하였습니다. 동 개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr;&cr;- 일반기업회계기준 제18장 '차입원가' (개정)&cr;&cr;개정된 기준은 특정차입금을 관련 적격자산 차입원가 자본화가 종료되기 전까지의 자금으로 한정하며, 자본화가 종료되면 일반차입금에 포함됨을 명확히 하여 자본화이자율 산정 시 고려할 수 있는 것으로 개정하였습니다. 동 개정이 재무제표에 미치는 중요한 영향은 없습니다.</SPAN>
</P>
<P USERMARK="F-GL11"> </P>

<P>
<SPAN USERMARK="F-GL11">회사의 중요한 회계처리방침은 다음과 같습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">(1) 금융상품</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">1) 공통사항&cr;금융자산이나 금융부채는 금융상품의 계약당사자가 되는 때에만 재무상태표에 인식하며, 최초인식시 공정가치로 측정합니다. 다만, 최초인식 이후 공정가치로 측정하고 공정가치의 변동을 당기손익으로 인식하는 금융자산이나 금융부채가 아닌 경우 당해 금융자산(금융부채)의 취득(발행)과 직접 관련되는 거래원가는 최초인식하는 공정가치에 가산(차감)합니다. &cr;&cr;최초 인식시 금융상품의 공정가치는 일반적으로 거래가격(자산의 경우에는 제공한 대가의 공정가치, 부채의 경우에는 수취한 대가의 공정가치)이며, 장기연불조건의 매매거래, 장기금전대차거래 또는 이와 유사한 거래에서 발생하는 채권,채무로서 명목금액과 공정가치의 차이가 유의적인 경우에는 이를 공정가치로 평가하고 있습니다. 한편, 제공하거나 수취한 대가에 금융상품이 아닌 다른 것에 대한 대가가 포함되었다면 그 금융상품의 공정가치는 시장가격으로 평가하되 시장가격이 없는 경우에는 평가기법(현재가치평가기법 포함)을 사용하여 공정가치를 추정하고 있습니다.&cr;&cr;최초 인식 후 금융상품은 당기손익인식지정항목, 유가증권, 파생상품 및 채권·채무조정을 제외하고는 상각후원가로 측정하며 금융상품의 현금흐름에 대한 추정 변경 또는 재협상 등으로 현금흐름이 변경되는 경우에는 실제 현금흐름과 변경된 계약상 현금흐름을 반영하여 해당 금융자산의 순장부금액이나 금융부채 상각후원가를 조정하고 조정금액은 당기손익으로 인식합니다.(해당 금융상품이 채권·채무조정에 해당되거나 대손상각비(손상차손)와 관련된 추정 변경 등의 경우는 제외)&cr;&cr;금융자산(유가증권 제외)의 양도의 경우에, 회사가 금융자산 양도후 당해 양도자산에 대한 권리를 행사할 수 없고, 양도후에 효율적인 통제권을 행사할 수 없으며, 양수인은 양수한 금융자산을 처분할 자유로운 권리를 갖고 있는 경우에 한하여 회사가 금융자산에 대한 통제권을 이전한 것으로 보아 금융자산을 제거하며, 이외의 경우에는 금융자산을 담보로 한 차입거래로 회계처리하고 있습니다.&cr;     &cr;회수가 불확실한 금융자산(유가증권 제외)은 합리적이고 객관적인 기준에 따라 산출한 대손추산액을 대손충당금으로 설정하고 있습니다.&cr;  &cr;</SPAN>
<SPAN USERMARK="F-GL11">2) 유가증권&cr;만기가 확정된 채무증권으로서 상환금액이 확정되었거나 확정이 가능한 채무증권을 만기까지 보유할 적극적인 의도와 능력이 있는 경우에는 만기보유증권으로, 주로 단기간 내의 매매차익을 목적으로 취득한 유가증권으로서 매수와 매도가 적극적이고 빈번하게 이루어지는 경우 단기매매증권으로, 단기매매증권이나 만기보유증권으로 분류되지 아니하는 유가증권은 매도가능증권으로 분류합니다.&cr;&cr;회사는 후속 측정시 만기보유증권을 상각후원가로 평가하며, 만기보유증권을 상각후원가로 측정할 때에는 장부금액과 만기액면금액의 차이를 상환기간에 걸쳐 유효이자율법에 의하여 상각하여 취득원가와 이자수익에 가감합니다.&cr;단기매매증권과 매도가능증권은 공정가치로 평가합니다. 다만, 매도가능증권 중 시장성이 없는 지분증권의 공정가치를 신뢰성있게 측정할 수 없는 경우에는 취득원가로 평가하고 있습니다. &cr;단기매매증권에 대한 미실현보유손익은 당기손익항목으로 처리합니다. 매도가능증권에 대한 미실현보유손익은 기타포괄손익누계액으로 처리하고, 당해 유가증권에 대한 기타포괄손익누계액은 그 유가증권을 처분하거나 손상차손을 인식하는 시점에 일괄하여 당기손익에 반영합니다.&cr;한편, 유가증권의 양도에 따른 실현손익을 인식하기 위한 원가결정방법은 이동평균법을 적용하고 있습니다.&cr;&cr;회사는 손상차손의 발생에 대한 객관적인 증거가 있는지를 보고기간종료일마다 평가하고 유가증권으로부터 회수할 수 있을 것으로 추정되는 금액이 채무증권의 상각후원가 또는 지분증권의 취득원가보다 작은 경우에는 손상차손이 불필요하다는 명백한 반증이 없는 한, 회수가능액을 추정하여 손상차손을 인식하여 당기손익에 반영하고 있습니다. 손상차손의 회복이 손상차손 인식 후에 발생한 사건과 객관적으로 관련된 경우, 만기보유증권 또는 원가로 평가하는 매도가능증권의 경우에는 회복 후 장부금액이 당초에 손상차손을 인식하지 않았다면 회복일 현재의 상각후원가(매도가능증권의 경우, 취득원가)가 되었을 금액을 초과하지 않는 범위내에서 회복된 금액을 당기이익으로 인식하며,  공정가치로 평가하는 매도가능증권의 경우에는 이전에 인식하였던 손상차손 금액을 한도로 하여 회복된 금액을 당기이익으로 인식합니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">3) 파생상품&cr;회사는 파생상품의 계약에 따라 발생된 권리와 의무를 자산과 부채로 인식하며 공정가치로 평가하고 있습니다. 동 계약으로부터 발생한 손익은 발생시점에 당기손익으로 인식하며, 다만, 위험회피를 목적으로 하는 경우, 특정위험으로 인한 자산, 부채 및 확정계약의 공정가치의 변동위험을 회피하는 계약에서 발생한 평가손익은 당기손익으로 처리하고, 특정위험으로 인한 자산, 부채 및 예상거래의 미래현금흐름변동위험을 회피하는 계약에서 발생한 평가손익 중 위험회피에 효과적인 부분은 기타포괄손익누계액으로 처리하고 있습니다.&cr;&cr;한편, 파생상품이 아닌 주계약을 포함하는 복합상품의 구성요소인 내재파생상품의 경우, 내재파생상품의 경제적 특성 및 위험도와 주계약의 경제적 특성 및 위험도 사이에 명확하고 밀접한 관련성이 없으며, 내재파생상품과 동일한 조건을 가진 별도의 금융상품 등이 파생상품의 정의를 충족하며, 복합상품이 공정가치 평가 대상이 아닌 경우 주계약과 분리하여 별도의 파생상품으로 회계처리하고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>
<P USERMARK="F-GL11">(2) 재고자산</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">재고자산 중 상품 및 제품은 선입선출법을, 그 외는 이동평균법을 사용하여 재고자산의 단위원가를 결정하고, 이를 장부금액으로 계상하고 있습니다.&cr;&cr;재고자산의 순실현가능가치(원재료는 현행대체원가)가 취득원가보다 하락한 경우 항목별로</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"> 저가법을 사용하여 장부금액을 결정하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">재고자산은 이를 판매하여 수익을 인식하는 기간에 매출원가로 인식하고 있습니다. 재고자산의 시가가 장부금액이하로 하락하여 발생한 평가손실은 재고자산의 차감계정으로 표시하고 매출원가에 가산하고 있으며, 이후 저가법의 적용에 따른 평가손실을 초래하였던 상황이 해소되어 새로운 시가가 장부금액보다 상승한 경우에는 최초의 장부금액을 초과하지 않는 범위 내에서 평가손실을 환입하고, 동 환입액은 매출원가에서 차감하고 있습니다. 재고자산의 장부상수량과 실제 수량과의 차이에서 발생하는 감모손실의 경우 정상적으로 발생한 감모손실은 매출원가에 가산하고, 비정상적으로 발생한 감모손실은 영업외비용으로 분류하고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">(3) 유형자산의 취득원가와 감가상각방법 등&cr;&cr;1) 유형자산의 취득원가&cr;&cr;유형자산은 구입원가 또는 제작원가와 자산을 사용할 수 있도록 준비하는데 직접 관련되는 지출과 매입할인 등을 취득원가에 가감하며, 현물출자, 증여, 기타 무상으로 취득한 자산은 공정가치를  취득원가로 계상하고 있으며, 장기후불조건으로 구입하거나, 대금지급기간이 일반적인 신용기간보다 긴 경우 취득원가는 취득시점의 현금가격상당액으로 계상하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;정부</SPAN>
<SPAN USERMARK="F-GL11">보조 등에 의해 자산을 무상 또는 공정가치보다 낮은 대가로 취득한 경우 취득원가는 취득일의 공정가치로 계상하고</SPAN>
<SPAN USERMARK="F-GL11"> 있고</SPAN>
<SPAN USERMARK="F-GL11">, 이종자산과의 교환으로 취득한 자산의 취득원가는 교환을 위하여 제공한 자산의 공정가치로 계상하고 있으며, 교환으로 제공한 자산의 공정가치가 불확실한 경우 교환으로 취득한 자산의 공정가치로 계상하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">2) 감가상각방법&cr;&cr;유형자산에 대해서는 다음의 내용연수에 따라</SPAN>
<SPAN USERMARK="F-GL11"> 감가상각하고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="620" BORDER="1">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="207" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">과             목</TH>
<TH ALIGN="CENTER" WIDTH="207" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">내  용  연  수</TH>
<TH ALIGN="CENTER" WIDTH="206" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">감가상각방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="28" USERMARK="F-10">건물</TD>
<TD ALIGN="CENTER" WIDTH="207" HEIGHT="28" USERMARK="F-10">40년</TD>
<TD ALIGN="CENTER" WIDTH="206" HEIGHT="28" USERMARK="F-10">정액법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="28" USERMARK="F-10">기계장치</TD>
<TD ALIGN="CENTER" WIDTH="207" HEIGHT="28" USERMARK="F-10">5년</TD>

<TD ALIGN="CENTER" WIDTH="206" HEIGHT="28" USERMARK="F-10">
<SPAN>정액법</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="28" USERMARK="F-10">차량운반구</TD>
<TD ALIGN="CENTER" WIDTH="207" HEIGHT="28" USERMARK="F-10">5년</TD>

<TD ALIGN="CENTER" WIDTH="206" HEIGHT="28" USERMARK="F-10">
<SPAN>정액법</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="28" USERMARK="F-10">비품</TD>

<TD ALIGN="CENTER" WIDTH="207" HEIGHT="28" USERMARK="F-10">
<SPAN>5년</SPAN>
</TD>

<TD ALIGN="CENTER" WIDTH="206" HEIGHT="28" USERMARK="F-10">
<SPAN>정액법</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="28" USERMARK="F-10">시험검사기기</TD>

<TD ALIGN="CENTER" WIDTH="207" HEIGHT="28" USERMARK="F-10">
<SPAN>5년</SPAN>
</TD>

<TD ALIGN="CENTER" WIDTH="206" HEIGHT="28" USERMARK="F-10">
<SPAN>정액법</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="207" HEIGHT="28" USERMARK="F-10">시설장치</TD>

<TD ALIGN="CENTER" WIDTH="207" HEIGHT="28" USERMARK="F-10">
<SPAN>5년</SPAN>
</TD>

<TD ALIGN="CENTER" WIDTH="206" HEIGHT="28" USERMARK="F-10">
<SPAN>정액법</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">유형자산의 감가상각방법, 잔존가치 및 내용연수를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 회계처리하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">3) 자본적지출과 수익적지출의 구분&cr;&cr;유형자산의 취득 또는 완성 후의 지출이 </SPAN>
<SPAN USERMARK="F-GL11">미래 경제적 효익이 기업에 유입될 가능성이 매우 높고 그 금액이 신뢰성 있게 측정할 수 있는 경우에는 자본적지출로 처리하고, 그렇지 않은 경우에는 발생한 기간의 비용으로 인식하고 있습니다.&cr;&cr;4) 표시방법&cr;&cr;감가상각누계액, 손상차손누계액 및 </SPAN>
<SPAN USERMARK="F-GL11">정부보조금</SPAN>
<SPAN USERMARK="F-GL11"> 등은 해당 자산과목에서 차감하는 형식으로 기재하고 있습니다.&cr; &cr;5) 복구비용의 회계처리방법&cr;&cr;유형자산의 경제적 사용이 종료된 후에 원상회복에 소요될 것으로 추정되는 비용이 충당부채의 인식요건을 충족하는 경우 그 지출의 현재가치는 취득원가에 포함시키고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">6) 유형자산의 제거&cr;유형자산의 장부금액은 처분하는 때, 사용이나 처분을 통하여 미래경제적효익이 예상되지 않을 때 제거하고 있으며 제거로 인하여 발생하는 손익은 자산을 제거할 때 당기손익으로 인식하고 있으며, 유형자산의 재평가와 관련하여 인식한 기타포괄손익의 잔액이 있다면, 그 유형자산을 폐기하거나 처분할 때 당기손익으로 인식하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;(4) 무형자산의 취득원가와 상각방법 등&cr; &cr;1) 무형자산의 취득원가&cr;&cr;무형자산을 개별취득하는 경우 취득원가는 구입원가와 자산을 의도한 목적에 사용할 수 있도록 준비하는데 직접 관련된 지출로 구성되며, 매입할인 등을 차감하여 취득원가를 산출하고 있으며, 취득자금에 대한 지급기간이 일반적인 신용기간보다 긴 경우 취득원가는 현금가격상당액으로 계상하고 있습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">사업결합으로 취득한 무형자산은 취득일의 공정가치로 계상하고 있으며,취득일 현재 식별가능하지 않은 취득한 무형자산의 가치와 자산의 요건을 충족하지 못한 항목에 귀속되는 가치는 영업권에 포함시키고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">정부</SPAN>
<SPAN USERMARK="F-GL11">보조 등에 의해 자산을 무상 또는 공정가치보다 낮은 대가로 취득한 경우 취득원가는 취득일의 공정가치로 계상하고 </SPAN>
<SPAN USERMARK="F-GL11">있고</SPAN>
<SPAN USERMARK="F-GL11">, 자산교환으로 취득한 자산의 취득원가는 교환으로 제공한 자산의 공정가치로 계상하고 있으며, 교환으로 제공한 자산의 공정가치가 불확실한 경우 교환으로 취득한 자산의 공정가치로 계상하고 있습니다.&cr;&cr;취득 또는 완성 후의 지출이 무형자산의 미래경제적효익을 실질적으로 증가시킬 가능성이 매우 높고, 관련된 지출을 신뢰성 있게 측정할 수 있으며, 무형자산과 직접 관련된 경우에는 자본적지출로 처리하고, 그렇지 않은 경우에는 발생한 기간의 비용으로 인식합니다.&cr;&cr;2) 상각방법&cr;&cr;무형자산에 대해서는 다음의 상각연수에 따라 정액법으로 상각하고 있으며, 잔존가치는 없는 것을 원칙으로 하고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">과              목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="28" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">상각연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">특허권</TD>
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">7년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">상표권</TD>
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">면허권</TD>
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">개발비</TD>
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">5년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">소프트웨어</TD>
<TD ALIGN="CENTER" WIDTH="300" HEIGHT="28" USERMARK="F-10">5년</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">최근 보고기간 이후 무형자산의 사용방법, 기술적 진보 그리고 시장가격의 변동과 같은 지표가 존재하는 경우 내용연수 등에 대한 종전의 추정치를 재검토하고 있으며, 최근의 기대와 달라진 경우 잔존가치, 상각방법 또는 상각기간의 변경이 적절하다고 판단되는 경우 회계추정의 변경으로 회계처리하고 있습니다</SPAN>
<SPAN USERMARK="F-GL11">.&cr;&cr;3) 무형자산의 표시방법&cr;&cr;상각액과 손상차손은 해당 자산과목에서 직접 차감하여 기재하고 </SPAN>
<SPAN USERMARK="F-GL11">정부보조금</SPAN>
<SPAN USERMARK="F-GL11">은 해당자산과목에서 차감하는 형식으로 기재하고 있습니다.&cr; &cr;4) 무형자산의 제거&cr;무형자산의 장부금액은 처분하는 때, 사용이나 처분으로 미래 경제적 효익이 예상되지 않을 때에 제거하며, 제거 손익은 순매각금액(매각금액에서 매각부대원가를 뺀 금액)과 장부금액의 차액으로 산정하며, 손익계산서에서 당기손익으로 인식합니다.&cr;&cr;&cr;(5) </SPAN>
<SPAN USERMARK="F-GL11">차입원가</SPAN>
<SPAN USERMARK="F-GL11">자본화&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">회사는 제조, 매입, 건설 또는 개발이 개시된 날로부터 의도된 용도로 사용하거나 판매할 수 있는 상태가 될 때까지 1년 이상의 기간이 소요되는 재고자산과 유형자산, 무형자산 및 투자부동산과 관련하여 발생된 </SPAN>
<SPAN USERMARK="F-GL11">차입원가</SPAN>
<SPAN USERMARK="F-GL11"> 등을 기간비용으로 회계처리하고 있습니다.&cr;&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">(6) </SPAN>
<SPAN USERMARK="F-GL11">정부</SPAN>
<SPAN USERMARK="F-GL11">보조금 </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">회사는 정부보조금에 부수되는 조건의 준수와 보조금 수취에 대한 합리적인 확신이 있을 경우에만 정부보조금을 인식하고 있으며 시장이자율보다 낮은 이자율의 정부대여금의 효익은 정부보조금으로 처리하고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;자산취득에 충당할 </SPAN>
<SPAN USERMARK="F-GL11">정부</SPAN>
<SPAN USERMARK="F-GL11">보조금 등으로 자산을 취득한 경우에는 이를 관련 자산에서 차감하는 형식으로 표시하고 해당 자산의 내용연수에 걸쳐 </SPAN>
<SPAN USERMARK="F-GL11">상각금액과</SPAN>
<SPAN USERMARK="F-GL11"> 상계하며, 해당 자산을 처분하는 경우에는 그 잔액을 처분손익에 반영하고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">수익관련 보조금을 받는 경우에 대응되는 비용이 없는 경우 회사의 주된 영업활동과 직접적인 관련성이 있다면 영업수익으로, 그렇지 않다면 영업외수익으로 회계처리하고 있습니다. 반면 수익관련보조금이 특정의 비용을 지원할 목적으로 지급되는 경우에는  동 기관으로부터 수령한 </SPAN>
<SPAN USERMARK="F-GL11">정부</SPAN>
<SPAN USERMARK="F-GL11">보조금을 선수수익으로 계상하여 관련 조건이 충족되어 사용되는 시점에 관련 비용과 상계처리하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">비</SPAN>
<SPAN USERMARK="F-GL11">화폐성자</SPAN>
<SPAN USERMARK="F-GL11">산을 정부보조금으로 수취하는 경우 비화폐성자산의 공정가치를 평가하여 보조금과 자산 모두를 그 공정가치로 회계처리하고 있으</SPAN>
<SPAN USERMARK="F-GL11">며,  상환의무가 발생하게 된 정부보조금은 회계추정의 변경으로 회계처리하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 U"></SPAN>
<SPAN USERMARK="F-GL11 U"></SPAN>
<SPAN USERMARK="F-GL11 U"></SPAN>
<SPAN USERMARK="F-GL11 U"></SPAN>
<SPAN USERMARK="F-GL11 U"></SPAN>
<SPAN USERMARK="F-GL11 U"></SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(7) 외화 환산</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">외화거래를 최초로 인식하는 경우에 거래일의 외화의 현물환율을 외화금액에 적용하여 기록합니다. 다만, 환율이 유의적으로 변동하지 않는 경우에는 일정기간의 평균환율을 사용하고 있습니다. 보고기간말 화폐성 외화항목은 마감환율로 환산하며, 역사적원가로 측정하는 비화폐성 외화항목은 거래일의 환율로 환산하고, 공정가치로 측정하는 비화폐성 외화항목은 공정가치가 결정된 날의 환율로 환산하고 있습니다. &cr; &cr;화폐성항목의 결제시점에 발생하는 외환차손익 또는 화폐성항목의 환산에 사용한 환율이 회계기간 중 최초로 인식한 시점이나 전기의 재무제표 환산시점의 환율과 다르기 때문에 발생하는 외화환산손익은 그 외환차이가 발생하는 회계기간의 손익으로 인식하고 있으며, 외화표시 매도가능채무증권의 경우에는 동 금액을 기타포괄손익에 인식합니다.&cr;&cr;비화폐성항목에서 생긴 손익을 기타포괄손익으로 인식하는 경우에 그 손익에 포함된환율변동효과도 기타포괄손익으로 인식하며, 비화폐성항목에서 생긴 손익을 당기손익으로 인식하는 경우에는 그 손익에 포함된 환율변동효과도 당기손익으로 인식하고 있습니다. &cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>
<P USERMARK="F-GL11">(8) 리스</P>

<P>
<SPAN USERMARK="F-GL11">&cr;회사는 리스자산의 소유에 따른 위험과 효익이 회사에 대부분 이전된 리스의 경우에는 금융리스로 분류하며, 일반적으로 리스기간 종료시 또는 그 이전에 리스자산의 소유권을 회사에 이전하기로 약정한 경우이거나, 리스실행일 현재 리스자산의 염가매수선택권을 가지고 있고 이를 행사할 것이 확실한 경우 또는 리스기간이 리스자산의 내용연수의 상당부분</SPAN>
<SPAN USERMARK="F-GL11"> 차</SPAN>
<SPAN USERMARK="F-GL11">지하는 경우, 리스실행일 현재 최소리스료를 내재이자율로 할인한 현재가치가 리스자산의 공정가치의 대부분</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">을 차지하는 경우 또는 리스자산의 범용성이 없는 경우의 리스거래를 금융리스로 , 기타의 리스거래는 운용리스로 분류하여 각각 다음과 같이 회계처리하고 있습니다. &cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">[ 금융리스 ]&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">리스실행일에 최소리스료의 현재가치와 리스자산의 공정가치 중 작은 금액을 금융리스자산과 금융리스부채로 각각 인식하며, 최소리스료의 현재가치를 계산할 때 적용해야 할 할인율은 내재이자율이며</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11">리스개설직접원가는 금융리스자산으로 인식하는 금액에 포함하고 있습니다.&cr;&cr;매기 지급되는 최소리스료는 금융원가와 리스부채의 상환액으로 나누고 금융원가는 매기 부채의 잔액에 대하여 일정한 기간이자율이 산출되도록 리스기간의 각 회계기간에 배분하고 있으며, 조정리스료는 발생한 기간의 비용으로 회계처리하고 있습니다. &cr;&cr;금융리스자산의 감가상각대상금액은 회사가 소유한 다른 감가상각대상자산에 대하여 채택한 감가상각정책과 일관된 체계적인 기준으로 매 회계기간에 배분하고 있으며, 리스기간 종료시점까지 자산의 소유권을 획득할 것이 확실시 된다면 기대사용기간이 자산의 내용연수가 되며, 그러하지 않은 경우에는 리스기간과 자산의 내용연수 중 짧은 기간에 걸쳐 감가상각하고 있습니다. &cr;&cr;[ 운용리스 ]&cr;&cr;운용리스에서 리스료는 리스기간에 걸쳐 정액기준으로 비용을 인식하고 있으며, 신규 또는 갱신되는 운용리스 계약에 따른 모든 인센티브는 총효익을 리스기간에 걸쳐 정액기준에 따라 리스비용에서 차감하여 인식하고 있습니다. &cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;(9) 충당부채, 우발부채 및 우발자산 &cr;&cr;1) 충당부채&cr; &cr;회사는 과거 사건이나 거래의 결과로 인하여 존재하는 현재의무로서, 지출의 시기 또는 금액이 불확실하지만 당해 의무를 이행하기 위하여 자원이 유출될 가능성이 매우 높고 또한 당해 의무의 이행에 소요되는 금액을 신뢰성 있게 추정할 수 있는 경우 그 금액을 충당부채로 인식하고 있습니다.&cr;&cr;2) 우발부채&cr;&cr;회사는 다음의 경우를 우발부채로 보아 부채로 인식하지 않고 있습니다.&cr; &cr;① 과거사건은 생겼으나 기업이 전적으로 통제할 수 없는 하나 이상의 불확실한 미래 사건의 발생 여부로만 그 존재 유무를 확인할 수 있는 잠재적인 의무인 경우&cr;&cr;② 과거사건으로 생긴 현재 의무이지만 그 의무를 이행하기 위하여  자원을 유출할 가능성이 매우 높지 않거나, 또는 그 가능성은 매우 높으나 해당 의무의 이행에 필요한 금액을 신뢰성 있게 측정할 수 없는 경우&cr;&cr;3) 우발자산&cr; &cr;회사는 과거사건으로 생겼으나, 기업이 전적으로 통제할 수 없는 하나 이상의 불확실한 미래 사건의 발생 여부로만 그 존재 유무를 확인할 수 있는 잠재적 자산을 우발자산으로 보아 자산으로 인식하지 않고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">(10) 수익</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">수익은 재화의 판매, 용역의 제공이나 자산의 사용에 대하여 받았거나 또는 받을 대가 (이하 "판매대가"라 한다)의 공정가치로 측정하며 판매자에 의해 제공된 매출에누리와 할인 및 환입은 수익에서 차감하고 있습니다.  &cr;&cr;1) 재화의 판매&cr;&cr;재화의 소유에 따른 유의적인 위험과 보상이 구매자에게 이전되고, 판매자는 판매된 재화의 소유권과 결부된 통상적 수준의 지속적인 관리상 관여를 하지 않을 뿐만 아니라 효과적인 통제를 하지도 아니하며, 수익금액을 신뢰성 있게 측정할 수 있고, 거래와 관련된 경제적효익의 유입가능성이 높으며, 거래와 관련하여 발생했거나 발생할 원가를 신뢰성 있게 측정할 수 있을 때 재화의 판매로 인한 수익을 인식하고 있습니다. &cr;&cr;2) 반품가능판매&cr;&cr;판매시점에 반품이 예상되는 매출액에 해당하는 금액은 환불충당부채로 설정하고, 보고기간 말마다 반품 예상량의 변동에 따라 그 부채의 측정치를 새로 수정하며 그 조정액을 수익(또는 수익의 차감)으로 인식합니다.&cr;환불충당부채를 결제할 때 고객에게서 제품을 회수할 기업의 권리는 자산으로 인식합니다. 해당 자산을 처음 측정할 때 제품의 직전 장부금액에서 그 제품 회수에 예상되는 원가(반품되는 제품이 기업에 주는 가치의 잠재적인 감소를 포함)를 차감하며, 보고기간 말마다 반품될 제품에 대한 예상의 변동을 반영하여 자산의 측정치를 새로 수정합니다. 이 자산은 환불충당부채와는 구분하여 표시합니다.&cr;&cr;3) 용역의 제공&cr;&cr;수익금액을 신뢰성 있게 측정할 수 있고, 거래와 관련된 경제적효익의 유입가능성이 높으며, 보고기간말에 그 거래의 진행률을 신뢰성 있게 측정할 수 있고, 이미 발생한 원가 및 거래의 완료를 위한 원가를 신뢰성 있게 측정할 수 있을 때 용역제공거래의 결과를 신뢰성 있게 추정할 수 있는 것으로 보아 보고기간말에 그 거래의 진행률에 따라 용역의 제공으로 인한 수익을 인식하고 있습니다. &cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;용역제공거래의 성과를 신뢰성 있게 추정할 수 없는 경우에는 발생한 비용의 범위 내에서의 회수가능한 금액만을 수익으로 인식하고 있으며, 용역제공거래의 성과를 신뢰성 있게 추정할 수 없고 발생한 원가의 회수가능성이 높지 않은 경우에는 수익은 인식하지 아니하고 발생한 원가를 비용으로 인식하고 있습니다.&cr;&cr;4) 이자수익, 로열티수익 및 배당수익&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">자산을 타인에게 사용하게 함으로써 창출되는 이자수익, 로열티수익 및 배당수익은거래와 관련된 경제적효익의 유입가능성이 높으며, 수익금액을 신뢰성 있게 측정할 수 있을 때  수익을 인식하며, 이자수익은 원칙적으로 유효이자율법으로 인식하고, 로열티수익은 관련된 계약의 경제적 실질을 반영하여 발생기준에 따라 인식하며, 배당수익은 주주로서 배당을 받을 권리와 금액이 확정되는 시점에 수익을 인식하고 있습니다.  &cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">(11) 퇴직급여&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">회사는 보고기간종료일 현재 확정기여형 퇴직연금제도를 시행하여 당해 회계기간에 대하여 회사가 납부하여야 할 부담금을 퇴직급여로 인식하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 U">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;(12) 자산손상&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">금융자산, 재고자산, 건설형 공사계약에서 발생한 자산, 이연법인세자산, 공정가치에서 추정 처분부대원가를 차감한 금액으로 측정되는 농림어업활동과 관련되는 생물자산, 중단사업에 속하는 자산을 제외한</SPAN>
<SPAN USERMARK="F-GL11"> 모든 자산의 손상은 아래의 방법으로 손상차손을 인식하고 있습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">아직 사용가능하지 않은 무형자산 및 사용을 중지하고 처분을 위해 보유하는 자산에 대해서는 자산손상을 시사하는 징후가 있는지에 관계없이  매년  회수가능액을 추정하며 , 그 외의 자산은 매 보고기간말마다 자산손상을 시사하는 징후가 있는지를 검토하고 그러한 징후가 있다면 회수가능액을 추정하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">자산의 진부화 및 시장가치의 급격한 하락 등으로 인하여 회수가능액이 장부금액에 중요하게 미달하게 되는 경우에는 장부금액을 회수가능액으로 조정하고 그 차액을 손상차손으로 처리하고 있습니다. 다만, 유형자산의 경우에는 유형자산의 손상징후가 있다고 판단되고, 당해 유형자산(개별 자산 또는 유형자산만으로 구성된 현금창출단위 포함)의 사용 및 처분으로 부터 기대되는 미래의 현금흐름총액의 추정액이 장부금액에 미달하는 경우에 장부금액을 회수가능액으로 조정하고 그 차액을 손상차손으로 처리하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11 U">&cr;</SPAN>
<SPAN USERMARK="F-GL11">회사는 개별 자산별로 회수가능액을 추정하고 있으며 만약 개별 자산의 회수가능액을 추정할 수 없다면 그 자산이 속한 현금창출단위로 회수가능액을 결정하고 있습니다. 현금창출단위의 회수가능액이 장부금액에 미달하는 경우에는 손상차손을 인식하며 손상차손은 우선적으로 현금창출단위(또는 현금창출단위집단)에 배분된 영업권의 장부금액을 감소시키는데 배분되고, 그 다음 현금창출단위(또는 현금창출단위집단)에 속하는 다른 자산에 각각 장부금액에 비례하여 배분합니다. &cr;&cr;매 보고기간말마다 영업권을 제외한 자산에 대해 과거에 인식한 손상차손이 더 이상 존재하지 않거나 감소된 것을 시사하는 징후가 있는지를 검토하여 징후가 있는 경우 당해 자산의 회수가능액을 추정하고 있으며 직전 손상차손의 인식시점 이후 회수가능액을 결정하는 데 사용된 추정치에 변화가 있는 경우에만 환입하고 있습니다. 손상차손환입으로 증가된 장부금액은 과거에 손상차손을 인식하기 전 장부금액의 감가상각 또는 상각 후 잔액을 초과할 수 없으며, </SPAN>
<SPAN USERMARK="F-GL11">손상차손환입은 즉시 당기손익으로 인식하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11 U"> </SPAN>
<SPAN USERMARK="F-GL11 U"></SPAN>
<SPAN USERMARK="F-GL11 U">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;현금창출단위의 손상차손환입은 현금창출단위를 구성하는 자산들(영업권 제외)의 장부금액에 비례하여 배분하며, 영업권에 대해 인식한 손상차손은 후속기간에 환입하지 않고 있습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11 U"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 U"></SPAN>
<SPAN USERMARK="F-GL11">(13) </SPAN>
<SPAN USERMARK="F-GL11">중소기업의 회계처리에 대한 특례&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">중소기업기본법에 의한 중소기업으로서 일반기업회계기준 제31장 "중소기업 회계처리 특례"에 의하여 다음과 같이 회계처리하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;1) 장기연불조건의 매매거래 및 장기금전대차거래 등에서 발생하는 채권ㆍ채무는 명목가액을 재무상태표가액으로 하고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;2) 유형자산과 무형자산의 내용연수 및 잔존가치는 법인세법 등의 법령에 따랐습니다.&cr;&cr;3) 토지 또는 건물 등을 장기할부조건으로 처분하는 경우 당해 자산의 처분손익을 할부금회수기일이 도래한 날에 실현되는 것으로 회계처리하고 있습니다.&cr;&cr;4) 법인세비용은 법인세법 등의 법령에 의하여 납부하여야 할 금액으로 계상하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;(14) </SPAN>
<SPAN USERMARK="F-GL11">전기 </SPAN>
<SPAN USERMARK="F-GL11">재무제표의 계정과목 재분류</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">전기</SPAN>
<SPAN USERMARK="F-GL11">재무제표는 </SPAN>
<SPAN USERMARK="F-GL11">당기</SPAN>
<SPAN USERMARK="F-GL11">와의 비교를 용이하게 하기 위하여 일부 계정과목을 </SPAN>
<SPAN USERMARK="F-GL11">당기</SPAN>
<SPAN USERMARK="F-GL11">재무제표의 계정과목에 따라 재분류하고 있습니다. 이러한 재분류는 </SPAN>
<SPAN USERMARK="F-GL11">전기</SPAN>
<SPAN USERMARK="F-GL11">에 보고된 순손익이나 순자산가치에 영향을 미치지 아니합니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;(15) 추정의 사용&cr;&cr;한국의 </SPAN>
<SPAN USERMARK="F-GL11">일반기업회계기준</SPAN>
<SPAN USERMARK="F-GL11">에 따라 재무제표를 작성하기 위해서 회사의 경영자는 자산 및 부채의 금액 및 충당부채 등에 대한 공시, 수익 및 비용의 측정과 관련하여 많은 합리적인 추정과 가정을 사용합니다. 여기에는 유형자산의 장부금액, 매출채권, 재고자산, 이연법인세자산 및 충당부채 등이 포함됩니다. 이러한 평가금액은 실제와 다를 수 있습니다.&cr;&cr;2020년도 중 COVID-19의 확산은 국내외 경제에 중대한 영향을 미치고 있습니다. 이는 생산성 저하와 매출의 감소나 지연, 기존 채권의 회수 등에 부정적인 영향을 미칠 수 있으며 이로 인해 회사의 재무상태와 재무성과에도 부정적인 영향이 발생할 수 있습니다. 재무제표 작성시 사용된 중요한 회계추정 및 가정은 COVID-19에 따른 불확실성의 변동에 따라 조정될 수 있으며, COVID-19로 인하여 회사의 사업, 재무상태 및 경영성과 등에 미칠 궁극적인 영향은 현재 예측할 수 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>
<PGBRK></PGBRK>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">3. 유</SPAN>
<SPAN USERMARK="F-GL">가증권&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">(1) 매도가능증권의 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="606" BORDER="1">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구        분</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">수 익 증 권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">196,078,432 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">190,850,773 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">196,078,432 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">193,872,462 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="53">시장성없는&cr;지 분 증 권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53">150,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53">150,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="53">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">합         계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">346,078,432 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">340,850,773 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">196,078,432 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">193,872,462 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">유 동 자 산</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">투 자 자 산</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">346,078,432 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">340,850,773 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">196,078,432 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">193,872,462 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;(2) </SPAN>
<SPAN USERMARK="F-GL">매도가능증권 중 시장성 없는 지분증권의 내용은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="668" BORDER="1">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="248" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회 사 명</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="210" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="210" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="248" HEIGHT="30">재단법인 한국혁신의약품컨소시엄</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">50,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">50,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="248" HEIGHT="30">한국제약협동조합</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">100,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">100,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="248" HEIGHT="30">출자금 합계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">150,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">150,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;(</SPAN>
<SPAN USERMARK="F-GL">3) </SPAN>
<SPAN USERMARK="F-GL">기</SPAN>
<SPAN USERMARK="F-GL">중 매도가능증권의 평가에 따른 매도가능증권평가손익(기타포괄손익누계액)의 변동  내용은 다음과 같습니다.&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="626" BORDER="1">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구           분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손익반영액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가손익증감액</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="32" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>기말</SPAN>
<SPAN>잔액</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="32">지 분 증 권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="32">(2,205,970)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="129" HEIGHT="32">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="32">(3,021,689)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="128" HEIGHT="32">(5,227,659)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구           분</TH>
<TH WIDTH="129" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="129" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손익반영액</TH>
<TH WIDTH="128" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가손익증감액</TH>

<TH WIDTH="128" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>기말</SPAN>
<SPAN>잔액</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">지 분 증 권</TD>
<TD WIDTH="129" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="129" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="128" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">(2,205,970)</TD>
<TD WIDTH="128" HEIGHT="32" ALIGN="RIGHT" VALIGN="MIDDLE">(2,205,970)</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">4. 유형자산</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">(1) 유형자산의 변동 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="944">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기초</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득</TH>
<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">대체증감</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">감가상각</TH>
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">보조금상계</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정부보조금</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30">토지</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,691,942,704 </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">5,056,797,583 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">6,748,740,287 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30">건물</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">6,524,254,794 </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">100,906,357 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(179,514,687)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">6,445,646,464 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30">기계장치</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,729,907,614 </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">7,900,000 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">508,403,000 </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(652,506,608)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">(4,835,050)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(91,865,950)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,497,003,006 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30">차량운반구</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">177,890,275 </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">30,000,000 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(97,729,979)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">110,160,296 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30">비품</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">815,131,474 </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">95,783,533 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(245,627,283)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">665,287,724 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30">시험검사기기</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,443,041,925 </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">453,021,569 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">59,000,000 </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(506,731,035)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,448,332,459 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30">시설장치</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">152,193,334 </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">399,300,000 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(69,674,998)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">481,818,336 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">5,157,943,000 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">(567,403,000)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,733,176,664)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">3,011,240,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">12,534,362,120 </TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">11,301,652,042 </TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,751,784,590)</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">(4,835,050)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,825,042,614)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">20,408,228,572 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="723">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분및폐기</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30">토지</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,691,942,704 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,691,942,704 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30">건물</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">6,619,842,865 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">80,980,850 </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(176,568,921)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">6,524,254,794 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30">기계장치</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">2,130,811,869 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">386,312,522 </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(787,216,777)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,729,907,614 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30">차량운반구</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">273,081,447 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(95,191,172)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">177,890,275 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30">비품</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">874,491,696 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">167,888,392 </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(227,248,614)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">815,131,474 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30">시험검사기기</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">988,760,643 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">871,222,424 </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(416,941,142)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,443,041,925 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30">시설장치</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">35,203,334 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">142,900,000 </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(25,910,000)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">152,193,334 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">12,614,134,558 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,649,304,188 </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">(1,729,076,626)</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">12,534,362,120 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-10">
<SPAN USERMARK="F-GL11"></SPAN>
</P>
<P USERMARK="F-GL11">(2) 보유토지의 공시지가 현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="753" BORDER="1">

<COLGROUP>
<COL WIDTH="272"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="281" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보유토지</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="236" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="236" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공시지가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공시지가</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="281" HEIGHT="30">서울특별시 동작구 신대방동 395-67</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">1,362,778,007 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">2,355,996,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">1,362,778,007 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">2,233,345,620 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="281" HEIGHT="30">경상북도 경산시 진량읍 신상리 1204</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">329,164,697 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">582,024,960 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">329,164,697 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">577,141,070 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="281" HEIGHT="30">경상북도 경산시 진량읍 신상리 1199-5</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">213,800,493 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">134,375,100 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="281" HEIGHT="30">전라북도 익산시 삼기면 오룡리 1252</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">4,842,997,090 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">3,444,826,780 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="281" HEIGHT="30" ALIGN="CENTER">합    계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">6,748,740,287 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">6,517,222,840 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">1,691,942,704 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">2,810,486,690 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;(3) 당기에 익산공장 토지에 존속기간 30년의 지상권이 설정되었으며, 지상권자는 중소기업은행입니다. 지상권의 목적은 건물 기타 공작물이나 수목의 소유로서 지상권의 범위는 토지 전부입니다. 또한 익산공장 토지는 </SPAN>
<SPAN USERMARK="F-GL">익산시</SPAN>
<SPAN USERMARK="F-GL">와 체결한 매매계약의 내용에 따라 공장용지 용도로만 사용 가능합니다.&cr;</SPAN>
</P>
<P USERMARK="F-GL11">&cr;5. 무형자산</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(1) 무형자산의 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="776" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과         목</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="348" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="335" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">특 허 권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">679,530,759 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">(364,087,053)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">315,443,706 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">679,530,759 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">(266,704,873)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">412,825,886 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">상 표 권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">4,820,528 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">(4,059,392)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">761,136 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">4,820,528 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">(3,044,544)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">1,775,984 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">면 허 권</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">356,078,530 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">(311,071,540)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">45,006,990 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">356,078,530 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">(250,102,848)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">105,975,682 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">개 발 비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">583,283,701 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">(527,202,690)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">56,081,011 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">583,283,701 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">(433,708,557)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">149,575,144 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">소프트웨어</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">103,010,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">(60,089,166)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">42,920,834 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">103,010,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">(39,487,166)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">63,522,834 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">합        계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">1,726,723,518 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">(1,266,509,841)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">460,213,677 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30">1,726,723,518 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30">(993,047,988)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">733,675,530 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">(2) 무형자산의 변동내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="621" BORDER="1">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과         목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취     득</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상     각</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">특 허 권</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">412,825,886 </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(97,382,180)</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">315,443,706 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">상 표 권</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">1,775,984 </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(1,014,848)</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">761,136 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">면 허 권</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">105,975,682 </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(60,968,692)</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">45,006,990 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">개 발 비</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">149,575,144 </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(93,494,133)</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">56,081,011 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">소프트웨어</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">63,522,834 </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(20,602,000)</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">42,920,834 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">합         계</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">733,675,530 </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(273,461,853)</TD>
<TD ALIGN="RIGHT" WIDTH="124" HEIGHT="30">460,213,677 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL"> </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과         목</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취     득</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상     각</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER">특 허 권</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">510,208,066 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(97,382,180)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">412,825,886 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER">상 표 권</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,790,832 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(1,014,848)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">1,775,984 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER">면 허 권</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">167,551,441 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(61,575,759)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">105,975,682 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER">개 발 비</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">266,056,136 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(116,480,992)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">149,575,144 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER">소프트웨어</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">84,124,834 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(20,602,000)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">63,522,834 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER">합         계</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">1,030,731,309 </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(297,055,779)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">733,675,530 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">(3) 무형자산상각액은 전액 판매비와관리비에 포함되어 있습니다.</SPAN>
</P>
<P USERMARK="F-GL11">&cr;</P>
<P USERMARK="F-GL11">6. 장단기차입금의 내용</P>

<P>
<SPAN USERMARK="F-GL11">&cr;(1) 장단기차입금의 내용은 다음과 같습니다.&cr;&cr;1) </SPAN>
<SPAN USERMARK="F-GL11">단기차입금</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="678">

<COLGROUP>
<COL WIDTH="164"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="168" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">차입처</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">연이자율</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="678" HEIGHT="30" COLSPAN="5">유동성장기차입금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.605%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">112,640,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.046%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">199,360,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.67%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">157,860,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.60%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">119,580,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.47%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">84,960,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.90%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">150,040,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.662%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">570,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">국민은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.20%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,500,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">우리은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.56%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">240,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 신성장자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">중소벤처기업진흥공단</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.55%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">124,920,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">166,560,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 창업자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">중소벤처기업진흥공단</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">1.91%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">144,600,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">144,600,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30"> 할부금융</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">신한카드 등</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.7%~4.9%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">43,259,025 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">43,173,039 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소계</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">　</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">　</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">2,694,779,025 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,106,773,039 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30">기타단기차입금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">　</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">　</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">　</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">산업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.00%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">2,000,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,000,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">산업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.74%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,000,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,000,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">농협은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.73%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">300,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">300,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">농협은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.74%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">700,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">700,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.916%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,569,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,569,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 시설자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.095%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.289%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">700,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">700,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.15%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">810,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">810,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 할인어음</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">165,548,722 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">324,236,912 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">우리은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.62%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">265,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">270,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">우리은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.58%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">270,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">270,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 운전자금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">우리은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">2.25%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">216,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 외상매출채권담보대출</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">우리은행</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">207,859,311 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE"> 특수관계자 차입금</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">(주)마더스바이오메드</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">3.00%</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,500,000,000 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" ALIGN="CENTER">소계</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">　</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">　</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">9,803,408,033 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">8,043,236,912 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="173" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="168" HEIGHT="30" ALIGN="CENTER">　</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER">　</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">12,498,187,058 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">9,150,009,951 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;2) 원화장기차입금</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="934" BORDER="1">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="212"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차   입   처</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차 입 용 도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="251" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금       액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최종 만기일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="221" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상환방법</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">시설자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">2.605%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">535,040,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">620,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2025-09-11</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환(2.5년 거치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">시설자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">2.046%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">946,960,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">1,097,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2025-09-14</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환(2.5년 거치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">시설자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">1.50%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">3,800,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">- </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2035-04-13</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">시설자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">1.519%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">961,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">- </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2028-11-24</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">시설자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">2.67%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">157,860,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2020-07-08</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환(1.5년 거치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">시설자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">2.60%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">119,580,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2020-05-21</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환(1.5년 거치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">운전자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">2.662%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">570,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">570,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2021-08-17</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">일시상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">국민은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">운전자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">2.20%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">1,500,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">1,500,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2021-03-15</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">일시상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">국민은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">운전자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">2.22%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">2,000,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">2,000,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2022-09-15</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">일시상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">국민은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">시설자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">2.63%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">250,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">- </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2025-03-15</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환(2년 거치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">우리은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">운전자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">3.56%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">240,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2020-03-06</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">일시상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">중소벤처기업진흥공단</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">신성장자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">3.55%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">124,920,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">291,480,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2021-09-29</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환(2년 거치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">중소벤처기업진흥공단</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">창업자금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">1.91%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">144,600,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">289,200,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2021-12-07</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원금균등분할상환(2년 거치)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="168" HEIGHT="30">신한카드 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">할부금융</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30">3.7%~4.9%</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">67,341,942 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">110,514,981 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">2023-11-26</TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30">원리금균등분할상환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" VALIGN="MIDDLE" WIDTH="364" HEIGHT="30">    합         계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">10,899,861,942 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">6,995,634,981 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" VALIGN="MIDDLE" WIDTH="364" HEIGHT="30">유동성대체</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">(2,694,779,025)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">(1,106,773,039)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" VALIGN="MIDDLE" WIDTH="364" HEIGHT="30">비 유 동 부 채</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">8,205,082,917 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">5,888,861,942 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="221" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;(2) </SPAN>
<SPAN USERMARK="F-GL11">당기</SPAN>
<SPAN USERMARK="F-GL11">말 현재 회사의 장기차입금(유동성 포함)의 연도별 상환계획은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="613" BORDER="1">

<COLGROUP>
<COL WIDTH="320"></COL>
<COL WIDTH="275"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="329" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연      도      별</TH>
<TH ALIGN="CENTER" WIDTH="284" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원화장기차입금</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="329" HEIGHT="30">2021.1.1 - 2021.12.31</TD>
<TD ALIGN="RIGHT" WIDTH="284" HEIGHT="30">2,694,779,025 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="329" HEIGHT="30">2022.1.1 - 2022.12.31</TD>
<TD ALIGN="RIGHT" WIDTH="284" HEIGHT="30">2,332,015,579 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="329" HEIGHT="30">2023.1.1 - 2023.12.31</TD>
<TD ALIGN="RIGHT" WIDTH="284" HEIGHT="30">316,067,338 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="329" HEIGHT="30">2024.1.1 - 2024.12.31</TD>
<TD ALIGN="RIGHT" WIDTH="284" HEIGHT="30">312,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="329" HEIGHT="30">2025.1.1 - 2025.12.31</TD>
<TD ALIGN="RIGHT" WIDTH="284" HEIGHT="30">484,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="329" HEIGHT="30">2026.1.1 이후</TD>
<TD ALIGN="RIGHT" WIDTH="284" HEIGHT="30">4,761,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="329" HEIGHT="30">합             계</TD>
<TD ALIGN="RIGHT" WIDTH="284" HEIGHT="30">10,899,861,942 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">,</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;7. 퇴직급여</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">확정기여제도와 관련하여 비용으로 인식한 금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="612">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="195"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구분</TH>
<TH WIDTH="204" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기</TH>
<TH WIDTH="204" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">212,959,045 </TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">269,498,928 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30">제조원가</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">323,794,550 </TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">250,848,919 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합             계</TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">536,753,595 </TD>
<TD WIDTH="204" HEIGHT="30" ALIGN="RIGHT">520,347,847 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;8. 우발상황과 약정사항의 내용</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">우발상황</SPAN>
<SPAN USERMARK="F-GL11"> 및 주요 약정사항의 내용은 다음과 같습니다.&cr;</SPAN>
</P>
<P USERMARK="F-GL11">(1) 사용이 제한된 예금의 내용은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="138" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과           목</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관명</TH>
<TH COLSPAN="2" ALIGN="CENTER" WIDTH="241" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금                  액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용제한내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="138" HEIGHT="53" VALIGN="MIDDLE">현금및현금성자산&cr;(정부보조금)</TD>
<TD WIDTH="93" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">기업은행</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="53" VALIGN="MIDDLE">3,506,823,336 </TD>
<TD ALIGN="RIGHT" WIDTH="123" HEIGHT="53" VALIGN="MIDDLE">- </TD>
<TD WIDTH="128" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">보조금 교부조건</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="60" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="2">장기금융상품</TD>
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기업은행</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="123" HEIGHT="30">2,000,000 </TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당좌개설보증금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">우리은행</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="123" HEIGHT="30">2,000,000 </TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">당좌개설보증금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="138" HEIGHT="30">합       계</TD>
<TD WIDTH="93" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">3,510,823,336 </TD>
<TD ALIGN="RIGHT" WIDTH="123" HEIGHT="30">4,000,000 </TD>
<TD WIDTH="128" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;(2) </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">매출채</SPAN>
<SPAN USERMARK="F-GL">권 양도액 중 만기 미도래분은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="172"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="181" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">양도조건</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30" VALIGN="MIDDLE">배서양도</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">329,391,500 </TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,590,148,401 </TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상환청구권</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="181" HEIGHT="30" VALIGN="MIDDLE">외상매출채권담보대출</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">207,859,311 </TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">81,290,330 </TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">담보책임 있음</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;(3) 제공자산과 지급보증의 내용</SPAN>
</P>
<P USERMARK="F-GL11">&cr;예금이외에 담보제공(소유권제한 포함)된 자산과 지급보증의 내용은 다음과 같습니다.&cr;&cr;1) 담보제공</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="740" BORDER="1">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보제공자산</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">설정금액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수혜자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">설정권자</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관련채무의 내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과  목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="7" VALIGN="MIDDLE" WIDTH="740" HEIGHT="30">(자기를 위한 담보)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">본사건물(6층)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">963,485,020 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">2,100,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">산업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">3,000,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">경산공장전체</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">4,481,066,824 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">4,082,800,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">3,315,960,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">경산별관건물</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">217,947,082 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">300,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">국민은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">250,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">익산토지</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">4,842,997,090 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">30,120,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">3,800,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">차량운반구</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">17,574,237 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">9,500,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">현대캐피탈</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">17,848,785 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">차량운반구</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">7,860,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">1,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">BNK캐피탈</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">8,218,071 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">차량운반구</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">11,928,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">24,750,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">BNK캐피탈</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">11,774,897 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">소      계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">10,542,858,253 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">36,638,050,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">　</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">　</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">10,403,801,753 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="7" VALIGN="MIDDLE" WIDTH="740" HEIGHT="30">(특수관계자를 위한 담보)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">본사건물(5층)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">1,024,088,482 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">1,200,000,000 </TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">㈜마더스팜</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">1,000,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30">합        계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">11,566,946,735 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">43,602,650,600 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">11,403,801,753 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;2) 지급보증</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="218"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구            분</TH>
<TH WIDTH="227" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지급보증의 내용</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지급보증금액</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수혜자</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" COLSPAN="4" VALIGN="MIDDLE">(특수관계자를 위한 지급보증)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">연대보증</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">운영자금대출 지급보증</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,000,000 </TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">㈜마더스바이오메드</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">연대보증</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">시설자금대출 지급보증</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">316,800,000 </TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">㈜마더스팜</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">연대보증</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">서울보증보험 지급보증</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">337,400,000 </TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">㈜마더스팜</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합      계</TD>
<TD WIDTH="227" HEIGHT="30" VALIGN="MIDDLE">　</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,976,800,000 </TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">　</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(3) 회사가 타인으로부터 제공받은 보증의 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="603" BORDER="1">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증 제공자</TH>
<TH ALIGN="CENTER" WIDTH="143" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제공받은 보증내용</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증금액</TH>
<TH ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증기간</TH>
<TH ALIGN="CENTER" WIDTH="128" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증처</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="603" HEIGHT="30">(특수관계자)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">대표이사</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">차입금 연대보증</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">22,550,040,600</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">-</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기업은행 등</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="603" HEIGHT="30">(기       타 )</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="150" ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER">기술보증기금</TD>
<TD WIDTH="143" HEIGHT="150" ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER">대출보증</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">729,000,000 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2021-05-15</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기업은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">76,500,000 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2021-05-21</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기업은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">183,600,000 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2021-03-05</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">우리은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">256,500,000 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2021-05-15</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">우리은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">225,250,000 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2021-05-15</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">우리은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="180" ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER">서울보증보험&cr;(*)</TD>
<TD WIDTH="143" HEIGHT="150" ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER">지방투자촉진&cr;보조금지원 &cr; (설비보조금)</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">1,152,920,120 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2028-07-30</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">전라북도 익산시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">1,152,920,120 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2027-07-30</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">전라북도 익산시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">1,152,920,120 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2026-07-30</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">전라북도 익산시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">1,152,920,120 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2025-07-30</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">전라북도 익산시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">1,152,920,120 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2024-07-30</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">전라북도 익산시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">인허가보증보험</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">147,950,000 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">2022-09-30</TD>
<TD WIDTH="128" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">전라북도 익산시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">소     계</TD>
<TD WIDTH="143" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">7,383,400,600 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">　</TD>
<TD WIDTH="128" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="30">합     계</TD>
<TD WIDTH="143" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30" VALIGN="MIDDLE">29,933,441,200 </TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30">　</TD>
<TD WIDTH="128" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(*) 회사는 서울보증보험㈜에 상기 이행지급보증보험을 포함하여 총 5,915백만원의 보증보험에 가입하였습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">(4) </SPAN>
<SPAN USERMARK="F-GL11">회사가 가입하고 있는 보험의 </SPAN>
<SPAN USERMARK="F-GL11">종류, 보험금액 및 보험에 가입된 자산의 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="682" BORDER="1">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보험의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부보자산</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보험금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보험료</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보험기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보험회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ROWSPAN="2">재산종합보험</TD>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ALIGN="CENTER">경산공장</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">21,478,721,208 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30"> 10,352,671 </TD>
<TD VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ALIGN="CENTER">20.10.24~21.10.24</TD>
<TD VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ALIGN="CENTER">메리츠화재보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">본사건물</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">5,782,900,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30">732,900 </TD>
<TD VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ALIGN="CENTER">20.10.31~21.10.31</TD>
<TD VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ALIGN="CENTER">MG손해보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30">합        계</TD>
<TD VALIGN="MIDDLE" WIDTH="78" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">27,261,621,208 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30">11,085,571 </TD>
<TD VALIGN="MIDDLE" WIDTH="145" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" WIDTH="123" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">경산공장의 보험금은 질권 설정되어 있으며, 설정 금액은 3,957백만원입니다. 회사는 상기 보험이외에 임상시험배상책임보험, 산업재해보상보험, 자동차종합보험, 국민건강보험 및 고용보험 등에 가입하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(5) 금융기관 등과 체결한 주요 약정사항은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="644" BORDER="1">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="159" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH ALIGN="CENTER" WIDTH="168" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관명</TH>
<TH ALIGN="CENTER" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정한도액</TH>
<TH ALIGN="CENTER" WIDTH="106" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실행금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="30">매출채권/단기차입금</TD>
<TD WIDTH="168" HEIGHT="30">상업어음할인</TD>
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기업은행</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,000,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="106" HEIGHT="30">165,548,722 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="30">매입채무/단기차입금</TD>
<TD WIDTH="168" HEIGHT="30">수입신용장</TD>
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기업은행</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">$250,000.00 </TD>
<TD ALIGN="RIGHT" WIDTH="106" HEIGHT="30">$190,000.00 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="30">매출채권/단기차입금</TD>
<TD WIDTH="168" HEIGHT="30">외상매출채권담보대출</TD>
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">하나은행</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">200,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="106" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="30">매출채권/단기차입금</TD>
<TD WIDTH="168" HEIGHT="30">외상매출채권담보대출</TD>
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">우리은행</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,200,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="106" HEIGHT="30">207,859,311 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<P USERMARK="F-16">
<SPAN USERMARK="F-GL11">9. 정부보조금&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">정부</SPAN>
<SPAN USERMARK="F-GL11">보조금의 수령 내용과 회계처리 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="607" BORDER="1">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">배  부  처</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금        액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="89" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회계처리</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>당 기</SPAN>
</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER">지방투자촉진보조금&cr;(*1)(*2)</TD>
<TD VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ALIGN="CENTER">산업통상자원부</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">4,192,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" WIDTH="89" HEIGHT="30" ALIGN="CENTER">자산 차감</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ALIGN="CENTER">익산시</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">1,048,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" WIDTH="89" HEIGHT="30" ALIGN="CENTER">자산 차감</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="153" HEIGHT="30" ALIGN="CENTER">스마트팩토리사업</TD>
<TD VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ALIGN="CENTER">산업통상자원부</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">96,701,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" WIDTH="89" HEIGHT="30" ALIGN="CENTER">자산 차감</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="276" HEIGHT="30">합         계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">5,336,701,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="121" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" WIDTH="89" HEIGHT="30" ALIGN="CENTER">　</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(*1) 보조금 관리에 관한 법률 및 국가균형발전 특별법에 의거 회사가 보조금 신청시 제출한 사업계획에 따른 투자 및 고용을 수행하지 않는 경우 기교부받은 보조금은 이자를 포함하여 환수될 수 있습니다. 또한 보조금 교부조건에 따른 사업이행기간은 신청한 날일 속한 달의 1일부터 5년간입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">(*2) 회사는 당기에 수령한 보조금 중 미사용 금액(약 35억원)을 익산공장 건설을 위하여 차기에 지출할 예정이며 현금및현금성자산의 차감계정으로 계상하고 있습니다. 한편 미사용된 정부보조금은 보조금 교부조건에 한하여 사용이 가능합니다(주석8 참조).&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;10. </SPAN>
<SPAN USERMARK="F-GL11">자</SPAN>
<SPAN USERMARK="F-GL11">본금과 자본잉여금</SPAN>
<SPAN USERMARK="F-GL11">의 내용</SPAN>
</P>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">(1) </SPAN>
<SPAN USERMARK="F-GL11">당기</SPAN>
<SPAN USERMARK="F-GL11">말 현재 자본금의 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 :주, 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="608" BORDER="1">

<COLGROUP>
<COL WIDTH="295"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="304" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구                   분</TH>
<TH ALIGN="CENTER" WIDTH="304" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보  통  주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" HEIGHT="30">     1주당금액</TD>
<TD ALIGN="RIGHT" WIDTH="304" HEIGHT="30">500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" HEIGHT="30">     발행한 주식의 총수</TD>
<TD ALIGN="RIGHT" WIDTH="304" HEIGHT="30">11,194,420 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="304" HEIGHT="30">
<SPAN>     당기</SPAN>
<SPAN>말 현재 자본금</SPAN>
</TD>
<TD ALIGN="RIGHT" WIDTH="304" HEIGHT="30">5,617,210,000 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1) 회사는 2019년 중에 상환우선주의 상환을 완료하였습니다. 그 결과 당기말 현재 발행주식수에 액면금액을 곱한 금액(11,194,420주*500원=5,597,210천원)과 자본금(</SPAN>
<SPAN USERMARK="F-GL11">5,617,210천</SPAN>
<SPAN USERMARK="F-GL11">원)간에 차이가 발생하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;정관상 회사가 발행할 주식의 총수는 100,000,000주입니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">(2) </SPAN>
<SPAN USERMARK="F-GL11">당기</SPAN>
<SPAN USERMARK="F-GL11">와 전기의 자본금과 주식발행초과금의 변동 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 주, 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="754" BORDER="1">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">변동일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">변동사유</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">증감주식수&cr;(주)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">주당&cr;발행가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="215" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">자본금증감액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">주식발행초과금&cr;증감액(*1)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">우선주</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="114" HEIGHT="30">전기초</TD>
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">104,660 </TD>
<TD ALIGN="RIGHT" WIDTH="78" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">503,300,000 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">20,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">983,937,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="114" HEIGHT="30">2019-10-07</TD>
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">우선주 상환(*2)</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">(4,000)</TD>
<TD ALIGN="RIGHT" WIDTH="78" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="114" HEIGHT="30">2020-07-07</TD>
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">액면분할</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">905,940 </TD>
<TD ALIGN="RIGHT" WIDTH="78" HEIGHT="30">500 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="114" HEIGHT="30">전기말/당기초</TD>
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">1,006,600 </TD>
<TD ALIGN="RIGHT" WIDTH="78" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">503,300,000 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">20,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">983,937,500 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="114" HEIGHT="30">2020-09-25</TD>
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">유상증자</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">112,842 </TD>
<TD ALIGN="RIGHT" WIDTH="78" HEIGHT="30">75,000 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">56,421,000 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">8,402,608,800 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="114" HEIGHT="30">2020-10-23</TD>
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">무상증자</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">10,074,978 </TD>
<TD ALIGN="RIGHT" WIDTH="78" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">5,037,489,000 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(5,112,809,830)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="114" HEIGHT="30">당기말</TD>
<TD ALIGN="CENTER" WIDTH="125" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">11,194,420 </TD>
<TD ALIGN="RIGHT" WIDTH="78" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">5,597,210,000 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">20,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">4,273,736,470 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(*1) 증자시 주식발행비용은 주식발행초과금에서 차감하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">(*2) 상법 제345조에 따라 발행한 상환우선주로서 회사의 이익으로 상환하여 소각하였으므로 주식수는 감소하고 자본금은 감소하지 않았습니다(주석11 참조).&cr;</SPAN>
</P>
<P USERMARK="F-GL11">11. 이익잉여금처분계산서</P>

<P>
<SPAN USERMARK="F-GL11">&cr;당기 및 전기의 이익잉여금처분계산서</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">는 다음과 같습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">                                      </SPAN>
<SPAN USERMARK="F-GL11 B">이 익 잉 여 금 처 분 계 산 서</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="64">제10기</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="32">
<SPAN>2020년  </SPAN>
<SPAN>1월   1일</SPAN>
</TD>
<TD VALIGN="MIDDLE" WIDTH="48" HEIGHT="32">부터</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="64">제9기</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="151" HEIGHT="32">
<SPAN>2019년  </SPAN>
<SPAN>1월   1일</SPAN>
</TD>
<TD VALIGN="MIDDLE" WIDTH="48" HEIGHT="32">부터</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="32">
<SPAN>2020년 </SPAN>
<SPAN>12월 31일</SPAN>
</TD>
<TD VALIGN="MIDDLE" WIDTH="48" HEIGHT="32">까지</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="151" HEIGHT="32">
<SPAN>2019년 </SPAN>
<SPAN>12월 31일</SPAN>
</TD>
<TD VALIGN="MIDDLE" WIDTH="48" HEIGHT="32">까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="32">처분예정일</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="155" HEIGHT="32">
<SPAN>2021년</SPAN>
<SPAN>  3월 30일</SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="32"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="101" HEIGHT="32">처분확정일</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="151" HEIGHT="32">
<SPAN>2020년</SPAN>
<SPAN>  3월 18일</SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="32"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="33">주식회사 마더스제약</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="33">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="726" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="252" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 10(당) 기</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="251" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 9(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">Ⅰ. 미처분이익잉여금</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">10,172,879,322 </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">11,070,943,795 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" USERMARK=" P16">전기이월미처분이익잉여금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">11,070,943,795 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">9,283,025,533 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" USERMARK=" P16">우선주 상환</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30">(1,005,767,215)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" USERMARK=" P16">당기순이익</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">(898,064,473)</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">2,793,685,477 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">Ⅱ. 이익잉여금처분액</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30">Ⅲ. 차기이월미처분이익잉여금</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">10,172,879,322 </TD>
<TD ALIGN="RIGHT" WIDTH="125" HEIGHT="30">　</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">11,070,943,795 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>
<P USERMARK="F-GL11">12. 배당금의 산정과 배당성향의 내용&cr;&cr;주주에 대한 배당금 산정내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="595">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구   분</TH>
<TH WIDTH="156" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">배당대상 주식수</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">배당률</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">배당금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">당기</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중간배당</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">-</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연차배당</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">-</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">전기</TD>
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">중간배당</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">-</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">연차배당</TD>
<TD WIDTH="156" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">104,660 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="119" HEIGHT="30">95.55%</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500,000,000 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;&cr;13. 이익잉여금의 내용</P>
<P USERMARK="F-GL11">&cr;법령 등에 의하여 이익배당이 제한된 잉여금의 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="610" BORDER="1">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과     목</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="244" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금                     액</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제  한  근  거</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">법정적립금</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">이익준비금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">79,980,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">79,980,000 </TD>
<TD WIDTH="122" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 상법</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">14</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">. 특수관계자와의 주요거래내용</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;(1) 특수관계자 현황&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="620" BORDER="1">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="207" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관        계</TH>
<TH ALIGN="CENTER" WIDTH="207" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH ALIGN="CENTER" WIDTH="206" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비    고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="207" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">기타 특수관계자</TD>
<TD ALIGN="CENTER" WIDTH="207" HEIGHT="30">㈜마더스팜</TD>
<TD ALIGN="CENTER" WIDTH="206" HEIGHT="30">동일 지배주주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="207" HEIGHT="30">㈜마더스바이오메드</TD>
<TD ALIGN="CENTER" WIDTH="206" HEIGHT="30">㈜마더스팜의 종속기업</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="207" HEIGHT="30">㈜마더스코스메틱</TD>

<TD ALIGN="CENTER" WIDTH="206" HEIGHT="30">
<SPAN>㈜마더스팜의 종속기업</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;(2) 특수관계자와의 중요한 영업상의 거래내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="643" BORDER="1">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자&cr;(회사명 또는 성명)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타수익</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">㈜마더스팜</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">1,840,433,169</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">9,288,678</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">54,545,460</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">150,707,358</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">㈜마더스바이오메드</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">1,456,895,148</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">65,454,546</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">㈜마더스코스메틱</TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">54,545,460</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">58,293,650</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">합   계</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="113" HEIGHT="30">3,297,328,317</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30">9,288,678</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">174,545,466</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">209,001,008</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="671">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자&cr;(회사명 또는 성명)</TH>
<TH WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출</TH>
<TH WIDTH="97" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타수익</TH>
<TH WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">㈜마더스팜</TD>
<TD WIDTH="93" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,737,121,679 </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">20,762,553 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">54,545,460 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">151,092,691 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">㈜마더스바이오메드</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">18,935,741,858 </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">81,818,184 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">㈜마더스코스메틱</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">54,545,460 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">20,114,690 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">20,672,863,537 </TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">20,762,553 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">190,909,104 </TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT">171,207,381 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">(3) 특수관계자와의 매출채권ㆍ매입채무의 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="663" BORDER="1">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자&cr;(회사명 또는 성명)</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출채권</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="194" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입채무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">㈜마더스팜</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">504,154,790 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">182,285,854 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">11,051,746 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">㈜마더스바이오메드</TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">47,626,119 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">5,415,641,318 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">합   계</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">551,780,909 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">5,597,927,172 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">11,051,746 </TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 특수관계자와의 중요한 기타채권ㆍ채무의 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="638" BORDER="1">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자&cr;(회사명 또는 성명)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미수금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타보증금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임대보증금</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미지급금</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="145" HEIGHT="30">㈜마더스팜</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">50,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">100,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">14,868,918</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="145" HEIGHT="30">㈜마더스바이오메드</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">45,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="145" HEIGHT="30">㈜마더스코스메틱</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">30,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">275,520</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="238" HEIGHT="30" COLSPAN="2">합   계</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">50,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">175,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="100" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자&cr;(회사명 또는 성명)</TH>
<TH WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH WIDTH="98" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미수금</TH>
<TH WIDTH="98" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타보증금</TH>
<TH WIDTH="98" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임대보증금</TH>
<TH WIDTH="98" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미지급금</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">㈜마더스팜</TD>
<TD WIDTH="93" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">50,000,000 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">100,000,000 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">54,001,960 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">㈜마더스바이오메드</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">45,000,000 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">㈜마더스코스메틱</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">90,269,010 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">30,000,000 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30" ALIGN="CENTER" COLSPAN="2">합   계</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">90,269,010 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">50,000,000 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">175,000,000 </TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">54,001,960 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(5) 특수관계자와의 기타거래내용은 다음과 같습니다.</P>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">1) 특수관계자와의 담보 및 지급보증의 내용&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;특수관계자에 대한 담보제공(주석 8) 설정금액 1,200,000천원과 특수관계자에 대한 지급보증(주석 8) 보증금액 3,976,800천원이 있으며, 대표이사로부터 제공받은 지급보증(주석 8) 보증금액 </SPAN>
<SPAN USERMARK="F-GL">22,550,040천</SPAN>
<SPAN USERMARK="F-GL">원이 있습니다. </SPAN>
<SPAN USERMARK="F-GL">한편 배서양도한 어음 중 240,944천원은 ㈜마더스팜이 발</SPAN>
<SPAN USERMARK="F-GL">행한</SPAN>
<SPAN USERMARK="F-GL"> 어음입니다(주석 8).&cr;</SPAN>
</P>
<P USERMARK="F-GL11">2) 특수관계자 대여금에 대한 내용</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="731" BORDER="1">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="412" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중증가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중감소액</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>기말</SPAN>
<SPAN>잔액</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30">㈜마더스팜</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="90" ROWSPAN="3">기타&cr;특수관계자</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="90" ROWSPAN="3">단기대여금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30">대표이사</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">591,971,616 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">17,397,134 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">138,140,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">471,228,750 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30">주주.임원.종업원</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="319" HEIGHT="30" COLSPAN="3">합   계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">591,971,616 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30">17,397,134 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">138,140,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">471,228,750 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE BORDER="0" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="739" BORDER="1">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="420" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중증가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중감소액</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>기말</SPAN>
<SPAN>잔액</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30">㈜마더스팜</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="90" ROWSPAN="3">기타&cr;특수관계자</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="90" ROWSPAN="3">단기대여금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">90,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">90,000,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30">대표이사</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">286,853,150 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">456,501,626 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">151,383,160 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">591,971,616 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30">주주.임원.종업원</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">47,850,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">55,200,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">103,050,000 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="319" HEIGHT="30" COLSPAN="3">합   계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">334,703,150 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">601,701,626 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">344,433,160 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30">591,971,616 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">3) 특수관계자 차입금에 대한 내용</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="711">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자</TH>
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH WIDTH="432" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중증가액</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중감소액</TH>

<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>기말</SPAN>
<SPAN>잔액</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">㈜마더스&cr;바이오메드</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="118" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,500,000,000 </TD>
<TD WIDTH="118" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,000,000,000 </TD>
<TD WIDTH="118" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,500,000,000 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE BORDER="0" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="645">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자</TH>
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH WIDTH="366" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중증가액</TH>
<TH WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중감소액</TH>

<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>기말</SPAN>
<SPAN>잔액</SPAN>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">㈜마더스팜</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">기타&cr;특수관계자</TD>
<TD WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
<TD WIDTH="105" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">100,000,000 </TD>
<TD WIDTH="105" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">100,000,000 </TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">- </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;&cr;15. 연구비와 경상개발비의 내용</P>
<P USERMARK="F-GL11">&cr;비용으로 인식한 연구비와 경상개발비의 내용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="615" BORDER="1">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="178"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="240" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구        분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="240" HEIGHT="30">  원재료비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">395,137,032 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">359,703,954 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="240" HEIGHT="30">  인건비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">844,387,474 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">802,917,303 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="240" HEIGHT="30">  유형자산감가상각비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="240" HEIGHT="30">  위탁용역비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">1,614,265,334 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">1,155,735,448 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="240" HEIGHT="30">  기        타</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">284,049,142 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">204,711,546 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="240" HEIGHT="30">  합        계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">3,137,838,982 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">2,523,068,251 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="90">회계처리</TD>
<TD VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">  판매비와관리비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">2,817,184,187</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">2,115,477,856 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">  제조경비</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">320,654,795 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">407,590,395 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="157" HEIGHT="30">  합      계</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="188" HEIGHT="30">3,137,838,982 </TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="187" HEIGHT="30">2,523,068,251 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;</P>
<P USERMARK="F-GL11">16. 부가가치계산에 필요한 계정과목과 그 금액</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">부가가치계산에 필요한 계정과목과 그 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="1011" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구        분</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="236" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제   조   원   가</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="236" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">판매비와관리비</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="210" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기        타</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="236" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합        계</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">급         여</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">3,611,592,437 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">3,335,541,720 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,845,456,824 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,044,633,771 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">844,387,474 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">802,917,303 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">6,301,436,735 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">6,183,092,794 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">퇴 직 급 여</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">323,794,550 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">250,848,919 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">212,959,045 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">269,498,928 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">536,753,595 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">520,347,847 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">복리후생비</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">511,501,954 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">400,801,487 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">238,150,230 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">305,367,475 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">749,652,184 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">706,168,962 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">임   차   료</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">74,738,000 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">111,208,023 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">17,445,000 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">18,390,000 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">92,183,000 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">129,598,023 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">감가상각비</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,235,152,735 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,243,430,189 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">521,466,905 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">485,646,437 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,756,619,640 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,729,076,626 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">세금과공과</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">26,750,220 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">38,758,200 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">138,211,517 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">42,158,960 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">164,961,737 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">80,917,160 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30">합        계</TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">5,783,529,896 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">5,380,588,538 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,973,689,521 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">3,165,695,571 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">844,387,474 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">802,917,303 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">9,601,606,891 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">9,349,201,412 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;</P>
<P USERMARK="F-GL11">17. 포괄손익계산서</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">당기</SPAN>
<SPAN USERMARK="F-GL11"> 및 </SPAN>
<SPAN USERMARK="F-GL11">전기</SPAN>
<SPAN USERMARK="F-GL11"> 중 회사의 포괄손익의 내용은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">
<SPAN>포괄손익계산서</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">제10기 2020년 01월 01일부터 2020년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">제9기 2019년 01월 01일부터 2019년 12월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">
<SPAN>    (단위 : 원)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="620" BORDER="1">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="207" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구             분</TH>
<TH ALIGN="CENTER" WIDTH="207" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" WIDTH="206" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">당기순손익</TD>
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(898,064,473)</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,793,685,477 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">기타포괄손익</TD>
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(3,021,689)</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(2,205,970)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30">당기포괄손익</TD>
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(901,086,162)</TD>
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,791,479,507 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;</P>
<P USERMARK="F-GL11">18. 현금흐름표에 관한 사항</P>
<P USERMARK="F-GL11">&cr;현금흐름표는 간접법으로 작성되었으며, 현금의 유입과 유출이 없는 거래는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="622" BORDER="1">

<COLGROUP>
<COL WIDTH="284"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="293" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구                            분</TH>
<TH COLSPAN="2" ALIGN="CENTER" WIDTH="329" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금                   액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="165" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" WIDTH="164" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="293" HEIGHT="30">매도가능증권의 평가</TD>
<TD ALIGN="RIGHT" WIDTH="165" HEIGHT="30"> 3,021,689 </TD>
<TD ALIGN="RIGHT" WIDTH="164" HEIGHT="30">2,205,970 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="293" HEIGHT="30">유형자산 미지급금</TD>
<TD ALIGN="RIGHT" WIDTH="165" HEIGHT="30"> 1,133,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="164" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="293" HEIGHT="30">건설중인자산의 본계정 대체</TD>
<TD ALIGN="RIGHT" WIDTH="165" HEIGHT="30">567,403,000 </TD>
<TD ALIGN="RIGHT" WIDTH="164" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="293" HEIGHT="30">이익준비금의 적립</TD>
<TD ALIGN="RIGHT" WIDTH="165" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="164" HEIGHT="30">50,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="293" HEIGHT="30">장기차입금의 유동성대체</TD>
<TD ALIGN="RIGHT" WIDTH="165" HEIGHT="30"> 2,694,779,025 </TD>
<TD ALIGN="RIGHT" WIDTH="164" HEIGHT="30">866,773,039 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="293" HEIGHT="30">무상증자</TD>
<TD ALIGN="RIGHT" WIDTH="165" HEIGHT="30"> 5,037,489,000 </TD>
<TD ALIGN="RIGHT" WIDTH="164" HEIGHT="30">- </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">19. </SPAN>
<SPAN USERMARK="F-GL11">유동성위험 관리방법 및 금융부채의 만기분석&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">(1) 유동성위험 관리 방법&cr;회사</SPAN>
<SPAN USERMARK="F-GL11">는 미래 현금흐름을 예측하여 단기 및 중장기 자금조달 계획을 수립하고 예측현금흐름과 실제현금흐름을 계속하여 관찰하고 있으며</SPAN>
<SPAN USERMARK="F-GL11"> 충분한 유동성을 확보하기 위하여  일정 수준의 차입한도를 유지하고 수시입출금식 예금 등</SPAN>
<SPAN USERMARK="F-GL11">의 금융상품에 잉여자금을 투자하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11 B"></SPAN>
<SPAN USERMARK="F-GL11">&cr;(2) 금융부채의 만기분석&cr;현금 등 금융자산을 인도하여 결제하는 금융부채의 종류별 만기분석 내역은 다음과  같습니</SPAN>
<SPAN USERMARK="F-11">다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><당기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="855" BORDER="1">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3개월 이하</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3개월~1년</TH>
<TH ALIGN="CENTER" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년~2년 </TH>
<TH ALIGN="CENTER" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2년~5년</TH>
<TH ALIGN="CENTER" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5년 초과</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">매입채무</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">18,350,819,858 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">14,704,111,881 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">3,646,707,977 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">기타유동부채</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">4,751,726,408 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">4,751,726,408 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">20,703,269,975 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">5,259,748,419 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">7,238,438,639 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,332,015,579 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,112,067,338 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">4,761,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">기타비유동부채</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">190,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">190,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">합계</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">43,995,816,241 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">24,715,586,708 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">10,885,146,616 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,332,015,579 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">1,302,067,338 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">4,761,000,000 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"><전기></TD>
<TD WIDTH="300" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="842" BORDER="1">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3개월 이하</TH>
<TH ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3개월~1년</TH>
<TH ALIGN="CENTER" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년~2년 </TH>
<TH ALIGN="CENTER" WIDTH="118" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2년~5년</TH>
<TH ALIGN="CENTER" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">5년 초과</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">매입채무</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">20,703,139,904 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">17,427,878,049 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">3,275,261,855 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">기타유동부채</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">2,831,579,331 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">2,831,579,331 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">차입금</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">15,038,871,893 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">2,414,252,224 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">6,735,757,727 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,721,033,039 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">3,039,188,903 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">128,640,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">기타비유동부채</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">175,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">175,000,000 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">- </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="123" HEIGHT="30">합계</TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">38,748,591,128 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">2,831,579,331 </TD>
<TD ALIGN="RIGHT" WIDTH="126" HEIGHT="30">29,853,149,855 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">2,896,033,039 </TD>
<TD ALIGN="RIGHT" WIDTH="118" HEIGHT="30">3,039,188,903 </TD>
<TD ALIGN="RIGHT" WIDTH="105" HEIGHT="30">128,640,000 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-11"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>

<P>
<SPAN USERMARK=" U"></SPAN>
<SPAN USERMARK="F-11"></SPAN>
</P>
</SECTION-2>
</LIBRARY>
</INSERTION>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 기타 재무에 관한 사항</TITLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">가. 재무제표 재작성 등 유의사항&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">(1) (연결)재무제표를 재작성한 경우 재작성 사유&cr;당사</SPAN>
<SPAN USERMARK="F-GL11">는 사업보고서</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"> 작성기준일 현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">(2) 합병, 분할, 자산양수도, 영업양수도&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 작성기준일 현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">(3) 자산유동화와 관련한 자산매각의 회계처리 및 우발채무 등에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 작성기준일 현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">(4) 기타 재무제표 이용에 유의하여야 할 사항&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는</SPAN>
<SPAN USERMARK="F-GL11"> 사업보고서 작성기준일 현재 해당사항이 없습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">나. 대손충당금 현황</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">(1) 계정과목별 대손충당금 설정내용&cr; </SPAN>
</P>

<TABLE WIDTH="608" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="599"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="608" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계정과목</P>
</TH>

<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>채권금액</P>
</TH>

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>대손충당금 </P>
</TH>

<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>대손충당금</P>
<P>설정률</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제10기 </P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 매출채권</P>
</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,980,070</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,784</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.0010</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제 9기</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 매출채권</P>
</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,192,941</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,367</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.0021</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제 8기</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 매출채권</P>
</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,281,785</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,157</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.0041</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK="F-GL11 0X000000">&cr;2)  대손충당금 변동현황</SPAN>
</P>

<TABLE WIDTH="611" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="602"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="611" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> (단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="266"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="275" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 10기</P>
</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 9기</P>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 8기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>1. 기초 대손충당금 잔액합계</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,367</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,157</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,122</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>2. 순대손처리액(①-②±③)</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>  ① 대손처리액(상각채권액)</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> (221,112)</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>  ② 상각채권회수액</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>  ③ 기타증감액</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,034</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>3. 대손상각비 계상(환입)액</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">195,529</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(25,790)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>4. 기말 대손충당금 잔액합계</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,784</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,367</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">75,157</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">(3) 매출채권 관련 대손충당금 설정방침</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">당사는 매출채권 잔액에 대하여 경과기간별 분석을 하고 있으며, </SPAN>
<SPAN USERMARK="F-GL11">경과기간별  </SPAN>
<SPAN USERMARK="F-GL11">매출채권 잔액에 아래의 대손경험률을 적용하여 대손충당금을 설정하고 있습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="305"></COL>
<COL WIDTH="281"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="314" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">경과기간</TH>
<TH WIDTH="290" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손설정율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="314" HEIGHT="30" VALIGN="MIDDLE">4개월 초과 1년 이하</TD>
<TD WIDTH="290" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="314" HEIGHT="30" VALIGN="MIDDLE">1년 초과 </TD>
<TD WIDTH="290" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100%</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK="F-GL11 0X000000">&cr;</SPAN>
<SPAN USERMARK="F-GL11 0X000000">(4) 당기말 현재 경과기간별 매출채권 잔액 현황</SPAN>
</P>

<TABLE WIDTH="608" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="599"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="608" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">

<P USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">(단위 : 천원</SPAN>
<SPAN USERMARK=" 0X000000">)</SPAN>
</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="32"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>4개월이하</P>
</TH>

<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>4개월 초과</P>
<P>1년 이하</P>
</TH>

<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>1년 초과</P>
</TH>

<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="41" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>금액</P>
</TD>

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>일반</P>
</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,313,866</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,924</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,432,790</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>특수관계자</P>
</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">547,280</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">547,280</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계</P>
</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,861,146</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">118,924</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,980,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>구성비율</P>
</TD>
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99.45%</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.55%</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">다.  재고자산 현황,&cr;(1) 재고자산의 사업부문별 보유현황</SPAN>
</P>

<TABLE WIDTH="563" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="554"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="563" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="82"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사업부문 </P>
</TH>

<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계정과목</P>
</TH>

<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 10기 </P>
</TH>

<TH WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 9기</P>
</TH>

<TH WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 8기</P>
</TH>

<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="131" VALIGN="MIDDLE" HEIGHT="120">
<P>   의약품 제조</P>
</TD>

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품</P>
</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,298,741</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,036,738</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,860,567</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>원.부재료</P>
</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,935,977</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,893,049</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,645,125</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>재공품</P>
</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,651,532</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,437,012</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,067,537</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소    계</P>
</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,886,250</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,366,799</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,573,229</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="262" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>총자산대비 재고자산 구성비율(%)</P>
<P>[재고자산합계÷기말자산총계×100]</P>
</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">20.04</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">19.98</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">17.26</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="262" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>재고자산회전율(회수)</P>
<P>[연환산 매출원가÷{(기초재고+기말재고)÷2}]</P>
</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">3.00</TD>
<TD WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">3.87</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">4.17</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">(2) 재고자산의 실사내용</SPAN>
</P>

<TABLE BORDER="1" WIDTH="612" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="206"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>일자</P>
</TH>

<TH WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내용</P>
</TH>

<TH WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>실사방법</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" ALIGN="CENTER" HEIGHT="30">2021.01.05</TD>

<TD WIDTH="215" ALIGN="CENTER" HEIGHT="30">
<P>제10기 기말 재고자산 실사</P>
</TD>
<TD WIDTH="303" ALIGN="CENTER" HEIGHT="30">삼덕회계법인의 입회하에 재고조사 실시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" ALIGN="CENTER" HEIGHT="30">2020.09.30</TD>

<TD WIDTH="215" ALIGN="CENTER" HEIGHT="30">
<P>제10기 반기말 재고자산 실사</P>
</TD>
<TD WIDTH="303" ALIGN="CENTER" HEIGHT="30">당사가 자체적으로 실시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" ALIGN="CENTER" HEIGHT="30">2020.01.03</TD>

<TD WIDTH="215" ALIGN="CENTER" HEIGHT="30">
<P>제9기 기말 재고자산 실사</P>
</TD>
<TD WIDTH="303" ALIGN="CENTER" HEIGHT="30">삼덕회계법인의 입회하에 재고조사 실시</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1) 당사는 2021년 01월 05일자에 삼덕회계법인의 회계사 2인 입회하에 재고조사&cr;   실사를 실시하였습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;&cr;1) 실사 일자&cr;① 본사 : 매월 1회 실시(월말)&cr;&cr;2) 실사 방법 :&cr;① 기말 : 자체 전수실사 시행&cr;② 자체 전수실사 시행 시 감사인 입회하여 일부 항목에 대해 표본 추출하여 실재성 및 완전성 확인&cr;&cr;3) 평가기준 :원.부재고자산은 총평균법에 의한 취득원가로 평가하고 있으며, 그 수량은 계속기록법과 실지재고조사법을 병용하여 확정하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">(3) 재고자산의 담보제공&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는</SPAN>
<SPAN USERMARK="F-GL11"> 사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 작성기준일 현재 재고자산을 담보로 제공한 사실이 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">라. 수주계약 현황&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는</SPAN>
<SPAN USERMARK="F-GL11"> 사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 작성기준일 현재 해당사항이 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">마. 금융자산 공정가치 평가내역&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 작성기준일 현재 해당사항 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;바. 채무증권 발행 실적&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 작성기준일 현재 해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">사. 기업인수목적회사의 재무규제 및 비용 등&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 작성기준일 현재 해당사항이 없습니다.</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE2" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『진행률적용 수주계약 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*진행률적용수주계약현황*.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="1">(단위 : 원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="748" BORDER="1">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『사채관리계약 주요내용 및 충족여부 등』 삽입</COMMENT>
<LIBRARYLIST>11011#*사채관리계약주요내용.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과&cr;20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P USERMARK="F-GL11">1. 예측정보에 대한 주의 사항&cr;    당사가 동 사업보고서에서 미래에 발생할 것으로 예상 . 예측한 활동 , 사건 또는 &cr;    현상은 당해 공시서류 작성시점의 사건 및 재무성과에 대하여 회사의 견해를 반영   한 것입니다 , 동 예측정보는 미래 사업환경과 관련된 다양한 가정에 기초하고 있    으며 , 동 가정들은 결과적으로 부정확한 것으로 판명될 수도 있습니다 . 또한 이러   한 가정들에는 예측정보에서 기재한 예상치와 실제 결과 간에 중요한 차이를 초래    할 수 있는 위험 , 불확실성 및 기타 요인을 포함하고 있습니다. 이러한 중요한 차이  를 초래할수 있는 요인에는 회사 내부경영과 관련된 요인과 외부환경에 관한 요인   이 포함되어 있으며, 이에 한하지 않습니다&cr;&cr;  당사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위    하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다.     결론적으로 , 동 사업 보고서상에 회가가 예상한 결과 또는 사항이 실현되거나 회사  가 당초에 예상한 영향이 발생한다는 확신을 제공할 수 없습니다. 동 보고서에 기재  된 예측정보는 동보고서 작성시점을 기준으로 작성한 것이며 , 회사가 이러한 위험   요인이나 예측정보를 수정할 예정이 없음을 유의하시기 바랍니다.&cr;&cr;2. 개요&cr;  회사의 경영에 대한 전반적인 사항을 파악하기 위하여 장부와 관계서류를 열람하고  재무제표 및 분석명세서에 대하여도 면밀히 검토하였습니다. 경영활동에 중대한 영 햐</P>
<P USERMARK="F-GL11">  향을 미칠 수 있는 사항에 대하여는 그 내용을 면밀히 검토하는 등 적정한 방법으로   회사 경영에 대한 내용을 진단하였습니다.&cr;&cr;3. 재무상태 및 영업실적&cr;  아래 별도 기준 재무상테 및 영업실적은 감사후 결산 자료입니다.&cr; -별도기준&cr;&cr;가.재무상태                            &cr;                                                                                     ( 단위: 원 ,%)</P>

<TABLE ACLASS="NORMAL" WIDTH="548" BORDER="1">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="176"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30">      구           분</TD>
<TD WIDTH="185" HEIGHT="30">         제10기 (2020년)</TD>
<TD WIDTH="203" HEIGHT="30">          제  9  기 (2019년)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">유동자산</TD>
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">41,692,801,876</TD>
<TD ALIGN="CENTER" WIDTH="203" HEIGHT="30">37,564,876,599 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비유동자산</TD>
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">22,794,296,915</TD>
<TD ALIGN="CENTER" WIDTH="203" HEIGHT="30">14,309,417,872</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자산총계</TD>
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">64,487,098,791</TD>
<TD ALIGN="CENTER" WIDTH="203" HEIGHT="30">51,874,294,471</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">유동부채</TD>
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">35,762,862,741</TD>
<TD ALIGN="CENTER" WIDTH="203" HEIGHT="30">32,963,902,204</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비유동부채</TD>
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">8,395,082,917</TD>
<TD ALIGN="CENTER" WIDTH="203" HEIGHT="30">6,063,861,942</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">부채총계</TD>
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">44,157,945,658</TD>
<TD ALIGN="CENTER" WIDTH="203" HEIGHT="30">39,027,764,146</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자본총계</TD>
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">20,329,153,133</TD>
<TD ALIGN="CENTER" WIDTH="203" HEIGHT="30">12,846,530,325</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">부채비율</TD>
<TD WIDTH="185" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">217.21%</TD>
<TD ALIGN="CENTER" WIDTH="203" HEIGHT="30">  303.80%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;나. 영업실적&cr;                                                                                                     (단위: 원)</P>

<TABLE ACLASS="NORMAL" WIDTH="577" BORDER="1">

<COLGROUP>
<COL WIDTH="226"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="160"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="235" HEIGHT="53" VALIGN="MIDDLE">구          분</TD>
<TD ALIGN="CENTER" WIDTH="173" HEIGHT="53" VALIGN="MIDDLE"> 제10기&cr;(2020년)</TD>
<TD ALIGN="CENTER" WIDTH="169" HEIGHT="53" VALIGN="MIDDLE">제09기&cr;(2019년)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 매   출   액</TD>
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">70,767,092,805</TD>
<TD ALIGN="CENTER" WIDTH="169" HEIGHT="30" VALIGN="MIDDLE">  64,633,534,009</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 매출총이익</TD>
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">35,901,236,043</TD>
<TD ALIGN="CENTER" WIDTH="169" HEIGHT="30" VALIGN="MIDDLE"> 29,988,748,377</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 영 업 이 익</TD>
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">798,255,072</TD>
<TD ALIGN="CENTER" WIDTH="169" HEIGHT="30" VALIGN="MIDDLE">3,088,190,882</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 법인세비용차   감전순이익</TD>
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">294,830,900</TD>
<TD ALIGN="CENTER" WIDTH="169" HEIGHT="30" VALIGN="MIDDLE">2,834,139,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 당기순이익</TD>
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(898,064,473)</TD>
<TD ALIGN="CENTER" WIDTH="169" HEIGHT="30" VALIGN="MIDDLE">2,793,685,477</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기본주당순이익</TD>
<TD WIDTH="173" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(80.22)</TD>
<TD ALIGN="CENTER" WIDTH="169" HEIGHT="30" VALIGN="MIDDLE">27,753</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;4. 유동성에 관한 분석&cr; -별도기준&cr;  당사는 미사용 차입금한도를 적정수준으로 유지하고 영업 자금수요를 충족시킬수 있도록 유동성에 대한 예측을 항시 모니터링하여 차입금 한도나 약정을 위반하는 일이 없도록 하고 있습니다. 유동성에 대한 예측 시에는 회사의 자금조달 계획, 약정주수,회사내부의 목표재무비율 및 통화에  대한 제한과 같은 외부 법규나 법률 요구사항이 있는 경우 그런한 요구사항을 고려하고 있습니다.&cr;&cr;  당사의 별도기준 유동성위험 분석내역은 다음과 같습니다.&cr;   (당기)                                                                                          (단위:원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="855">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구    분</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">장부금액</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3개월 이하</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4개월이상 ~1년</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1년~2년</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2년~5년</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5년 초과</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매입채무</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">18,350,819,858 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14,704,111,881 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3,646,707,977 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타유동부채</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4,751,726,408 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4,751,726,408 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">20,703,269,975 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5,259,748,419 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7,238,438,639 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2,332,015,579 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,112,067,338 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4,761,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타비유동부채</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">190,000,000 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">190,000,000 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">43,995,816,241</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">24,715,586,708</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10,885,146,616 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2,332,015,579 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1,302,067,338 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4,761,000,000 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;&cr;  (전기)                                                                                (단위: 원)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="842">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">구    분</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">장부금액</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">3개월 이하</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">4개월이상~1년</TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">1년~2년</TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">2년~5년</TD>
<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">5년 초과</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">매입채무</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">20,703,139,904 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">17,427,878,049 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">3,275,261,855 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">- </TD>
<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">기타유동부채</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">2,831,579,331 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">2,831,579,331 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">- </TD>
<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">차입금</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">15,038,871,893 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">2,414,252,224 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">6,735,757,727 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">4,721,033,039 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">1,039,188,903 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">128,640,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">기타비유동부채</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">175,000,000 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">- </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">- </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">175,000,000 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">- </TD>
<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">합계</TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">38,748,591,128 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">22,673,709,604 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="30">10,011,019,582 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">4,896,033,039 </TD>
<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">1,039,188,903 </TD>
<TD WIDTH="105" VALIGN="MIDDLE" HEIGHT="30">128,640,000 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;&cr;5. 기타 투자판단에 필요한 사항&cr;   당사는 한국채택국제회계기준 (K-IFRS)을 적용하고 있습니다.</P>
<P USERMARK="F-GL11">&cr;</P>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 감사인의 감사의견 등</TITLE>
<P USERMARK="F-GL11"></P>
<WARNING>※ 회계감사인의 감사(검토)의견, 회계감사인과의 감사/비감사 용역 체결현황이 있을 경우&cr;    아래 『회계감사인의 감사의견』단위서식을 클릭하여 삽입하신 후 입력하세요.</WARNING>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『회계감사인의 감사의견』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인의감사의견.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">25_회계감사인의감사의견</FILENAME>
<P USERMARK="F-GL11">1. 회계감사인의 명칭 및 감사의견(검토의견 포함한다. 이하 이 조에서 같다)을 다음의 표에 따라 기재한다.</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="172" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="41" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제10기(당기)</TE>

<TE ALIGN="CENTER" WIDTH="117" HEIGHT="41" ACODE="OPN_AUR1" VALIGN="MIDDLE">

<P>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11"> 삼덕회계법인</SPAN>
</P>
</TE>

<TE ALIGN="CENTER" WIDTH="84" HEIGHT="41" ACODE="OPN_CMT1" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 적정</P>
</TE>

<TE ALIGN="CENTER" WIDTH="172" HEIGHT="41" ACODE="OPN_EMP1" VALIGN="MIDDLE">
<P USERMARK="F-GL11">해당사항 없음</P>
</TE>

<TE ALIGN="CENTER" WIDTH="112" HEIGHT="41" ACODE="OPN_POT1" VALIGN="MIDDLE">
<P USERMARK="F-GL11">해당사항 없음</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="35" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제09기(전기)</TE>

<TE ALIGN="CENTER" WIDTH="117" HEIGHT="35" ACODE="OPN_AUR2" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 삼덕회계법인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="84" HEIGHT="35" ACODE="OPN_CMT2" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 적정</P>
</TE>

<TE ALIGN="CENTER" WIDTH="172" HEIGHT="35" ACODE="OPN_EMP2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">해당사항 없음</P>
</TE>

<TE ALIGN="CENTER" WIDTH="112" HEIGHT="35" ACODE="OPN_POT2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">해당사항 없음</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="43" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제08기(전전기)</TE>

<TE ALIGN="CENTER" WIDTH="117" HEIGHT="43" ACODE="OPN_AUR3" VALIGN="MIDDLE">
<P USERMARK="F-GL11">  삼덕회계법인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="84" HEIGHT="43" ACODE="OPN_CMT3" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 적정</P>
</TE>

<TE ALIGN="CENTER" WIDTH="172" HEIGHT="43" ACODE="OPN_EMP3" VALIGN="MIDDLE">
<P USERMARK="F-GL11">해당사항 없음</P>
</TE>

<TE ALIGN="CENTER" WIDTH="112" HEIGHT="43" ACODE="OPN_POT3" VALIGN="MIDDLE">
<P USERMARK="F-GL11">해당사항 없음</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">2. 감사용역 체결현황은 다음의 표에 따라 기재한다.&cr;                                                                                              </SPAN>
<SPAN USERMARK="F-GL11">  (단위 : 백만원)</SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="51"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="157" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="66" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="84" HEIGHT="43" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">
<P USERMARK="F-GL11">제10기 </P>
</TE>

<TE ALIGN="CENTER" WIDTH="107" HEIGHT="43" ACODE="SIGK_AUR1" VALIGN="MIDDLE">
<P USERMARK="F-GL11">삼덕회계법인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="157" HEIGHT="43" ACODE="SIGK_CNT1" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 연간 재무제표 감사</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="43" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">30</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="43" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">393</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="43" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">30</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="43" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">393</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="84" HEIGHT="45" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">제 9기</P>
</TE>

<TE ALIGN="CENTER" WIDTH="107" HEIGHT="45" ACODE="SIGK_AUR2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">삼덕회계법인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="157" HEIGHT="45" ACODE="SIGK_CNT2" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 연간 재무제표 감사</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="45" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">25</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="45" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">360 </TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="45" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">25</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="45" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">360</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="84" HEIGHT="49" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">
<P USERMARK="F-GL11">제 8기</P>
</TE>

<TE ALIGN="CENTER" WIDTH="107" HEIGHT="49" ACODE="SIGK_AUR3" VALIGN="MIDDLE">
<P USERMARK="F-GL11">삼덕회계법인</P>
</TE>

<TE ALIGN="CENTER" WIDTH="157" HEIGHT="49" ACODE="SIGK_CNT3" VALIGN="MIDDLE">
<P USERMARK="F-GL11"> 연간 재무제표 감사</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="49" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">20</TE>
<TE ALIGN="RIGHT" WIDTH="66" HEIGHT="49" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">424 </TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="49" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">20</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="49" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">424</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">3. 회계감사인과의 비감사용역 계약체결 현황은 다음의 표에 따라 기재한다.</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR1" VALIGN="MIDDLE" ROWSPAN="2">
<P USERMARK="F-GL11">제 10기 </P>
</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">

<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" ROWSPAN="2">
<P USERMARK="F-GL11">제 9기</P>
</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="2">제8기</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">  </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 최근 3사업연도 이내 당사의 회계감사인이었던 삼덕회계법인과 외부감사 계약이  체결되어 있는 동안 비감사용역계약을 체결한 사실이 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『내부감사기구가 회계감사인과 논의한 결과』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인과논의한결과.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">46_회계감사인과논의한결과</FILENAME>
<P USERMARK="F-GL11">4. 재무제표 중 이해관계자의 판단에 상당한 영향을 미칠 수 있는 사항에 대해 내부감사기구가 회계감사인과 논의한 결과를 다음의 표에 따라 기재한다.</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="43"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="52" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="131" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="171" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="52" HEIGHT="76" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="131" HEIGHT="76" AUNIT="DIS_DATE" AUNITVALUE="20200213" VALIGN="MIDDLE">2020년 02월 13일</TU>
<TE ALIGN="CENTER" WIDTH="171" HEIGHT="76" ACODE="DIS_ATT" VALIGN="MIDDLE">(감사인) 업무수행이사&cr;(회사) 감사</TE>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="76" ACODE="DIS_WAY" VALIGN="MIDDLE">대면보고</TE>
<TE ALIGN="CENTER" WIDTH="177" HEIGHT="76" ACODE="DIS_CONT" VALIGN="MIDDLE">결산시 고려사항에 대한 논의</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="52" HEIGHT="76" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="131" HEIGHT="76" AUNIT="DIS_DATE" AUNITVALUE="20201221" VALIGN="MIDDLE">2020년 12월 21일</TU>
<TE ALIGN="CENTER" WIDTH="171" HEIGHT="76" ACODE="DIS_ATT" VALIGN="MIDDLE">(감사인) 업무수행이사&cr;(회사) 감사</TE>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="76" ACODE="DIS_WAY" VALIGN="MIDDLE">대면보고</TE>

<TE ALIGN="CENTER" WIDTH="177" HEIGHT="76" ACODE="DIS_CONT" VALIGN="MIDDLE" USERMARK="F-BT">
<SPAN USERMARK="F-GL">중간감사 결과 보고</SPAN>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="52" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="131" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20210308" VALIGN="MIDDLE">2021년 03월 08일</TU>
<TE ALIGN="CENTER" WIDTH="171" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">(감사인) 업무수행이사&cr;(회사) 감사</TE>
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면보고</TE>
<TE ALIGN="CENTER" WIDTH="177" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">결산시 고려사항에 대한 논의</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11">&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『조정협의회내용 및 재무제표 불일치정보』 삽입</COMMENT>
<LIBRARYLIST>11011#*조정협의회내용및재무제표불일치정보.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">가. 이사회 구성 개요</P>
<P USERMARK="F-GL11">사업보고서 작성기준일 현재 당사의 이사회는 4명의 사내이사로 구성되어 있으며, 의장은 대표이사가 맡고 있습니다. 또한 이사회 내에 위원회는 별도로 설치되어 있지않습니다. 각 이사의 주요 이력 및 업무분장은 『Ⅷ. 임원 및 직원 등에 관한 사항』을 참고 하시기 바랍니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">나. 중요의결사항 등</P>

<TABLE BORDER="1" WIDTH="993" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="40"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="3" WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회 차</TH>
<TH ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>
<TH ROWSPAN="3" WIDTH="225" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의 안 내 용</TH>
<TH ROWSPAN="3" WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가결&cr;여부</TH>
<TH COLSPAN="2" WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사내이사</TH>
<TH COLSPAN="2" WIDTH="226" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타비상무이사</TH>
<TH ROWSPAN="3" WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">김좌진&cr;(출석률 : 100%)</TH>
<TH WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이시은&cr;(출석률 : 100%)</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">박준형&cr;(출석률 : 100%)</TH>

<TH WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<SPAN>송현순&cr;(</SPAN>
<SPAN>출석률 :</SPAN>
<SPAN> 15%</SPAN>
<SPAN>)</SPAN>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="4" WIDTH="469" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">찬반여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020-01</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.03.18</TD>
<TD WIDTH="225" HEIGHT="53">부패방비 방침 승인의 건&cr;(ISO37001 인증 승인의 건)</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-02</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.03.05</TD>
<TD WIDTH="225" HEIGHT="30">제9기 정기주주총회 소집의 건</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">불참</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020-03</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.04.09</TD>
<TD WIDTH="225" HEIGHT="53">산업은행 운영자금 대출10억원 대환의 건</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2020-04</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2020.05.11</TD>

<TD WIDTH="225" HEIGHT="76">
<SPAN>임시 주주총회 소집의 건</SPAN>
<SPAN USERMARK=" BC0X31FFFF">&cr;</SPAN>
<SPAN USERMARK=" BC0X31FFFF">(</SPAN>
<SPAN USERMARK=" BC0X31FFFF">주식액면분할</SPAN>
<SPAN USERMARK=" BC0X31FFFF">, 정관일부변경,유상증자)</SPAN>
</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">불참</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-05</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.06.24</TD>
<TD WIDTH="225" HEIGHT="30">농협대출 여신기한 연기 신청</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<SPAN>2020-</SPAN>
<SPAN>06</SPAN>
</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.07.28</TD>

<TD WIDTH="225" HEIGHT="53">
<SPAN>임시 주주총회 소집의 건</SPAN>
<SPAN USERMARK=" BC0X31FFFF">&cr;</SPAN>
<SPAN USERMARK=" BC0X31FFFF">(</SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF">정관변경)</SPAN>
</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020-07</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.08.12</TD>
<TD WIDTH="225" HEIGHT="53">임시 주주총회 의사록 (정관 변경의 건)</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020-08</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020.08.13</TD>

<TD WIDTH="225" HEIGHT="55">
<SPAN>신주발행의 건</SPAN>
<SPAN USERMARK=" BC0X31FFFF">&cr;</SPAN>
<SPAN USERMARK=" BC0X31FFFF">(</SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF">제3자배정 유상증자)</SPAN>
</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">불참</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" B"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020-09</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020.09.01</TD>

<TD WIDTH="225" HEIGHT="55">
<SPAN>신주발행의 건</SPAN>
<SPAN USERMARK=" BC0X31FFFF">&cr;</SPAN>
<SPAN USERMARK=" BC0X31FFFF">(</SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF">제3자배정 유상증자)</SPAN>
</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">불참</SPAN>
</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55" USERMARK=" B"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2020-10</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2020.09.21</TD>
<TD WIDTH="225" HEIGHT="76">명의개서대리인의 상호 및 본점소재지&cr;</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<SPAN>불참</SPAN>
</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020-11</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020.09.25</TD>
<TD WIDTH="225" HEIGHT="55">산업운용자금 대출20억 대환의 건</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<SPAN>불참</SPAN>
</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020-12</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020.10.05</TD>
<TD WIDTH="225" HEIGHT="55">무상증자의 건 (준비금의 자본전입)</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<SPAN>불참</SPAN>
</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020-13</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">2020.10.06</TD>
<TD WIDTH="225" HEIGHT="55">바이오메드 운영자금25억원 연대보증의 건</TD>
<TD WIDTH="49" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">가결</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>
<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">찬성</TD>

<TD WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55">
<SPAN>불참</SPAN>
</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="55"></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">&cr;다. 이사회내 위원회&cr;당사는 이사회 내에 위원회를 두고 있지 않습니다. </P>
<P USERMARK="F-GL11">&cr;라. 이사의 독립성&cr;</P>
<P USERMARK="F-GL11">1) 이사의 선임</P>
<P USERMARK="F-GL11">당사는 사외이사를 포함한 이사의 선임에 있어서 관련 법령에서 요구하는 자격요건의 충족 여부를 확인하고 있습니다. 법령 상 자격요건 준수 외에 이사 선임에 관한 독립성 기준을 별도로 운영하고 있지는 않으나, 이사의 독립성 강화를 위해 이사선임시주주총회소집공고에 최대주주 또는 주요주주와의 관계 등 이사에 대한 모든 정보를 투명하게 공개하고 주주총회에서 최종적으로 선임하고 있습니다. 이러한 절차에 따라 선임된 이사는 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="1126" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="416"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직명</TH>
<TH WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임기</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연임여부&cr;(횟수)</TH>
<TH WIDTH="425" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">선임배경</TH>
<TH WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추천인</TH>
<TH WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">활동분야</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사와의&cr; 거래</TH>
<TH WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최대주주 또는&cr;주요주주와의 관계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>사내이사&cr;(대표이사)</P>
</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">김죄진</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">2018.03.25 ~&cr;2021.03.24</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">연임&cr;(3)</TD>

<TD WIDTH="425" VALIGN="MIDDLE" HEIGHT="122" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">회사의 내부 사정에 정통하며 조직에 대한 이해도가 높아, 이를 바탕으로 내부 임직원들의 통합과 회사의 발전에 필요한 지도력 및 리더십을 갖추고 있으며 회사의 지속적인 성장을 위한기여도가 클 것으로 판단</SPAN>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>이사회</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">경영 총괄</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">당사의 주식 4,430,100 &cr;보유</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">최대주주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">사내이사</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">이시은</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">2018.03.25 ~&cr;2021.03.24</SPAN>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">연임&cr;(2)</SPAN>
</TD>

<TD WIDTH="425" VALIGN="MIDDLE" HEIGHT="99">
<SPAN></SPAN>
<SPAN>의약품 영업에 관한 폭넓은 경험과 지식을 바탕으로 시장에 대한 이해도가 높으므로 시장에서 당사의 정확한 포지셔닝 전략을 수립하여 회사에 기여할 것으로 판단</SPAN>
</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">이사회</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">영업 총괄</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<SPAN USERMARK=" BC0X31FFFF">당사의 주식 33,660주 &cr;보유</SPAN>
</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">기타비상무이사</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">박준형</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">2018.03.25 ~&cr;2021.03.24</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">연임&cr;(3)</TD>

<TD WIDTH="425" VALIGN="MIDDLE" HEIGHT="122">
<SPAN></SPAN>
<SPAN>의약품 관련 학업과 약국 경영 경험을 통하여 우수한 제품 개발에 중요한 역할을 할 것으로 기대되고, 제네릭의약품만이 아닌 바이오의약품에 대한 지식과 경험으로 당사 바이오의약품 시장 진출에도 기여할 것으로 판단</SPAN>
</TD>

<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>이사회</P>
</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">제품개발</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<SPAN USERMARK=" BC0X31FFFF">당사의 주식 </SPAN>
<SPAN USERMARK=" BC0X31FFFF">646,730주 &cr;보유</SPAN>
</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">기타비상무이사</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">송현순</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">2018.06.19 ~&cr;2021.06.18</SPAN>
</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">해당 없음</TD>
<TD WIDTH="425" VALIGN="MIDDLE" HEIGHT="99">의약품 관련 학업과 약국 경영 경험을 통하여 우수한 제품 개발에 중요한 역할을 할 것으로 기대되고, 제네릭의약품만이 아닌 바이오의약품에 대한 지식과 경험으로 당사 바이오의약품 시장 진출에도 기여할 것으로 판단</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">이사회</TD>
<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제품개발</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">당사의 주식 93,330주</TD>
<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">2) 사외이사후보추천위원회</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">  당사는 </SPAN>
<SPAN USERMARK="F-GL">사</SPAN>
<SPAN USERMARK="F-GL">업보고서 작성기준일 현재 사외이사후보추천위원회를 별도로 설치하고 있지않  습니다.</SPAN>
</P>
<P USERMARK="F-GL11">&cr;마. 사외이사의 전문성 &cr;</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">1) 사외이사 지원조직 현황&cr;  </SPAN>
<SPAN USERMARK="F-GL">사</SPAN>
<SPAN USERMARK="F-GL">업보고서 작성기준일 현재 당사의 사외이사는 없습니다. </SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>

<P USERMARK="F-GL11">
<SPAN>2) 사외이사 교육실시 현황&cr; </SPAN>
<SPAN>사</SPAN>
<SPAN>업보고서 작성기준일 현재 당사의 사외이사는 없습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">교육일자</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">교육실시주체</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">참석 사외이사</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">불참시 사유</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주요 교육내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">사외이사 및 그 변동현황</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">4</TE>
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『사외이사 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_사외이사_교육_*.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회 위원의 인적사항 및 사외이사 여부』 삽입</COMMENT>
<LIBRARYLIST>11011#*감사위원현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">47_감사위원현황</FILENAME>
<P USERMARK="F-GL11">감사위원 현황</P>

<TABLE-GROUP ACLASS="AUD_HUM" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사&cr;여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">경력</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="291" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">회계ㆍ재무전문가 관련</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당 여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전문가 유형</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관련 경력</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="83" HEIGHT="76" ACODE="AUD_NAME" VALIGN="MIDDLE">최익순</TE>
<TU ALIGN="CENTER" WIDTH="104" HEIGHT="76" AUNIT="AUD_OUT_YN" AUNITVALUE="Y" VALIGN="MIDDLE">예</TU>
<TE ALIGN="CENTER" WIDTH="122" HEIGHT="76" ACODE="AUD_WRK" VALIGN="MIDDLE">-원광대 약학과 졸업(약사)&cr;-약국전문경영</TE>
<TU ALIGN="CENTER" WIDTH="103" HEIGHT="76" AUNIT="AUD_FIN_YN" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
<TE ALIGN="CENTER" WIDTH="103" HEIGHT="76" ACODE="AUD_FIN_TYP" VALIGN="MIDDLE">약사</TE>
<TE ALIGN="CENTER" WIDTH="85" HEIGHT="76" ACODE="AUD_FIN_WRK" VALIGN="MIDDLE"> -</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11">가 . 감사위원회 설치여부&cr;    당사는</SPAN>
<SPAN USERMARK="F-GL11 0X0000FF"> </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 작성기준일 현재 감사위원회를 별도로 설치하고 있지 아니하며, 정    관에 의거 주주총회 결의에 따라 선임된 감사 1명이 감사업무를 수행하고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">나. 감사의 독립성&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">감사는 이사회에 참석하여 독립적으로 이사의 업무를 감독할 수 있으며, 제반 업무  와 관련하여 관련 장부 및 관계 서류를 해당부서에 제출을 요구 할 수 있습니다. 또   한 필요 시 회사로부터 영업에 관한 사항을 보고 받을 수 있으며, 적절한 방법으로    경영정보에 접근할 수 있습니다.</SPAN>
</P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11">&cr;</P>
<P USERMARK="F-GL11">다. 감사의 주요 활동 내역</P>

<TABLE BORDER="1" WIDTH="685" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="49"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="308"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">연도</TH>
<TH WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">회차</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">개최일자</TH>
<TH WIDTH="317" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">의안내용</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">가결여부</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="376" ROWSPAN="11">2020</TD>
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.03.18</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">부패 방지 방침 승인의 건</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.03.05</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">정기 주주총회의 건</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.04.09</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">산업은행 자금대출 10억원 대환의 건</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">4</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.05.11</TD>

<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="53">
<SPAN>임시 주주총회 소집의 건&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN>주식액면분할</SPAN>
<SPAN>, 정관일부변경,유상증자)</SPAN>
<SPAN> </SPAN>
</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.06.24</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">농협대출 여신기한 연기 신청의 건</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">6</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.07.28</TD>

<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="53">
<SPAN>임시 주주총회 소집의 건&cr;</SPAN>
<SPAN></SPAN>
<SPAN>(</SPAN>
<SPAN></SPAN>
<SPAN>정관일부변경)</SPAN>
<SPAN> </SPAN>
</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.13</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">신주발행의 건</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.01</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">제3자배정 유상증자 의 건</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">9</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.21</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">명의개서대리인의 상호 및 본점 소재지 의 건</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.25</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">한국산업은행  20억원 대환의 건</TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.10.05</TD>
<TD WIDTH="317" VALIGN="MIDDLE" HEIGHT="30">무상증자 의 건 </TD>
<TD WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">41_01_감사위원회_교육_실시현황</FILENAME>
<P USERMARK="F-GL11">감사위원회 교육실시 현황</P>

<TABLE-GROUP ACLASS="ADTC_EDU" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">교육일자</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">교육실시주체</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">참석 감사위원</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">불참시 사유</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 교육내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="ADTC_EDU_DT" AUNITVALUE="-">-</TU>
<TE WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADTC_EDU_MA">-</TE>
<TE WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADTC_EDU_ATD">-</TE>
<TE WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADTC_EDU_ABS">-</TE>
<TE WIDTH="125" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADTC_EDU_DTL">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 작성기준일 현재 비상근감사를 선임하고 있으며 향후 감사의 전문능력 향상을 위해 교육 계획을 수립하여 시행할 계획입니다.</SPAN>
</P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">42_01_감사위원회_지원조직_현황</FILENAME>
<P USERMARK="F-GL11">감사위원회 지원조직 현황</P>

<TABLE-GROUP ACLASS="ADTC_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADTC_OGN_NM">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADTC_OGN_CNT">-</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADTC_OGN_PST" ALIGN="CENTER">-</TE>
<TE WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADTC_OGN_DTL">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"> 당사는 사업보고서 작성기준일 현재 해당사항이 없습니다</P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『준법지원인 등 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_준법지원인등_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">43_02_준법지원인등_지원조직_해당사항없음</FILENAME>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>지원조직이 없는 경우에는 그 사실을 기재한다.</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"> 당사는 사업보고서 작성기준일 현재 별도의 감사지원조직은 없습니다.</P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주의 의결권 행사에 관한 사항</TITLE>

<P>
<SPAN USERMARK="F-GL11">가. 집중투표제의 배제여부&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 제출일 현재 집중투표제를 채택하고 있지 않습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">나. 서면투표제 또는 전자투표제의 채택여부&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 제출일 현재 서면투표제 또는 전자투표제를 채택하고 있지 않습니다&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">다. 소수주주권의 행사여부&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 설립이래  </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 제출일 현재까지 소수주주권이 행사된 사실이 없습니다&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11">라.경영권 경쟁 여부&cr;</SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 제출일 현재 공시대상기간 중 경영권과 관련하여 경쟁이 발생한 사실이 없습니</SPAN>
<SPAN USERMARK="F-GL11">다.&cr;</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">최대주주 및 특수관계인의 주식소유 현황</P>
<P USERMARK="F-GL11"></P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="619" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="308" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="618" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="68"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="77" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="88" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="273" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="81" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="77" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김좌진</TE>
<TE ALIGN="CENTER" WIDTH="88" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">본인</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">44,301</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">44.01</TE>
<TE ALIGN="RIGHT" WIDTH="81" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">4,430,100</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">39.57</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="77" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김요섭</TE>
<TE ALIGN="CENTER" WIDTH="88" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">자녀</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">5,779</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">5.74</TE>
<TE ALIGN="RIGHT" WIDTH="81" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">577,900</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">5.16</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="77" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김예린</TE>
<TE ALIGN="CENTER" WIDTH="88" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">자녀</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">5,779</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">5.74</TE>
<TE ALIGN="RIGHT" WIDTH="81" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">581,230</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">5.19</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="77" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김회영</TE>
<TE ALIGN="CENTER" WIDTH="88" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">배우자</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">4,144</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">4.12</TE>
<TE ALIGN="RIGHT" WIDTH="81" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">414,400</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">3.70</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="77" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">기타</TE>
<TE ALIGN="CENTER" WIDTH="88" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">친인척</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="81" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">56,680</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.51</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="165" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="96" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">60,003</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">59.61</TE>
<TE ALIGN="RIGHT" WIDTH="81" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">6,060,310</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">54.13</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="96" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="81" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="55" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">주1) 2020년 5월 24일자 임시주주총회에서 주식 1주의 금액이 5,000원인 주식을 1주의          금액이 500원인 주식 10주로 액면분할 하였는 바, 최대주주 등의 주식수량이 증가하       였고 , 2020년9월25일 제3자배정유상증자 하여 112,842주 증가 하였으며 , 2020년 10      월23일 1주당 9주배정으로 무상증자 10,074,978주 진행하였습니다.&cr;  &cr;</SPAN>
<SPAN USERMARK="F-GL11">나. 최대주주에 관한 사항&cr;    </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">사업보고서 제출일 현재 당사의 최대주주는 김좌진 대표이사이며, 당사 경영을 총괄하     고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11"> &cr;다. 최대주주의 변동을 초래할 수 있는 특정거래&cr;    </SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 제출일 현재 해당사항이 없습니다</SPAN>
<SPAN USERMARK="F-GL11">.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;2. 최대주주 소유주식 변동현황&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">   당사는 </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 제출일 현재 해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>
<P USERMARK="F-GL11">최대주주의 주요경력 및 개요</P>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="52"></COL>
<COL WIDTH="35"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="237"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="61" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="44" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성별</TH>
<TH WIDTH="63" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">출생&cr;년월</TH>
<TH WIDTH="74" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직위</TH>
<TH WIDTH="69" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">등기임원&cr;여부</TH>
<TH WIDTH="55" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상근&cr;여부</TH>
<TH WIDTH="103" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담당&cr;업무</TH>
<TH WIDTH="246" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요 경력</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="61" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">김좌진</TD>
<TD WIDTH="44" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">남</TD>
<TD WIDTH="63" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">1961.07</TD>
<TD WIDTH="74" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">대표이사</TD>
<TD WIDTH="69" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">등기</TD>
<TD WIDTH="55" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">상근</TD>
<TD WIDTH="103" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">경영총괄</TD>

<TD WIDTH="246" HEIGHT="168" VALIGN="MIDDLE">
<SPAN USERMARK=" BC0X31FFFF">원광대학원졸업(박사)/연세대경영대학원수료&cr;</SPAN>
<SPAN>전 (주)베데스다대표이사&cr;전 크레지오팜㈜대표이사&cr;전 ㈜리드팜 부사장&cr;전 ㈜마더스팜 대표이사&cr;현 (주)마더스제약 대표이사</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주가 법인 또는 투자조합 등 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">최대주주의 최대주주(법인 또는 단체)의 개요</P>
<P USERMARK="F-GL11">  당사는 사업보고서 제출일 현재 해당사항이 없습니다.&cr;</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주의 최대주주(최대출자자)가 법인 또는 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주의최대출자자가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『최대주주 변동내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주변동내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">8_최대주주변동내역</FILENAME>

<TABLE-GROUP ACLASS="BSH_CHA" ADELETETABLE="N">
<TITLE ATOC="N">최대주주 변동내역</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="720" BORDER="0">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="410"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="78" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="149" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="74" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="419" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="735" BORDER="1">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">변동일</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">최대주주명</TH>
<TH WIDTH="107" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="79" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="108" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">변동원인</TH>
<TH WIDTH="205" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20120921">2012년 09월 21일</TU>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">김좌진</TE>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">         60,000 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">26.08%</TE>
<TE WIDTH="108" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상증자</TE>
<TE WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">　</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20140407">2014년 04월 07일</TU>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">김좌진</TE>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">       145,400 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">36.35%</TE>
<TE WIDTH="108" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상증자</TE>
<TE WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">　85,400주 유상증자</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSH_DATE" AUNITVALUE="20150817">2015년 08월 17일</TU>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSH_NAME">김좌진</TE>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSH_CNT">       198,182 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSH_RATE">49.55%</TE>
<TE WIDTH="108" VALIGN="MIDDLE" HEIGHT="53" ACODE="BSH_RSN"> 주식양수도 </TE>
<TE WIDTH="205" VALIGN="MIDDLE" HEIGHT="53" ACODE="NOTE">　52,782주 주식양수도</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20160620">2016년 06월 20일</TU>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">김좌진</TE>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">       211,031 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">52.76%</TE>
<TE WIDTH="108" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN"> 주식양수도 </TE>
<TE WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">　12,849주 주식양수도</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20171130">2017년 11월 30일</TU>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">김좌진</TE>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">       177,204 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">44.30%</TE>
<TE WIDTH="108" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">증여</TE>
<TE WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">　33,827주 증여</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20180605">2018년 06월 05일</TU>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">김좌진</TE>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">         44,301 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">44.01%</TE>
<TE WIDTH="108" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">유상감자</TE>
<TE WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">　132,903주 유상감자</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSH_DATE" AUNITVALUE="20200704">2020년 07월 04일</TU>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSH_NAME">김좌진</TE>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSH_CNT">       443,010 </TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSH_RATE">44.01%</TE>
<TE WIDTH="108" VALIGN="MIDDLE" HEIGHT="53" ACODE="BSH_RSN">액면분할</TE>
<TE WIDTH="205" VALIGN="MIDDLE" HEIGHT="53" ACODE="NOTE">　5,000->500원 액면분할</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSH_DATE" AUNITVALUE="20201023">2020년 10월 23일</TU>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_NAME">김좌진</TE>
<TE WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_CNT">    4,430,100</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSH_RATE">39.57%</TE>
<TE WIDTH="108" VALIGN="MIDDLE" HEIGHT="30" ACODE="BSH_RSN">무상증자</TE>
<TE WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ACODE="NOTE">3,987,090주 무상증자</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210" ROWSPAN="7" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">김좌진</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">4,430,100</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">39.57%</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">최익순</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">1,525,600</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">13.63%</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">최소영</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">752,300</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">6.72%</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">김선환</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">670,830</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">5.99%</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">박준형</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">646,730</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">5.78%</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">김예린</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">581,230</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">5.19%</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">김요섭</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">577,900</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">5.16%</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『소액주주현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*소액주주현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">10_소액주주현황</FILENAME>

<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">소액주주현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="601" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="49"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="57"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="171" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="66" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="58" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="58" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SH4_JJ_CNT">313</TE>
<TE WIDTH="58" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SH4_JJ_CNTT">320</TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_RT">97.81</TE>
<TE WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNT">2,009,730</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNTT">1,119,442</TE>
<TE WIDTH="71" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_RT">17.95</TE>
<TE WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">임원 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="931" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="582"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="591" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1183" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="29"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="281"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="38" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="72" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="57" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당&cr;업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="290" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="73" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="96" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="95" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="64" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="168" ACODE="SH5_NM_T" VALIGN="MIDDLE">김좌진</TE>
<TU ALIGN="CENTER" WIDTH="38" HEIGHT="168" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="70" HEIGHT="168" AUNIT="SH5_BIH" AUNITVALUE="196107" VALIGN="MIDDLE">1961.07</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="168" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="72" HEIGHT="168" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="57" HEIGHT="168" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="168" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영총괄</TE>

<TE ALIGN="CENTER" WIDTH="290" HEIGHT="168" ACODE="SH5_SKL" VALIGN="MIDDLE">
<SPAN USERMARK=" BC0X31FFFF">원광대학원졸업(박사)/연세대경영대학원수료&cr;</SPAN>
<SPAN>전 (주)베데스다대표이사&cr;전 크레지오팜㈜대표이사&cr;전 ㈜리드팜 부사장&cr;전 ㈜마더스팜 대표이사&cr;현 (주)마더스제약 대표이사</SPAN>
</TE>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="168" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">4,430,100</TE>
<TE ALIGN="RIGHT" WIDTH="64" HEIGHT="168" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="168" ACODE="SH5_RLTN" VALIGN="MIDDLE">본인</TE>

<TE ALIGN="CENTER" WIDTH="96" HEIGHT="168" ACODE="SH5_PER" VALIGN="MIDDLE">
<SPAN>2011.7.18 ~ 현재</SPAN>
</TE>
<TU ALIGN="CENTER" WIDTH="85" HEIGHT="168" AUNIT="SH5_FIH" AUNITVALUE="20210325" VALIGN="MIDDLE">2021.03.25</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="112" ACODE="SH5_NM_T" VALIGN="MIDDLE">이시은</TE>
<TU ALIGN="CENTER" WIDTH="38" HEIGHT="112" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="70" HEIGHT="112" AUNIT="SH5_BIH" AUNITVALUE="196602" VALIGN="MIDDLE">1966.02</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="112" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="72" HEIGHT="112" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="57" HEIGHT="112" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="112" ACODE="SH5_OBJ" VALIGN="MIDDLE">개발.마케팅</TE>

<TE ALIGN="CENTER" WIDTH="290" HEIGHT="112" ACODE="SH5_SKL" VALIGN="MIDDLE">
<SPAN>전 동양제과 </SPAN>
<SPAN USERMARK=" BC0X31FFFF">품질관리부&cr;</SPAN>
<SPAN>전 동아바이오텍</SPAN>
<SPAN USERMARK=" BC0X31FFFF"> 전</SPAN>
<SPAN USERMARK=" BC0X31FFFF">략</SPAN>
<SPAN>팀,상품기획팀     전 ㈜마더스팜 </SPAN>
<SPAN USERMARK=" BC0X31FFFF">대</SPAN>
<SPAN>표이사 역임&cr;현 (주)마더스제약</SPAN>
</TE>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="112" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">54,660</TE>
<TE ALIGN="RIGHT" WIDTH="64" HEIGHT="112" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="112" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="96" HEIGHT="112" ACODE="SH5_PER" VALIGN="MIDDLE">2015.03.25~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="85" HEIGHT="112" AUNIT="SH5_FIH" AUNITVALUE="20210325" VALIGN="MIDDLE">2021.03.25</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="114" ACODE="SH5_NM_T" VALIGN="MIDDLE">박준형</TE>
<TU ALIGN="CENTER" WIDTH="38" HEIGHT="114" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="70" HEIGHT="114" AUNIT="SH5_BIH" AUNITVALUE="197101" VALIGN="MIDDLE">1971.01</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="114" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="72" HEIGHT="114" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="57" HEIGHT="114" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="114" ACODE="SH5_OBJ" VALIGN="MIDDLE">제품개발</TE>

<TE ALIGN="CENTER" WIDTH="290" HEIGHT="114" ACODE="SH5_SKL" VALIGN="MIDDLE">
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF">원광대학교 약학대학원 졸업(박사)&cr;현,단국대학교 약학대학 외래교수&cr;현, 천안큰사랑약국 경영</SPAN>
<SPAN USERMARK=" BC0X31FFFF">&cr;</SPAN>
<SPAN>현 (주)마더스제약</SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
</TE>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="114" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">646,730</TE>
<TE ALIGN="RIGHT" WIDTH="64" HEIGHT="114" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="114" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="96" HEIGHT="114" ACODE="SH5_PER" VALIGN="MIDDLE">2012.09.06~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="85" HEIGHT="114" AUNIT="SH5_FIH" AUNITVALUE="20210325" VALIGN="MIDDLE">2021.03.25</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="69" HEIGHT="82" ACODE="SH5_NM_T" VALIGN="MIDDLE">송현순</TE>
<TU ALIGN="CENTER" WIDTH="38" HEIGHT="82" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="70" HEIGHT="82" AUNIT="SH5_BIH" AUNITVALUE="197105" VALIGN="MIDDLE">1971.05</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="82" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="72" HEIGHT="82" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="57" HEIGHT="82" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="82" ACODE="SH5_OBJ" VALIGN="MIDDLE">제품 개발</TE>

<TE ALIGN="CENTER" WIDTH="290" HEIGHT="82" ACODE="SH5_SKL" VALIGN="MIDDLE">
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN>우석대학교 약학과졸업(약사)&cr;현, 모범약국 경영&cr;현 (주)마더스제약 </SPAN>
</TE>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="82" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">670,830</TE>
<TE ALIGN="RIGHT" WIDTH="64" HEIGHT="82" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="82" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="96" HEIGHT="82" ACODE="SH5_PER" VALIGN="MIDDLE">2018.06.19~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="85" HEIGHT="82" AUNIT="SH5_FIH" AUNITVALUE="20210619" VALIGN="MIDDLE">2021.06.19</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" WIDTH="69" HEIGHT="77" ACODE="SH5_NM_T" VALIGN="MIDDLE">
<SPAN USERMARK=" BC0X31FFFF">최익순</SPAN>
</TE>
<TU ALIGN="CENTER" WIDTH="38" HEIGHT="77" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="70" HEIGHT="77" AUNIT="SH5_BIH" AUNITVALUE="196609" VALIGN="MIDDLE">1966.09</TU>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="77" ACODE="SH5_LEV" VALIGN="MIDDLE">감사</TE>
<TU ALIGN="CENTER" WIDTH="72" HEIGHT="77" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="57" HEIGHT="77" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="77" ACODE="SH5_OBJ" VALIGN="MIDDLE">-</TE>

<TE ALIGN="CENTER" WIDTH="290" HEIGHT="77" ACODE="SH5_SKL" VALIGN="MIDDLE">
<SPAN USERMARK=" BC0X31FFFF">원광대 약학과 졸업 (약사)&cr;</SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF">현, </SPAN>
<SPAN USERMARK=" BC0X31FFFF">목천약국 경영&cr;</SPAN>
<SPAN USERMARK=" BC0X31FFFF">현 (주)마더스제약 </SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
<SPAN USERMARK=" BC0X31FFFF"></SPAN>
</TE>
<TE ALIGN="CENTER" WIDTH="95" HEIGHT="77" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">1,525,600</TE>
<TE ALIGN="RIGHT" WIDTH="64" HEIGHT="77" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="73" HEIGHT="77" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="96" HEIGHT="77" ACODE="SH5_PER" VALIGN="MIDDLE">2011.7.18~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="85" HEIGHT="77" AUNIT="SH5_FIH" AUNITVALUE="20210323" VALIGN="MIDDLE">2021.03.23</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『등기임원후보자 및 해임대상자』 삽입</COMMENT>
<LIBRARYLIST>11011#*등기임원후보자및해임대상자.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">직원 등 현황</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="854" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="496" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="854" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="33"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="37"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="25"></COL>
<COL WIDTH="62"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="681" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외&cr;근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="42" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="296" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="70" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균&cr;근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여&cr;총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="87" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균&cr;급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="34" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="116" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이&cr;없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제&cr;근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="54" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="62" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="46" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">공통</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="54" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">76</TE>
<TE ALIGN="RIGHT" WIDTH="62" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="46" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">76</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">3.5</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">3,128,335,531</TE>
<TE ALIGN="RIGHT" WIDTH="87" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">41,162,309</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="34" HEIGHT="90" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">공통</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="54" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">61</TE>
<TE ALIGN="RIGHT" WIDTH="62" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="46" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">61</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">3.4</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">2,282,734,122</TE>
<TE ALIGN="RIGHT" WIDTH="87" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">37,421,870</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="54" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">137</TE>
<TE ALIGN="RIGHT" WIDTH="62" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="46" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="74" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">137</TE>
<TE ALIGN="RIGHT" WIDTH="70" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">3.45</TE>
<TE ALIGN="RIGHT" WIDTH="107" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">5,411,069,653</TE>
<TE ALIGN="RIGHT" WIDTH="87" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">78,584,179</TE>
<TE ALIGN="CENTER" WIDTH="71" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 직원 현황 표는 미등기임원을 포함하여 작성한다</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11">   주1) 연간급여 총액은 2020년 12월 상시근로자의  총액 급여 입니다  &cr;   주2) 성별 및 기간의 정함이 없는 근로자수는 2020년 12월기준 상시근로자수 인원         입니다</P>
<P USERMARK="F-GL11">미등기임원 보수 현황</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="787" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="429" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="786" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_CNT">7</TE>
<TE WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">666,896,082</TE>
<TE WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">95,270,869</TE>
<TE WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"> 주) 2020년 급여 지급총액 금액 입니다</P>
<P USERMARK="F-GL11"></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">1. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">등기이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_NUM">4</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">1,300,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감     사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">500,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11">주) 2020.03.23 주주총회에서 승인된 금액입니다&cr;</P>
<P USERMARK="F-GL11">2. 보수지급금액</P>
<P USERMARK="F-GL11">2-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_NUM">5</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_SUM">604,566</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_VIC">120,913</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11"> 주1) 보수총액은 2020년 연본 지급총액 입니다&cr; 주2) 1인 평균 보수액은  보수총액을</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11"> 사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 제출 현재 인원수로 나누어  산출         한 단순평균 금액입니다&cr;</SPAN>
</P>
<P USERMARK="F-GL11">2-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당&cr;평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사&cr;(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_NUM">2</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_SUM">604,566</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_VIC">120,913</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사&cr;(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="AUD_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="AUD_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="AUD_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">  </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 이사 및 감사의 개인별 보수 지급액이 5억원 이상에 해당하는 자가 없습니다&cr;</SPAN>
</P>
<P USERMARK="F-GL11">2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 :원  )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203"></TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권&cr; 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 이사 및 감사의 개인별 보수 지급액이 5억원 이상에 해당하는 자가 없습니다&cr;</SPAN>
</P>
<P USERMARK="F-GL11">2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203"></TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권&cr; 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『주식매수선택권의 부여 및 행사현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*주식매수선택권의부여및행사현황.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL11">사업보고서 제출일 현재 임원에 대한 주식매수선택권부 내역은 없습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『타법인출자 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*타법인출자현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">1. 타법인출자 현황</P>

<P>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 제출일 현재 타법인출자 현황은 존재하지 않습니다. </SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 이해관계자와의 거래내용</TITLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">1. 대주주 등에 대한 신용공여 등</SPAN>
<SPAN USERMARK="F-GL11"> &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">가. 가지급금, 대여금(증권의 대여 포함) 및 가수금 내역</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE WIDTH="630" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="321"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">(기준일: 2020년12월31일</TD>
<TD WIDTH="330" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="658">

<COLGROUP>
<COL WIDTH="75"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자</TH>
<TH WIDTH="72" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH WIDTH="105" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH WIDTH="397" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중증가액</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중감소액</TH>
<TH WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="84" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">김좌진</TD>
<TD WIDTH="72" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">대주주</TD>
<TD WIDTH="105" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">단기대여금</TD>
<TD WIDTH="96" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">591,971,616</TD>
<TD WIDTH="98" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">17,397,134</TD>
<TD WIDTH="98" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">138,140,000 </TD>
<TD WIDTH="105" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">471,228,750 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">나. 담보제공 내역</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
</P>

<TABLE WIDTH="629" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="320"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">(기준일: 2020년 12월31일</TD>
<TD WIDTH="329" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="841" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="79"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="48"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보제공 &cr;받은 회사</TH>
<TH ROWSPAN="2" WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보제공자산</TH>
<TH ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">설정금액</TH>
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">설정권자</TH>
<TH COLSPAN="2" WIDTH="184" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관련채무의 내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과  목</TH>
<TH WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜마더스팜</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계열회사</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">본사건물(5층)</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">997,034,418 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,200,000,000 </TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="57" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000,000 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11">다. 채무보증 내역</SPAN>
</P>
<P USERMARK="F-GL11"></P>

<TABLE WIDTH="632" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="323"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">(기준일: 2020년12월31일</TD>
<TD WIDTH="332" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1004" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="78"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="52"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">지급보증한&cr; 회사</TH>
<TH ROWSPAN="2" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">제공받은&cr; 회사</TH>
<TH ROWSPAN="2" WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">관계</TH>
<TH ROWSPAN="2" WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">채권자</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">보증&cr;시작일</TH>
<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">보증기한</TH>
<TH COLSPAN="4" WIDTH="379" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">거래내역</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2020</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">기초</TH>
<TH WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">증가</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">감소</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">기말</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">채무보증한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="87" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="159">마더스&cr;제약(주)</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">(주)마더스&cr;바이오메드</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계열회사</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">산업은행</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.10.31</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.10.30</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,000,000,000</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">500,000,000</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,500,000,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">㈜마더스팜</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계열회사</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기업은행</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2017.09.26</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2025.09.25</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">264,000,000</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">264,000,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">316,800,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">㈜마더스팜</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">계열회사</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">서울보증보험</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020.03.31</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022.08.28</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">367,400,000</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53"></TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">337,400,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">337,400,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="6" WIDTH="508" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLALL">3,631,400,000</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLALL">0</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">500,000,000</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLALL">3,101,400,000</TD>
<TD WIDTH="117" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLALL">3,654,200,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">&cr;2. 대주주와의 자산양수도 등&cr;당사는</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"> 사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 작성기준일 현재 해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;3. 대주주와의 영업거래</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는 </SPAN>
<SPAN USERMARK="F-GL11">사업보고서 작성기준일 현재 해당사항이 없습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;4. 대주주 이외의 이해관계자와의 거래</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
</P>
<P USERMARK="F-GL11">가. 특수관계자 현황</P>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="240"></COL>
<COL WIDTH="183"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관        계</TH>
<TH WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비    고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">기타 특수관계자</TD>
<TD WIDTH="249" ALIGN="CENTER" HEIGHT="30">㈜마더스팜</TD>
<TD WIDTH="192" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" ALIGN="CENTER" HEIGHT="30">㈜마더스바이오메드(*)</TD>
<TD WIDTH="192" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="249" ALIGN="CENTER" HEIGHT="30">㈜마더스코스메틱</TD>
<TD WIDTH="192" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">(*)당반기 중 상호를 더마텍코리아(주)에서 (주)마더스바이오메드로 변경하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">나. 특수관계자와의 중요한 영업상의 거래내용은 다음과 같습니다.</SPAN>
</P>

<TABLE WIDTH="629" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="320"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">(기준일: 2020년12월31일</TD>
<TD WIDTH="329" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="671" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자(회사명)</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타수익</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타비용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">㈜마더스팜</TD>
<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">기타특수관계자</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">1,840,433,169 </TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">9,288,678 </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">54,545,460 </TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">150,707,358 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">㈜마더스바이오메드</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">1,456,895,148 </TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">65,454,546 </TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">㈜마더스코스메틱</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">54,545,460 </TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">58,293,650 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="30"></TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">3,297,328,317 </TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">9,288,678 </TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">174,545,466 </TD>
<TD WIDTH="96" ALIGN="RIGHT" HEIGHT="30">209,001,008 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">다. 특수관계자와의 매출채권ㆍ매입채무의 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE WIDTH="629" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="320"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">(기준일: 2020년12월31일</TD>
<TD WIDTH="329" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="185"></COL>
<COL WIDTH="184"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출채권 </TH>
<TH WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">㈜마더스팜</TD>
<TD ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">기타&cr;특수관계자</TD>
<TD WIDTH="194" ALIGN="RIGHT" HEIGHT="30">504,154,790 </TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">11,051,746 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">㈜마더스바이오메드</TD>
<TD WIDTH="194" ALIGN="RIGHT" HEIGHT="30">47,626,119 </TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="30"></TD>
<TD WIDTH="194" ALIGN="RIGHT" HEIGHT="30">551,780,909</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">11,051,746</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 특수관계자와의 중요한 기타채권ㆍ채무의 내용은 다음과 같습니다.</P>

<TABLE WIDTH="636" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="327"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30">(기준일: 2020년12월31일</TD>
<TD WIDTH="336" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="638" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미수금</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임대보증금</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미지급금금</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타보증금</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">㈜마더스팜</TD>
<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">기타&cr;특수관계자</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">100,000,000 </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">14,868,918 </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">50,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">㈜마더스바이오메드</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">45,000,000 </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">㈜마더스코스메틱</TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">30,000,000 </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">275,520 </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="93" ALIGN="CENTER" HEIGHT="30"></TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">175,000,000 </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">15,144,438 </TD>
<TD WIDTH="100" ALIGN="RIGHT" HEIGHT="30">50,000,000 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK="F-GL11 0X000000"></SPAN>
</P>
<P USERMARK="F-GL11">2) 특수관계자 차입금에 대한 내용</P>

<TABLE WIDTH="631" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="322"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="300" HEIGHT="30">
<SPAN>(기준일: </SPAN>사업보고서 작성기준일)
</TD>
<TD WIDTH="331" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  (단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="765" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자</TH>
<TH ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관계</TH>
<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과   목</TH>
<TH COLSPAN="4" WIDTH="446" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중증가액</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기중감소액</TH>
<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">㈜마더스바이오메드</TD>
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기타특수관계자</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">단기차입금</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,500,000,000</TD>
<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,000,000,000-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">1,500,000,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>
<P USERMARK="F-GL11">견질 또는 담보용 어음ㆍ수표 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(기준일 : 2020.12.31)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(단위 :원 )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 출 처</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">은 행</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">금융기관(은행제외)</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">법 인</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">기타(개인)</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">  </SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">당사는</SPAN>
<SPAN USERMARK="F-GL11"> </SPAN>
<SPAN USERMARK="F-GL11">사</SPAN>
<SPAN USERMARK="F-GL11">업보고서 제출일 현재 해당사항이 없습니다.</SPAN>
</P>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『신용보강 제공 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*신용보강제공현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『장래매출채권 유동화 현황 및 채무비중』 삽입</COMMENT>
<LIBRARYLIST>11011#*장래매출채권유동화현황및채무비중.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『단기매매차익 미환수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*단기매매차익미환수현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『공모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*공모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">18_공모자금의사용내역</FILENAME>
<P USERMARK="F-GL11">공모자금의 사용내역</P>

<TABLE-GROUP ACLASS="FUND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="641" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="341" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="777" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="77"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="86" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="132" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="187" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증권신고서 등의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="190" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="102" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="86" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정유상증자</TE>
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="132" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200925">2020년 09월 25일</TU>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">시설자금</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">3,000,000</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">익산공장건설자금</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">1,975,000</TE>
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">2021년9월 완공예정 , 투입진행중</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="86" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정유상증자</TE>
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="132" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200925">2020년 09월 25일</TU>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">연구자금</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">2,500,000</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">임상.기계설비</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">1,990,000</TE>
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">2021년도 연구자금 투입예정</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="86" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정유상증자</TE>
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="132" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200925">2020년 09월 25일</TU>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">채무상환자금</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">2,000,000</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">바이오메드</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">2,000,000</TE>
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">완  료</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="86" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">제3자배정유상증자</TE>
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="132" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200925">2020년 09월 25일</TU>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">운영자금</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">963,150</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">법인세납부등</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">963,150</TE>
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">완  료</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="86" HEIGHT="30" ACODE="PO_TYPE" VALIGN="MIDDLE">계</TE>
<TE ALIGN="CENTER" WIDTH="53" HEIGHT="30" ACODE="MO_SEQ" VALIGN="MIDDLE">-</TE>
<TU ALIGN="CENTER" WIDTH="132" HEIGHT="30" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="-">-</TU>
<TE ALIGN="RIGHT" WIDTH="102" HEIGHT="30" ACODE="PLA_USE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="PLA_AMT" VALIGN="MIDDLE">8,463,150</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="BRK_CON" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="112" HEIGHT="30" ACODE="BRK_AMT" VALIGN="MIDDLE">6,928,150</TE>
<TE ALIGN="CENTER" WIDTH="129" HEIGHT="30" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL11">  미 사용금액 1,535,000천원입니다</P>
</LIBRARY>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『사모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*사모자금의사용내역.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『미사용자금의 운용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*미사용자금의운용내역.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">외국지주회사의 자회사 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="700" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(기준일 : )</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="400" HEIGHT="30">(단위 : )</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="701" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="143" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">A지주회사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">B법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">C법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">D법인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">...</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연결조정</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연결 후&cr;금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  내부 매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  순 매출액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">영업손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">계속사업손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">당기순손익</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자산총액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  현금및현금성자산</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  유동자산</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">  단기금융상품</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">부채총액</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자기자본</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">자본금</TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">(     )</TD>
<TD ALIGN="RIGHT" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">감사인</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">감사ㆍ검토 의견</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">비  고</TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="80" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD ALIGN="CENTER" WIDTH="79" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『합병등 전후의 재무사항 비교표』 삽입</COMMENT>
<LIBRARYLIST>11011#*합병등전후의재무사항비교표.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『보호예수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*보호예수현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『특례상장기업 관리종목 지정유예 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*특례상장기업관리종목지정유예현황.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P USERMARK="F-GL11"> -해당사항 없습니다.</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P USERMARK="F-GL11">-해당사항 없습니다.</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>